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GabR is a member of the MocR/GabR subfamily of the GntR family of bacterial 
transcription regulators. It regulates the metabolism of γ-aminobutyric acid (GABA), an 
important nitrogen and carbon source for many bacteria. The crystal structures reported 
here confirmed that this protein has evolved from the fusion of a type I aminotransferase 
and a winged helix-turn-helix (wHTH) DNA binding protein to form a chimeric protein 
that adopts a dimeric head-to-tail configuration. The pyridoxal 5′-phosphate (PLP)–
binding regulatory domain of GabR is therefore an example of a coenzyme playing a role 
in transcription regulation rather than in enzymatic catalysis. Our structural and 
biochemical studies have laid solid the mechanistic foundation for understanding the 
regulatory functions and mechanism of the MocR/GabR subfamily of transcription 
regulators.   
GabR is also an intriguing case of molecular evolution, displaying the 
evolutionary lineage between aminotransferase and a resulted regulation domain of a 
transcription regulator.  PLP’s native function is not a catalytic co-enzyme but an effector 
of transcription regulation.  The stable chemical species of GabR-PLP-GABA 
responsible for GabR-mediated transcription activation, has been revealed mechanistic 
crystallography, NMR spectroscopy and biological assays using both GABA and a 
 xix 
GABA analog (S)-4-Amino-5-Fluoropentanoic Acid (AFPA) as a molecular probe.  Our 
studies provide critical structural and chemical insights for a currently understudied 
subfamily of bacterial transcription regulators, MocR/GabR-type regulators in the GntR 
family.  
In parallel, I also worked on several other projects. Herein, I dedicated 2 full 
chapters to demonstrate the progress on the Sucrose Synthase project. We obtained 
biochemical and structural evidence of sucrose metabolism in non-photosynthetic 
bacteria. Until now, only sucrose synthases from photosynthetic organisms have been 
characterized. Here, we provide the crystal structure of the sucrose synthase from the 
chemolithoautotroph Nitrosomonas europaea. This supported that the enzyme functions 
with an open/close induced fit mechanism. It prefers as substrate adenine-based 
nucleotides rather than uredine-based like the eukaryotic counterparts, implying there is a 
strong connection between sucrose and glycogen metabolism in these bacteria. 
Mutagenesis data showed that the catalytic mechanism must be conserved not only in 











Research Aims: Potential Anti-Virulence Target for Secondary Infections of Cystic 
Fibrosis (CF) 
Cystic Fibrosis is a life-threatening genetic disorder that causes thick, sticky 
mucus to build up in the lungs, digestive tract, and other areas of the body. It is one of the 
most common chronic lung diseases among children and young adults. In Caucasian 
populations, the carrier frequency for Cystic Fibrosis is approximately one in twenty-five, 
with a prevalence of about 1 in 2000 1. Nearly 1,000 CF diagnoses are reported annually, 
and the disease caused 3,708 deaths in the United States from 1999-2006.  As of 2007, 
the medial survival age was 37.4 years, compared to a U.S. life expectancy of 70.7 years 
in the same year.  
The local environment of the cystic fibrosis lung is unique and results in 
characteristic disease patterns and specific spectrum of cystic fibrosis associated lung 
pathogens 1. Susceptibility to Staphylococcus aureus, Pseudomonas aeruginosa and other 
bacterial infections is significantly higher in patients with CF, as the lungs become 
largely ineffective at ridding the body of microbes when mucus build-up begins. Thus, a 
large number of deaths from CF are attributed to bacterial secondary infections that lead 
to lung disease in patients. With CF affecting 70,000 people across the world, and the 
bacteria's high resistance of a wide range of antibacterial agents, the novel antibiotic 




development becomes urgent for the treatment of bacterial infections and for an improved 
life quality of CF patients. 
The Burkholderia cepacia Complex (Bcc) is a subset of at least nine opportunistic 
pathogens that belong to the gram-negative Burkholderia genus associated with 
infections in CF patients. In efforts to develop more effective CF treatments, this 
complex is of particular interest in antibiotic development because of the well-
documented multi-drug resistance of bacterial strains and the capability of patient-to-
patient spread. Burkholderia cenocepacia and Burkholderia multivorans are two 
members of the Bcc responsible for a majority of the infections seen in CF patients, and 
they have been reported in both clinical and environmental settings (soil and water) as 
sources of infection.  
These two strains are related to Bacillus subtilis by their metabolism of γ-amino 
butyric acid (GABA) to produce glutamate, which is an important metabolite in bacterial 
nitrogen metabolism. Similarity existing between B. subtilis and Bcc strains in their 
glutamate production mechanisms makes B. subtilis an ideal, non-pathogenic model 
organism for our study on the inhibition/modulation of GABA/glutamate metabolism in 
B. cenocepacia and B. multivorans for therapeutically purposes. It also has been recently 
discovered that GABA is an essential cell-to-cell signal in eukaryotes. It acts as a single 
signal between eukaryotes and pathogenic bacterial. GABA production has been revealed 
to be crucial to bacterial stress response, especially acid resistance. All of which make the 
metabolism of GABA in bacteria a potential target for the development of a strategy to 





subtillis that represses the transcription of the gabR gene while also initiating the 
transcription of the gabT and gabD genes, which are key enzymes in glutamate 
biosynthesis utilizing GABA while responding to the increase of GABA’s concentration 
in vivo.  
The Transcription and the Transcription Factor 
As the first step of gene expression, transcription is a fundamental process that is 
often highly conserved and tightly regulated process in bacteria. Bacteria cells rely on 
very sophisticated responses to adapt to micro environmental changes, due to the 
frequently changing habitats conditions. Though transcription regulation, these responses 
most frequently lead to the activation and/or repression of a specific sets of genes to 
control metabolic pathway and adapt to the different environmental condition 2. 
Transcription is the process of synthesis of mRNA by using a single strand of 
DNA as a template; the process is performed by structurally conserved DNA-dependent 
RNA polymerase (RNAPs) 3. Transcription is tightly controlled by the transcription 
factors (TFs), which are the proteins that bind to specific sequence on the DNA near their 
target genes, thereby modulating the transcription initiation. TFs perform this function 
alone or with other proteins in a complex (homoprotein), by promoting (as an activator), 
or blocking (as a repressor) the recruitment of RNA polymerase to the promoter regions 
of specific genes.  
Based on contemporary X-ray crystallography and advanced computational 
simulation, TFs mostly revealed as the dimerization motif, both heterodimer and homo-





formation of an enlarged interaction surface, compared to the monomer. The enlarged 
surface area of the dimer provides increased potential for various protein-protein or 
protein-DNA interactions essential to transcription. Comparing to a monomer, TFs that 
dimerize can achieve a higher DNA binding affinity and specificity and twice as many 
base pairs can be recognized providing distinct DNA-binding specificities 4. 
Taking advantage of the intense and ongoing computationally studies, molecular 
and biophysical studies over the past decade, scientists have generated an unprecedented 
amount of information describing the location of the binding site/s, described in 
Parallelism Weight Matrix (PWM) and further deduced from aligning a set of DNA 
sequence that are experimentally known, for the transcription regulators 5. However the 
understanding of the binding mechanism is still very preliminary. The major challenge 
for our work is to be able to bridge this gap between the molecular description and the 
genome-scale overview.   
GntR family and the subfamily classification 
In 1990, Haydon and Guest first identified and described GntR family of bacterial 
transcription regulators, named after the first member identified, the B. subtilis 
transcription regulator - GntR - repressor of the gluconate operon 6. Among all the 
bacterial transcription regulators, GntR is known as one of the most abundant and widely 
distributed groups of Helix-Turn-Helix (HTH) transcription factors. To date, the 
metabolite-response GntR family has approximately 8,561 regulatory proteins in Pfam 
database (PfaM family GntR: PF00392)7, which spread out among 764 bacteria taxa. 





that they control, which in many cases allows insight into the metabolites that they bind 
to as effectors. There are also many cases where GntR-like regulators are not located 
close to the gene it regulates but elsewhere. One of the well-studied examples in this 
transcription regulator family is orphan regulator FadR/GntR, the fatty acid metabolism 
regulator in Escherichia coli. These studies have intensively focused on both the 
structural and functional aspects, serving as a critical reference case for our research.  
A striking characteristic feature of the GntR family is that the members possess a 
highly conserved N-terminal DNA-binding domain (DBD), which evolved in DNA 
binding, and an extensive diverse and heterogeneity C-terminal effector binding and / or 
oligomerization domain (Eb/O). It was hypothesized that binding of the effector 
molecules could trigger the conformational changes in the protein, which modulates the 
DNA-binding properties of the regulator resulting in either activation or repression of 
transcription. It is not surprising, though, that there are a large number of effector 
molecules that have not been identified, given the diversity of molecule that they bind 
and relative large number of the GunR-family members itself.  
The HTH DNA binding motif in this GntR family is the traditional tri-helical 
domain, whose original case demonstrated the critical role in DNA binding within the 
bacteirophage Lambda protein, cI and cro and the lac operon repressor, LacI and the 
generation of cell-type specific gene expression 8. The there-helical HTH domain is 
known as the winged-helix-turn-helix domain. In addition to the core three-helix bundle, 
it also contains a wing form by C-terminal beta-hairpin. In some versions of this domain, 





feature provides great interactions with the DNA due to the third alpha helix, which can 
fit well within the major groove of the DNA. This was suggested by the extensive 
sequence analysis and secondary structural analysis throughout 1980s and 1990s 7. It is 
being proposed that these domains descend from a common ancestor. 
Since the physiological role of these regulators critically depend upon the effector 
binding to the operon site of the DNA, therefore analysis based on the alignment of the C 
terminus and secondary structural predications were used to classify the members of the 
GntR family. The distinct structural topologies reveal seven major subfamilies: FadR, 
HutC, MocR, YtrA, and three minor subfamily AraR, DevA, and PlmA (Figure1) 10.  
The most abundant GntR sub-family, FadR subfamily, named after the fatty acid 
biosynthesis and degradation regulator, functions as a switch that coordinately regulates 
the machinery required for fatty acid beta-oxidation and the expression of a key enzyme 
in fatty acid biosynthesis. It contains the majority of the GntR-like regulators, 
approximately 40 %. The protein in this subfamily contains six or seven-helical C-
terminal domain, with the average length of 150-170 amino acid. The crystal structure is 
available for FadR of Escherichia coli (Figure2; PDB ID: 1EX1)11.      
The HTH domain is fused to a seven alpha helical bundle, which contains a large 
internal cavity required for binding its regulator molecule. The RMSD on the alpha 
carbons is 0.717 Å between the bound and unbound of the acyl CoA indicated the protein 
backbone undergoes conformational shift upon binding to the acyl CoA-its own 
regulator, further resulting in 7.2 Å movement of the DNA recognition helix preventing 







Figure 1. Unrooted tree of the proteins of GntR family regulators of M. smegmatis 
including representatives of all subfamily regulator from different Baterial Genomes with 
1000 bootstrap replicates. All the GntR regulators are clustered into six subfamilies. 











Figure 2. Quaternary structure of FadR and its corresponding DNA. 
 
The second proposed subfamily is the HutC subfamily, named after the histidine 
utilization operon regulator, comprising about 31 % of the GntR regulators. The C-
terminal regulatory domain of HutC response to various of the ligands, such as: histidine 
12; long chain fatty acids 13; trehaylose 6-phosphate or alkylphosphonate 14, which makes 
it not so surprising to find out that this subfamily regulate processes as diverse as amino 
acid uptake and plasmid transfer. The structure of HutC subfamily contains both alpha-
helical and beta-sheet on C-terminal domain and averages 170 amino acids in length; 
Three dimensional crystal structural and analysis of the HutC family member, PhnF from 
E. coli shows that the C-terminal domain had a chorismate lyase-like fold, comprising a 
six-stranded antiparallel beta-sheets, a two-stranded parallel beta-sheets and four short 
alpha-helices (Figure3; PDB ID: 2WV0). A large cavity on the surface of the PhnF C 
terminus indicates the putative effector molecule-binding pocket, which suggested to be  







                        Figure 3. Quaternary structure of PhnF. 
The YtrA sub-family represents only 6 % GntR-like regulators to date, among 
which forms part of operons involved in ATP-binding cassette (ABC) transport system. 
This sub-family contains the shortest C-terminal domain with about 50 amino acids on 
average (Figure 4), increasing certain extents of doubts regarding the efficiency for 
binding of the effecter molecule(/s). People hypothesizes that the binding of the small 
molecules may impair the dimerization of this particular family of the transcription 
regulators, which could cause the loss of DNA binding, thus further repress the 
transcription. Combining with the sequence comparison and the secondary structural 
predication, it was suggested that dimerization is quite necessary for this subfamily and 
could be formed by positively 






or negatively charged as well as hydrophobic and aromatic residues16. This hypothesis 
soon proved by the X-ray structure of CFL2947 from Corynebacterium glutamicum 
(Figure 4; PDB ID: 2EK5)17. 
The DevA sub family of GntR transcription regulators has only be found in 
bacterium Streptomyces 18. It showed that DevA is required for proper developments in S. 
coelicolor, although the exact roles of these proteins have not been highly elucidated. The 
C-terminal domain topology is clearly novel comparing to the others subfamilies. The N-
terminal domain shares the most similarity with the HutC sub family 18. Since there are 
no crystal structures available in this subfamily, the structure-function relationship 
remains unclear.  
AraR is another minor subfamily, which required for the extracellular degradation 
of arabinose-containing polysaccharides, transport of arabinose, arabinose oligomers, 
xylose, and galactose, intracellular degradation of arabinose oligomers, and further 
catabolism of this sugar in B. subtilis 19. The C-terminal domain shows extensive 
homology to the LacI/ GaIR regulator family. The crystal structure of the AraR (Figure 5; 
PDB ID: 4EGY) demonstrated a high-level repression by co-ordinarily binding two-in-
phase 20, which might correlate with different physiological requirements. The high level 
of repression is achieved by DNA bending requiring two in-phrase, whereas binding to a 





Figure 5. Quaternary structure of DNA binding domain from AraR and its corresponding 
DNA fragment. 
 
PlmA subfamiy, the most newly discovered minor subfamily in 2003 that found 
in cyanobacterial Anabaena sp. Strain PCC7120. It has been demonstrated that plmA can 
affect on a cell’s ability to maintain its relative plasmid content. However, regulation 
mechanism of PlmA remains unclear 22. Structurae wise, PlmA also has a novel topology 
on the C-terminal domain, and appears to confine to the Cyanobacateria. The N-terminal 
DNA binding domain appear to be closely similar to the MocR and YtrA subfamilies 
suggesting that the E-b/O domain of PlmA may have been divergently replaced during 
the evolution, despite their similarity in the DNA binding domain.  
The MocR subfamily’s C-terminal domain is readily distinguishable from others 
because of its exceptional average length of about 350 amino acids. It is also capable of 
binding to a vitamin B6 derivitive-PLP. The PLP-binding putative aminotransferase 
domains are closely related by amino acid sequence to the homodimeric type-I 
aminotransferases. Aminotransferases are of the central importance in amino acid 
metabolism and in links to carbohydrate and fat metabolism. Type-I aminotransferases 
almost excusively exist as dimers in a head-to-tail fashion, and each subunit binds to one 





conserved lysine residue in the PLP binding site. This characteristic feature suggests that 
the recruitment of such a domain in transcription regulation is likely to facilitate protein-
protein interaction/oligermerization.  
MocR/GabR                                   
 The representative member of the MocR/GabR subfamily, GabR, is essential for 
transcriptional activation of the pathway that controls the GABA degradation 23. GABA 
is an important nitrogen and carbon source in many bacteria. The GABA-inducible 
gabTD pathway in B. subtilis allows utilization of extracellular GABA as the sole 
nitrogen source to generate glutamate and succinate. The gabR gene in B. subtilis is 
located upstream of the gabTD operon and is transcribed divergently. GabR functions as 
the PLP- and GABA-dependent transcriptional activator of the gabTD operon and as a 
negative autoregulator 3(Figure 6). Mutations in the conserved residues  
 
Figure 6. Schematic of GabR binding sites at the gabR and gabTD promoters. A 
schematic of the gabR and gabTD gene loci, as previously elucidated (2), is shown here. 
The 47-bp GabR binding site (−63 to −17) within the gabR−gabT regulatory region is 
shown in detail, and the two direct repeats (ATACCA) are indicated. The arrows indicate 






of the putative aminotransferase domain presumed to be crucial for the folding of the 
domain and PLP-binding abolished the ability of GabR to activate the gabT promoter in 
vivo but did not affect its activity as an autorepressor 23. Therefore, while the ability to 
bind DNA may be sufficient for its autorepressor function, GabR is competent to activate 
transcription from the gabT promoter only in the presence of PLP and GABA. 
The gabT and gabD genes encode the two key enzymes for glutamate 
biosynthesis: GABA aminotransferase (GabT) and succinic semialdehyde dehydrogenase 
(SSDH or GabD), respectively. GabT is a type-I aminotransferase that catalyzes the Ping-
Pong transamination reaction using GABA as amino group donor, α-ketoglutarate as 
amino group acceptor and PLP as co-enzyme to form the products, succinic 
semialdehyde and glutamate 24.  During the first half-reaction, GABA donates its amino 
group to PLP, thereby releasing succinic semialdehyde and converting PLP to its 
pyridoxamine 5’-phosphate (PMP) form (Figure 7).  In the second half-reaction, α-
ketoglutarate accepts the amino group to become glutamate and regenerate the PLP form 
of the enzyme (Figure 7). In the downstream reaction, the NAD-dependent 
dehydrogenase, GabD converts succinic semialdehyde (SS) to succinate.  Null mutants of 
gabR, gabT and gabD in B. subtilis were reported to be incapable of using GABA as the 
sole nitrogen source 25, further demonstrating that the functions of GabR, GabT and 













Figure 7. The GabT-catalyzed aminotransferase reaction. The first half reaction (GABA 
to succinic semialdehyde) of the GabT-catalyzed Ping-Pong transamination is shown in 

















CRYSTAL STRUCTURE OF BACILLUS SUBTILIS GABR, AN AUTOREPRESSOR 
AND TRANSCRIPTIONAL ACTIVATOR OF GABT  
Research Significance 
B. subtilis GabR is a transcription factor that regulates gamma-aminobutyric acid 
(GABA) metabolism. GabR is a member of the understudied MocR/GabR subfamily of 
the GntR family of transcription regulators. A typical MocR/GabR-type regulator is 
a chimeric protein containing a short N-terminal winged-helix-turn-helix DNA-binding 
domain and a long C-terminal pyridoxal 5′-phosphate (PLP)-binding putative 
aminotransferase domain. In the presence of PLP and GABA, GabR activates the gabTD 
operon, which allows the bacterium to use GABA as nitrogen and carbon sources. GabR 
binds to its own promoter and represses gabR transcription in the absence of GABA. 
Here, we report two crystal structures of full length GabR from B. subtilis: a 2.7-Å 
structure of GabR with PLP bound and the 2.55-Å apo structure of GabR without PLP. 
The quaternary structure of GabR is a head-to-tail domain-swap homodimer. As 
predicted base on sequence similarity, each monomer comprises two domains: an N-
terminal winged-helix DNA-binding domain and a C-terminal PLP-binding type I 
aminotransferase-like domain. The winged-helix domain contains putative DNA-binding 
residues conserved in other GntR-type regulators. Together with sedimentation velocity 





DNA binding by GabR at the gabR and gabT promoters. The absence of GabR-mediated 
aminotransferase activity in the presence of GABA and PLP, and the presence of an 
active site configuration that is incompatible with stabilization of the GABA external 
aldimine suggest that a GabR aminotransferase-like activity involving GABA and PLP is 
not essential to its primary function as a transcription regulator.  
Introduction  
The MocR/GabR subfamily of chimeric proteins is widespread in bacteria and 
regulates a variety of biological processes. All members of this subfamily are typically 
composed of a 60- to 120-residue N-terminal winged-helix DNA-binding domain 
resembling other bacterial transcriptional regulators from the GntR family, and a large C-
terminal putative aminotransferase domain, averaging 300 aa in size and capable of 
binding to the vitamin B6 coenzyme, pyridoxal 5′-phosphate (PLP) 25. The PLP-binding 
putative aminotransferase domains are closely related by amino acid sequence to 
homodimeric type I aminotransferases 26,27. GABA is an important nitrogen and carbon 
source in many bacteria. The GABA-inducible gabTD pathway in Bacillus subtilis allows 
utilization of extracellular GABA as nitrogen and carbon sources. The gabR gene is 
located upstream of the gabTD operon and is transcribed divergently. GabR functions as 
the PLP- and GABA-dependent transcriptional activator of the gabTD operon and as a 
GABA-independent negative autoregulator (figure 6). 24, 25. Mutations in the conserved 
residues of the putative aminotransferase domain presumed to be crucial for the folding 





promoter in vivo but did not affect its activity as an autorepressor 25.  
The gabT and gabD genes encode two enzymes for an alternative route of 
glutamate biosynthesis using GABA: GABA aminotransferase (GabT) and succinic 
semialdehyde dehydrogenase (GabD), respectively 25. GabT is a type I aminotransferase 
28, 29 that catalyzes the Ping-Pong transamination reaction using GABA as an amino 
group donor, α-ketoglutarate as an amino group acceptor and PLP as coenzyme to form 
the products, succinic semialdehyde (SS) and glutamate. During the first half-reaction, 
GABA donates its amino group to PLP, thereby releasing SS and converting PLP 
to pyridoxamine 5′-phosphate (PMP) (Figure 7). In the second half-reaction, α-
ketoglutarate accepts the amino group became glutamate and regenerates the PLP form of 
the enzyme (Figure 7). In the downstream reaction, the NAD-dependent dehydrogenase, 
GabD converts SS to succinate. Null mutants of gabR, gabT, and gabD in B. subtilis were 
reported to be incapable of using GABA as the sole nitrogen source 25.  
GabR binds specifically to an extended region of DNA that overlaps the −35 and 
−10 elements of the gabT and gabR promoters, respectively 24(Figure 7). Using DNase I 
foot printing experiments and native gel-shift experiments with purified GabR, a 47-bp 
region of DNA (−63 to −17 relative to the gabT transcription start site) was identified as 
the GabR binding site. The 47-bp minimal fragment contains two copies of the direct 
repeat, ATACCA, which may be essential for GabR binding. Addition of PLP and 
GABA did not noticeably alter the DNase I footprints, indicating that GabR is capable of 





was proposed that GabR binds to DNA either as a dimer or tetramer 24. It has been 
reported that a GabR-catalyzed “partial” aminotransferase- like reaction involving GABA 
and PLP may be essential for its transcriptional activator function 24. Interestingly, no 
“full” two-step Ping-Pong–type GABA aminotransferase activity for GabR could be 
detected in vivo, and overexpression of GabR was unable to restore GABA 
aminotransferase activity in strains lacking gabT 24. Here, we report two crystal structures 
of the PLP-bound and PLP-free forms of full-length B. subtilis GabR determined to be 
2.7 and 2.55 Å, respectively. The crystal structure of GabR reveals a two-domain protein 
organized as a distinct head-to-tail domain-swap homodimer. A long linker of 29 aa 
separates the N-terminal winged-helix domain from the C-terminal domain, which has 
the same overall fold as type I aminotransferases and is hereby called AT-fold domain. 
Together with sedimentation velocity and fluorescence polarization data, the GabR 
structure provides a model for DNA binding at the gabR-gabT locus by one or more 
GabR homodimers. Key amino acid sequence changes in the putative substrate-binding 
pocket of GabR relative to those of well-characterized type I aminotransferases suggest 
that a GabR catalytic activity involving GABA and PLP is either absent or very poor 
under physiological conditions. Our results strongly suggest that the AT-fold domain in 
B. subtilis GabR, in a unique combination with the winged-helix domain, is primarily 







GabR is a Head-to-Tail Domain-Swap Homodimer 
Sequence alignments of members of the MocR/GabR subfamily show that these 
proteins comprise a small N-terminal winged-helix domain and a large C-terminal 
putative type I aminotransferase domain 16, 25. The crystal structure of GabR described 
here is 
Figure 8. Quaternary structure of GabR. GabR is a head-to-tail domain-swap homodimer. 
The AT-fold domains are shown in light gray. The long linkers connecting the N-terminal 





winged-helix domains are shown in blue-violet. The HTH motifs (orange) and the wing 
motifs are labeled. An orthogonal view of the structure is shown in Figure 10.  
 
the winged-helix subtype 30 and a C-terminal AT-fold domain (residues 110–470) 
characteristic of the type I aminotransferase family 31, 32 and containing the signature long 
bent α-helix (residues 345–386) connecting two subdomains. A long 29-residue linker 
(residues 81–109) connects the winged-helix domain to the AT-fold domain (Figure 8 and 






Figure 9. Quaternary structure of GabR. The structure is rotated 90° counterclockwise 
along the y axis relative to Figure 8. 
 
GabR crystallizes as a homodimer with the two monomers organized in the head-
to-tail domain-swapped interfaces. The larger interface is composed of two AT-fold 
domains, which are also arranged in a head-to-tail manner to form the characteristic 
homodimeric type I aminotransferase fold. The interface contains a buried area of 1,695 





GabR homodimer and is physiological. This interface of GabR, as seen in all type I 
aminotransferases 31, contains two PLP-binding pockets bound by one molecule of PLP 
in each pocket.  
The second interface is formed between the winged-helix domain of one 
monomer and the AT-fold domain of the other monomer. This interface has a buried area 
of 422 Å2 with a relatively low free energy of −3.8 kcal/mol, suggesting that the overall 
quaternary structure of GabR may be dynamic in solution and that the winged-helix 
domain may undergo large-scale domain movements, especially when bound by DNA. 
The large dimer interface between the two AT-domains further suggests that any such 
domain movements by the winged-helix domain do not require restructuring of the 
AT−AT interface. Interestingly, we note that the extended N-terminal arms of the two 
monomers of aspartate aminotransferase (Asp-AT) also reach over and interact with the 
other subunit in that homodimer 32. Because Asp-AT does not have an N-terminal 
winged-helix domain, the significance of this “crossing over” of the N-terminal arm to 
the other subunit in Asp-AT is not clear. Although there is reasonable electron density for 
the long extended linker that connects the winged-helix domain to the AT-fold domain, 
the linker does not form any significant contacts with the rest of the protein, suggesting 
that it may be flexible in solution and may thereby facilitate the proposed winged-helixed 






Figure 10. Imidazole is bound in the PLP-binding pocket of apo-GabR. The PLP-binding 
site of the crystal structure of apo-GabR is shown. The 2Fo − Fc map (green mesh) 
around the imidazole molecule is shown at 1σ level. The imidazole moiety and 
surrounding side chains are shown as sticks. Carbon atoms are shown in white, oxygen 
atoms in red, and nitrogen atoms in blue. 
 
We also crystallized GabR without exogenous PLP. In the resulting apo-GabR 
structure, PLP is no longer bound in the PLP-binding pocket, and instead, a molecule of 
imidazole is bound in the same pocket (Figure 10). The purified protein is pale yellow in 
color, suggesting that endogenous PLP from Escherichia coli is still bound to GabR 
immediately after purification. Because imidazole is present in high concentrations in the 
purification and crystallization buffers, the replacement of PLP by imidazole is most 





GabR−PLP structures suggests that the AT-fold domain maintains its overall structural 
integrity even when PLP is no longer bound. 
GabR is a Dimer in Solution  
We performed sedimentation velocity analysis to investigate the oligomeric state 
of GabR−PLP in solution. In the absence of GABA, the sedimentation velocity plot 
shows a predominant peak at 100 kDa, suggesting a dimer of GabR in solution even at 
very low protein concentration (Figure 11; GabR molecular weight, 56 kDa). The plot 
also shows two minor peaks at about 50 and 10 kDa, which may represent a small 
proportion of monomer and degradation products, respectively. The sedimentation 
velocity plot of GabR−PLP in the presence of GABA similarly shows a predominant 
peak at 100 kDa and two low–molecular-weight peaks (Figure 11), again indicating a 
dimer of GabR in solution. Also, during protein purification, GabR elutes as one major 
peak on a Superdex 200 gel-filtration column with an apparent molecular weight of a 
dimer (Figure 12). Based on the crystal structure, our expectation is that the AT−AT 
dimer interface in the solution state of GabR may be similar to that found in the crystal 
structure. Our sedimentation velocity data do not reveal tetramers and higher oligomers 
in solution; however, further oligomerization of GabR may still occur when 






Figure 11. Sedimentation velocity analysis of GabR. (A) Molecular weight of the 
GabR−PLP sample determined from the global fitting of sedimentation velocity 







Figure 12. The gel-filtration profile of GabR The major peak for GabR (fractions 7-9) on 
Superdex 200 16/60 corresponds to an apparent molecular weight of a dimer. The minor 
peak (fractions 9-10) corresponds to that for a monomer. 
 
Conserved Putative DNA-Binding Residues in the N-Terminal Winged Helix 
Domain 
The GabR N-terminal domain (residues 3–80) contains a canonical winged-helix 
domain (α1-β1-α2-T-α3-β2-W- β3), where α2-T-α3 (residues 42–66) form the HTH motif 
and W (residues 71–76) is the wing (Figure 13). In the case of GabR, a second wing is 
absent. Although many winged-helix proteins contain a second wing, there are several 
examples of wingedhelix proteins that bind DNA and in which the second wing is absent 
33. X-ray and NMR structures of winged-helix proteins in complex with DNA show that 
the winged-helix domain uses diverse modes of DNA binding, with examples of this 






Figure 13. The GabR N-terminal winged-helix domain. TheThe GabR N-terminal 
winged-helix domain (residues 3–80) is shown in detail. The various secondary structural 
elements (α1-β1-α2-T-α3-β2-W-β3) are labeled. The helix-turn-helix (HTH) motif (α2-T-
α3) is shown in orange. W is the wing (β2-W-β3). 
 
In general, the most basic or positively charged surface of the winged-helix 
domain binds to the negatively charged phosphate backbone or nucleotide side-chain 
groups 33. Because the putative DNA-binding domain is conserved among GntR-type 
transcriptional regulators, we searched the Conserved Domain Database 34 using the 
GabR winged-helix domain sequence as a query. We found several hits, including E. coli 
acyl-CoA–responsive transcription factor, FadR, and identified three putative DNA-
binding residues in GabR (R43, S52, and K75) based on sequence conservation in FadR 





K75 in the wing) also map to the most basic surface on the GabR winged-helix domain 
(Figure 14) and are fully exposed in the GabR homodimer (Figure 15), we predict that 
they may constitute a major DNA-binding surface.  
 
Figure 14. The most basic surface on the GabR winged-helix domain. The electrostatic 
potential surface of the GabR winged-helix domain is shown. The values 
−1.000 and 1.000 on the scale bar represent acidic and basic electrostatic potential 
surface charges, respectively. The orientation corresponds to the wingedhelix domain 
shown on the bottom in Figure 8. The labeled residues denote amino acids that are 







Figure 15. GabR electrostatic surface potential. The electrostatic surface potential 
representation for the GabR homodimer in two different views. The figure on the Left is 
in the same orientation as Figure 9. The dotted circle highlights the most basic surface on 
the winged-helix domain. The figure on the Right is rotated 90° counterclockwise relative 
to the figure on the Left. 
 
To examine the DNA-binding roles of these conserved residues, we generated a 
GabR−DNA model by superimposing the structural coordinates of the GabR winged-
helix domain onto those of the FadR−DNA complex [Protein Data Bank (PDB) ID code 
1H9T 35]. In the FadR−DNA complex (Figure 16A), two winged-helix domains of a 
FadR homodimer bind to a 19-bp operator sequence containing two copies of an inverted 
repeat, TCTGGT, separated only by 3 bp 35. In contrast, the 47-bp GabR binding site 
contains two copies of the direct repeat ATACCA separated by 34 bp of DNA. Because 





winged-helix domain for the structural superposition (Figure 16B). The resulting 
GabR−DNA model (Figure 16B) is identical no matter which FadR monomer we use for 
the superposition and has several salient features. First, the HTH motif in FadR binds in 
the major groove of DNA, whereas the wing invades the minor groove (Figure 16A). 
Residue R35 in helix α2 of the FadR HTH motif makes two H-bonds with the first 
guanine in the TCTGGT repeat (Figure 16A). 
The conserved arginine residue R43 in GabR (Figure 16B)may form similar 
sequence-specific contacts with one of the guanines in its direct repeat (double-stranded 
sequence, ATACCA•TATGGT). In the turn of the HTH motif, FadR residue T44 (S52 in 
GabR) makes H bonds with the phosphate backbone and provides a hydrophobic contact 
to the central C−G base pair in the 19-mer, whereas residues in the α3 recognition helix, 
which are typically known to bind the major groove of DNA 30, either contact the central 
C−G base pair in the 19-mer (T46 in FadR; N54 in GabR) or a phosphate group (T47 in 
FadR; S55 in GabR) in the major groove. In the FadR wing, residue K67 points between 
two phosphate groups  (Figure 16A). The GabR residue K75 (Figure 16B) could similarly 
point between two phosphate groups. Because many residues are conserved between 
FadR and GabR (Figure 17) and because the FadR and GabR DNA repeats have similar 
sequences, we predict that some of the protein−DNA interactions will be similar between 
the FadR−DNA and GabR−DNA complexes. However, because the GabR and FadR 
repeat sequences are dissimilar in type, direction, and spacing, a crystal structure of the 







Figure 16. Conserved putative DNA-binding residues in GabR. (A) The crystal structure 
of the FadR−DNA complex is shown (PDB ID code 1H9T) (12). FadR binds DNA as a 
homodimer. The protein and DNA are shown in cartoon and stick representation, 
respectively. Side chains of some of the DNA-binding residues are shown as sticks and 
labeled. The corresponding phosphate groups and nucleotides contacted by the protein 
side chains are colored in orange. The central base pair in the 19-mer DNA is shown in 
pink. Only the winged-helix domains of FadR are shown; the acyl-CoA–binding domains 
are hidden for clarity. (B) A model of the GabR winged-helix domain bound to the 19-bp 
FadR DNA sequence. Again, the central base pair in the 19-mer is colored in pink, 
although only 12 of the 19 bp are shown for clarity. The phosphate groups and 
nucleotides putatively contacted by GabR protein side chains are colored in orange. The 
GabR protein side chains predicted to be involved in DNA binding are shown as sticks 
and are labeled. 
 
 
Figure 17. Sequence alignment of the winged-helix domain sequences of B. subtilis GabR 
and E. coli FadR. A BLAST alignment of the HTH and wing motifs is shown. The green 







Second, because the two winged-helix domains of FadR interact with each other 
on DNA (Figure 16A) 35, we examined whether such an interface is possible in GabR. 
The GabR α3 helix is surface exposed (Figure 8) and has a sequence that is capable of 
forming an α3−α3 interface similar to that of FadR (Figure 17 and Figure 18). Thus, two 
copies of the GabR winged-helix domain may be able to interact with each other on DNA 
under specific circumstances, for instance, when the direct repeats that are 34 bp apart are 
brought into close proximity.  
 
Figure 18. Two DNA-binding domains of GabR can interact on DNA through the “α3−α3 
dimer interface.” A superposition of two molecules of GabR onto the FadR−DNA 
complex is shown. The α3−α3 interface is indicated by the magenta circle. The acyl-
CoA–binding domains of FadR and putative aminotransferase domains of GabR are not 
shown for clarity. The protein and DNA are shown in cartoon and stick representation, 
respectively. Side chains of some of the DNAbinding residues are shown as sticks and 
labeled. The corresponding phosphate groups and nucleotides contacted by the protein 





winged-helix domains of FadR are shown. The acyl-CoA–binding domains of FadR are 
hidden for clarity. 
 
Third, mutating the CC doublets in either of the two GabR direct repeats to GG led to a 
10-fold decrease in DNA-binding affinity. Furthermore, mutating both CC doublets to 
GG completely abolished GabR binding 24. These observations are consistent with our 
GabR−DNA model, which suggests that residue R43 of GabR may form sequence-
specific contacts with one of the guanines in its direct repeat. As is true for FadR (13) 36, 
our GabR−DNA model predicts that mutating conserved residues like R43 and K75 may 
abrogate or interfere with GabR−DNA interactions 
GabR Binds DNA with High Affinity  
The binding affinity of GabR for a 49-bp DNA containing the 47-bp GabR 
binding site was determined by fluorescence polarization and competitive binding assays. 
Previous studies estimated the apparent dissociationExperimental Procedures gabT 
fragment to be around 1 nM 24. When a range of GabR protein concentrations were 
titrated against the 47-bp carboxytetramethylrhodamine (TAMRA)-labeled DNA, we 
observed a dose-dependent increase in polarization (Figure 19A), indicative of the 
binding of GabR protein to DNA. The curve was fitted to the modified Hill equation (in 
Experiments Procedures) and the dissociation constant of the GabR−DNA complex was 
determined to be 70.2 ± 3.7 nM. A Hill coefficient of 2.2 ± 0.2 was obtained, indicating 
positive cooperativity in the binding process. To establish specificity of binding and rule 
out nonspecific effects from the TAMRA label, a competitive binding assay was 





TAMRA-labeled DNA (Figure 19B). A preformed mixture of equimolar concentrations 
of TAMRA-labeled DNA and GabR was titrated with increasing concentrations of 
unlabeled DNA. The fluorescence polarization decreased with increasing amounts of 
unlabeled DNA (Figure 19B). The curve was fitted to the Hill equation (Eq. 2 in 
Experiments Procedures) and the IE50 of unlabeled DNA for GabR was calculated to be 
98.1 nM ± 7.8 nM, which is similar to the dissociation constant of the TAMRA-labeled 
DNA−GabR complex (Figure 19B). A Hill coefficient of 1.7 ± 0.4 was obtained,  
 
Figure 19. Fluorescence polarization assays to measure DNA binding by GabR. Each 
data point was measured in triplicate. The average values and errors were plotted and 
fitted to the Hill equation. The abbreviations used in the figure are as follows: FPFTD, 
fluorescence polarization signal of free labeled DNA; FPGTD, fluorescence polarization 
signal of the GabR−DNA complex; KD, the dissociation constant; n, the Hill coefficient; 
and IE50, the concentration of unlabeled DNA required to bind 50% of protein. (A) 
Titration of GabR against 50 nM TAMRA-DNA. The GabR concentrations were varied 
from 0 to 1,000 nM. Error bars are too small to be displayed if the errors are less than 
1/1,000th of the measured value. (B) Competitive binding assay. Titration of unlabeled 
DNA (0–1,000 nM) against a fixed concentration of preformed GabR-labeled DNA 






supporting the same type of positive cooperativity as shown in (Figure 19A). Although 
the precise binding stoichiometry of GabR for DNA is still unknown, the dissociation 
constants that we determined suggest a high-affinity GabR−DNA complex. The Hill 
coefficients in both titrations indicate positive cooperativity in the binding of GabR 
dimers to DNA. 
PLP is bound in the C-terminal AT-Fold Domain  
Like in other type I aminotransferases 31, 32, the AT-fold domain of GabR has two 
subdomains, the large subdomain containing the invariant lysine (K312) that forms the 
Schiff base with PLP and the small subdomain that typically interacts with the α-
carboxylate group of the substrate. One molecule of PLP is bound per GabR monomer as 
an internal aldimine at K312. We next compared the PLP-binding pocket of B. subtilis 
GabR (Figure 20) with those of E. coli Asp-AT (PDB ID: 2AAT), the best-characterized 
member of the type I aminotransferase family; and pig liver GABA-AT bound to the 
substrate analog, γ-ethynyl GABA (GEG) (PDB ID: 1OHY) 32, 37. The active site residues 
that facilitate PLP binding are conserved in all three cases. For example, the phosphate 
group of PLP is situated very close to the N terminus of a nearby helix in all cases and is 
stabilized by hydrogen bonds from polar residues (T181, T309, and S311 in the case of 
GabR) to the phosphate oxygens. The salt bridge between an arginine residue (residue 
R319) and the phosphate group is also conserved in GabR, although the phosphate group 
has a different orientation compared with those in Asp-AT and GABA-AT. The primary 





transition state or external aldimine (Schiff base between an amino acid substrate and 
PLP) by delocalizing the negative charge through the π-electron system of the cofactor. A 
conserved aspartate residue [D279 in GabR, D222 in E. coli Asp-AT, D223 in chicken 
mitochondrial Asp-AT 27, and D298 in GABA-AT; Figs. 5A and 6A] promotes this 
electron sink nature of PLP by maintaining PLP in the protonated state through 
interaction with the pyridinium nitrogen. 
Figure 20. The PLP-binding pocket of B. subtilis GabR. The GabR residues that interact 
with PLP are labeled. 
 
Is GabR an enzyme?  
We were currently unable to obtain crystals of a GabR−PLP−GABA complex, and 
therefore, we examined the putative GABA-binding site in GabR−PLP to understand 





Transamination reactions are ping-pong reactions that require two different amino acids 
to be able to bind in the active site (GABA and glutamate, if GabR were an α-
ketoglutarate– dependent GABA aminotransferase). Most aminotransferases use either 
two conserved arginines or an extended hydrogenbonding network to recognize and bind 
two amino acids with different shapes and properties 31. We superimposed the crystal 
structures of B. subtilis GabR, pig liver GABA-AT−GEG 37, and E. coli Asp-AT 32 to 
elucidate how different amino acids might bind in the active site of GabR. Even though 
GabR, GABA-AT, and Asp-AT share the overall type I aminotransferase fold, their 
polypeptide sequences are highly divergent. Also, the lengths of their secondary structural  
 
Figure 21. PLP binding in aminotransferases and the arginine switch. (A) A schematic of 
the interactions of the phenolic ring of PLP with surrounding protein side chains. The 
corresponding residue numbers for Asp-AT (D223, N195, K258) and GABA-AT (D298, 
Q301, K329) are indicated. The precise locations of the hydrogen atoms have not been 
observed or measured so far. The H-atom positions indicated in the schematic are 
therefore only inferred from reaction chemistry. (B) A schematic model for the arginine 
switch in GABA-AT. The model is inferred from the crystal structure of pig liver GABA-
AT−GEG complex and adapted. The positions of the two conserved arginine residues in 
the active site of GABA-AT and their interactions with the α- and γ-carboxylate groups of 
glutamate are indicated. 
 





parts of the structures, making it difficult to obtain secondary structure-based 
superposition. Therefore, we manually superimposed the pyridine ring of PLP to compare 
the putative substrate- binding pockets in all cases. 
If GabR were a bona fide aminotransferase, then the active site must be able to 
interact with a keto acid such as α-ketoglutarate. In the active sites of Asp-AT and 
GABA-AT, two conserved arginines stabilize such a keto acid to subsequently form the  
related amino acid (Figure 21A)31. However, we found two key differences in the “active 
site” of GabR, compared with these aminotransferases, which may compromise its ability 
to transaminate GABA. First, the GabR active site may contain only one structurally 
conserved arginine (R207) that is, however, not conserved by sequence. In Asp-AT and 
GABA-AT, the equivalent arginine residue (R292* in the other subunit of the dimer in 
Asp-AT and R192 in GABAAT(Figure 21B), is known to form a bidentate hydrogen 
bond/ion pair with the γ-carboxylate of a dicarboxylate substrate such as glutamate, 
whereas the second arginine (R386 in Asp-AT and R445 in GABA-AT; Figure 21B) 
makes a similar direct contact with the α-carboxylate of the glutamate. Furthermore, 
GABA-AT employs an arginine switch to distinguish between GABA and glutamate 31, 37. 
When GABA binds, R192 stays in place to contact the carboxylate of GABA (Figure 22), 
which is located in the same position as the γ-carboxylate of glutamate, while R445 
moves away to accommodate GABA and engages instead in a salt bridge with a nearby 
glutamate residue (E270; Figure 22A). Because only the first arginine residue in GabR 





suggests that GabR may bind GABA but not glutamate or other dicarboxylate substrates. 
In the absence of conserved arginines, aromatic amino acid aminotransferases and 
branched-chain aminotransferases use large-scale rearrangements of the active site 
hydrogen-bond network or hydrophobic cavities lined with polar residues to 
accommodate two different amino acids in the same site (refs. 9 and 15, and references 
therein). However, because these features are not preserved in GabR, these alternative 
substrate-binding mechanisms are unlikely for GabR. The second key difference in the 
active site of GabR is related to its ability to stabilize the GABA external aldimine. When 
the amino acid substrate forms an external aldimine, the imine N atom of the amino acid 
and phenolic O atom of PLP could share an H-atom. Therefore, the phenolic O must be 
optimally oriented to accept the hydrogen from the imine N during reprotonation and 
hydrolysis to form PMP and release the deaminated substrate (Figure 21A). In Asp-AT, 
 
Figure 22. PLP is bound in the AT-fold domain of GabR. (A) The substrate-binding 
pocket in the GABA-AT−GEG structure. The secondary structure elements are shown in 
cartoon form. Side chains of the key residues that interact with PLP and substrate analog, 
GEG, are shown in stick representation and labeled. Hydrogen bonds are shown as dotted 
green lines. (B) The putative substrate-binding pocket in the crystal structure of GabR. 





shown at 1.2σ level. 
 
 
an asparagine (N195; Figure 21A) interacts with the phenolic O to hold it in place, and in 
GABA-AT, a glutamine residue (Q301; Figure 21A) and a water molecule perform the 
same function. In GabR, there is no such interaction with the phenolic O, implying that 
the GABA external aldimine might not be optimally oriented for catalysis. 
A sequence alignment of 10 MocR/GabR protein sequences from different strains 
of B. subtilis, E. coli, Pseudomonas aeruginosa, Salmonella enterica, and Streptococcus 
pneumoniae revealed an overall lack of evolutionary conservation for the arginine switch. 
Although the residues involved in PLP-binding (equivalent of B. subtilis GabR residues, 
D279, R319, and K312) are conserved in the examined homologs, we found the residue 
corresponding to B. subtilis GabR (R207) to be highly variable. In contrast to GabR, all 
of the PLP-interacting residues and the two substrate-interacting arginines are identical 
between B. subtilis GabT, a known GABA aminotransferase, and pig liver GABA-AT 
(Figure 23). Such a contrast indicates the functional divergence of GabR from its 
evolutionary relatives. Together, these critical differences in the active site architecture 
of GabR strongly suggest that GabR may bind GABA in a different manner than a true 
transaminase and may only catalyze the “full” transamination reaction with poor 
efficiency, if at all. Without the ability to accommodate glutamate effectively, 
GabR may not be able to complete the second half-reaction and enzymatically regenerate 





that GabR does not rescue GabT activity 24, we were unable to measure a GABA-AT 
activity for GabR in coupled steady-state enzyme assays (described in Experiments 
Procedures). Also, UV-visible scanning spectrophotometry experiments of GabR in the 
presence of PLP and GABA did not reveal any of the spectral shifts typically produced by  
 
 
Figure 23. BLAST protein sequence alignment. Sequence alignment between B. subtilis 
GabT GABA aminotransferase (upper sequence; 1–436) and pig liver GABA-AT (lower 
sequence; 1–472) are shown. The two proteins share 25% sequence identity and 43% 
similarity between their AT domains. The conserved residues interacting with the 





(D298 and Q301, respectively), and the invariant Schiff base lysine (K329) are 
highlighted. The residue numbers in parentheses denote residues from pig liver GABA-
AT. 
 
the PLP or PMP intermediates in a PLPdependent transamination reaction. Together, 
these experiments suggest that GabR may have very poor or no GABA aminotransferase 
activity under physiological conditions. Although the trifunctional NAD-dependent S. 
enterica repressor. NadR is an example of a cofactor-dependent protein containing an N-
terminal DNA-binding domain and two catalytically active domains [a middle 
adenylyltransferase domain and a C-terminal nicotinamide ribose kinase 4], there is also  
precedence for adaptation of enzymes to regulatory roles in other proteins. For instance, 
PyrR, a UMP-dependent transcription attenuator for pyrimidine biosynthesis in B. subtilis 
contains a type I phosphoribosyltransferase (PRT) domain without measurable catalytic 
activity 38. The B. subtilis purine repressor PurR has a two-domain architecture like 
GabR: an N-terminal wingedhelix domain and a C-terminal PRT domain devoid of 
catalytic activity 39. It is of course possible that GabR recognizes other substrates or 
possesses a different PLP-dependent enzymatic activity that may or may not be related to 
its function as a PLPand GABA-dependent transcriptional activator of gabT. However, so 
far, no other enzymatic activity for GabR has been reported. 
Model for GabR-Mediated Transcriptional Regulation at the gabR and gabT 
Promoters 
Based on the crystal structure of GabR, the sedimentation velocity data and the 





and regulation at the gabR and gabT promoters (Figure 24). Because we do not know the 
precise GabR:DNA binding ratio, we consider different models with one or more GabR 
dimers bound to DNA. In model 1, two copies of GabR dimers bind to the 47-bp DNA 
with only one winged-helix domain from each dimer binding to each direct repeat. That 
the Hill coefficient for the GabR−DNA complex is close to 2 (Figure 19) further suggests 
that GabR may cooperatively bind DNA as a dimer of dimers in the same way that a 
dimer of λcII dimers binds its DNA operator 40. In the λcII−DNA crystal structure, as in 
model 1, only one monomer from each λcII dimer binds its DNA sequence comprising 
two direct repeats. Even though the spacings between the direct repeats in the binding 
sites of λcII and GabR are different (6 and 34 bp, respectively), the cooperative binding 
of GabR to DNA as a dimer of dimers is still possible. In model 2, only one copy of the 
GabR dimer binds to the 47-bp DNA and both winged-helix domains of the dimer are 
involved in DNA binding. In this model, the two winged-helix domains of one GabR 
dimer may be rearranged and some bending of DNA may occur. The small buried surface 
area (422 Å2) between the winged-helix domain and AT-fold domains suggests that the 





Figure 24. A model for transcriptional regulation at the gabR and gabT promoters. 
Different models for GabR binding in the gabR–gabT regulatory region are depicted. The 
GabR homodimer is represented as a cartoon with one monomer shown in white and the 
other colored gray. The larger oval represents the AT-fold domain and the smaller oval 
represents the winged-helix domain. Putative conformational changes in the presence of 
GABA are indicated by symbols with dashed lines. 
 
solution and that the proposed domain movements are possible using large-scale 
movements facilitated by the long linker. We recognize that other viable models still 
exist. For example, the second winged-helix domain of a GabR dimer may bind to 
unidentified cis binding sites located at larger distances from the gabR−gabT locus to 
form large DNA loops. Intriguingly, a large basic surface at the AT−AT interface begs the 
question whether this surface is somehow also involved in DNA binding (Fig. S8). These 
models suggest that GABA may bring about conformational changes in GabR or the 
GabR−DNA complex, and that these changes may be necessary to activate gabT 





24). Crystal structures of GabR−DNA complexes with and without GABA may help 
unravel some of these unknowns. 
Biological Implicaions 
Our studies suggest that GabR may not possess “full” GABA aminotranferase 
activity, although it requires PLP and GABA to activate transcription at the gabT 
promoter. It is likely that the primary function of GabR in B. subtilis is to regulate 
transcription at the gabR and gabT promoters and that the AT-fold domain of GabR has 
adapted to primarily serve as an effector binding domain. How the AT-fold domain of 
GabR assists the wingedhelix domain in transcriptional regulation and how GABA 
mechanistically affects gabT activation by GabR still remain to be determined. 
In summary, these studies were published in the in the Proceedings of the 
National Academy of Sciences of the United States of America (PNAS): Raji 
Edayathumangalam, Rui Wu, Yuguang Wang, Roman Garcia, Wei Wang, Cheryl 
Kreinbring, Jingling Liao, Todd Stone, Quyen Q. Hoang, Boris Belitsky, Gregory A. 
Petsko, Dagmar Ringe, and Dali Liu. (2013) 110 (44), 17820-17825.(Equal contribution 
first author) 
Materials and Methods 
Protein Expression and Purification. The full-length coding region of the Bacillus 
subtilis gabR gene (residues 1–479) was subcloned from a pBAD construct into pETite 
C-His vector (Lucigen), which encodes an inducible T7 expression system. The C-





Transformed cells were grown in LB media containing kanamycin at 37 °C to OD600 of 
0.6 and induced with 0.5 mM isopropyl-β-D-thiogalactopyranoside (IPTG) at 37 °C for 
4 h. Cells were harvested, resuspended in buffer containing twofold PBS buffer and 10 
mM imidazole (pH 7.5), and sonicated. Insoluble material was removed by 
centrifugation. The GabR-His6 protein (molecular weight, 56 kDa) was purified to 
homogeneity by affinity chromatography Ni-NTA (GE Healthcare) and gel filtration 
(HiLoad 16/60 Superdex 200 pg; GE Healthcare) in buffer containing twofold PBS (274 
mM NaCl, 5.4 mM KCl, 16 mM Na2HPO4, 2.92 mMKH2PO4, pH 7.4), 475 mM 
imidazole (pH 7.5), 1 mM pyridoxal 5′-phosphate (PLP), and 5% (vol/vol) glycerol. The 
protein requires high salt and imidazole concentrations to stay soluble without 
precipitation. Alternatively, the presence of 5% (vol/vol) glycerol and 0.5% Nonidet P-40 
in the buffer helps to keep GabR soluble without the need for NaCl and imidazole. 
Purified GabR-His6 protein was concentrated (Centricon Plus centrifugal filter units; 
Millipore) and stored at 4 °C for short term (4 wk) or flash frozen in 50-μL aliquots in 
liquid nitrogen after the addition of 15% (vol/vol) glycerol and stored at −80 °C for long-
term use. The concentrated sample of purified GabR was pale yellow in color, indicating 
that PLP was bound to the protein. 
Analytical Ultracentrifugation Analysis. The oligomeric state of GabR−PLP in 
solution was analyzed by sedimentation velocity using a Beckman-Coulter Optima XL-I 
ultracentrifuge. The experiments were conducted at low protein concentrations (30, 50, 





GABA. In each experiment, 450 μL of the protein solution was loaded into a sector-
shaped centrifugation cell at concentrations corresponding to OD230 values of 0.3, 0.5, 
and 0.8. The samples were spun at 48,000 rpm (Beckman AN60Ti Rotor) for 5 h with 
radial scans capturing the boundary distribution every 2 min until the sample had almost 
completely pelleted. Boundary profiles from sedimentation velocity scans were collected 
and analyzed using the UltraScan II software suite. Initial model-independent van Holde–
Weischet analysis of the data clearly showed no evidence of mass action over the 
concentration range investigated, thereby confirming an absence of dynamic equilibrium 
between species. Therefore, all data were fit to a 50-iteration global genetic algorithm–
Monte Carlo (GA-MC50) model, which showed a narrow and randomly distributed 
residual, indicative of good data quality and modelfitting. 
Fluorescence Polarization DNA-Binding Assay. Fluorescence polarization data 
for the GabR–DNA complex were obtained using an EnVison 2102 Multilabel Plate 
Reader (Perkin-Elmer). Two 49-bp complementary single-stranded DNA 
oligonucleotides containing the 47-bp GabR binding region (5′ 
TCTGATACCATCAAAAAGTTATAATTGGTACTTTTCATCATACCAAAGA- 
3′) were purchased from Integrated DNA Technologies. The oligonucleotides were either 
unlabeled or labeled at the 3′ end with the fluorophore, TAMRA. The double-stranded 
oligonucleotides were prepared by annealing a mixture containing equimolar 
concentrations of the two single-stranded oligonucleotides. For the fluorescence 





fixed concentration of TAMRA-labeled DNA (50 nM). GabR protein was serially diluted 
in the DNA binding buffer [20 mM Tris·HCl, pH 8.0, 50 mM KCl, 2 mM MgCl2, 5% 
(vol/vol) glycerol, 1 mM EDTA, 1 mM DTT, and 0.05% Nonidet P-40]. The TAMRA-
DNA (50 nM) was mixed with the serially diluted GabR protein (final concentration, 
0–1,000 nM) and 100 μL of each sample mixture was loaded into the individual wells of 
a 384-well microplate. In the competitive binding assay, varying concentrations of 
unlabeled DNA were titrated against a fixed concentration of preformed GabR-labeled 
DNA complex (100 nM GabR and 100 nM TAMRA-DNA). The fluorescence 
polarization (FP) signals of the GabR−DNA mixtures were measured with fixed 
excitation (531 nm) and emission (595 nm) wavelength filters at room temperature. 
Fluorescence intensity remained constant throughout the polarization measurements. The 
fluorescence polarization signal for each sample was calculated and plotted against the 
GabR protein concentrations in the fluorescence polarization assay and against the 
concentrations of unlabeled DNA in the competitive binding assay. Each data point is the 
average of three independent measurements. The titration plot for GabR versus TAMRA-
DNA was fitted to a modified Hill equation (Eq. S1) in ORIGIN software to calculate the 
dissociation constants and Hill coefficient. For the competitive binding assay, the IE50 
value and Hill coefficient were obtained by fitting the data points to the 
Hill equation. (Eq. S2). 
(FPGTD – FPFTD) = [TAMRA-DNA]n / KnD+ [TAMRA-DNA]n;  [1] 





represents FP when all TAMRADNA is free in solution without any GabR bound; KD is 
the dissociation constant for the GabR–TAMRA-DNA complex; and n is the Hill 
coefficient. 
(FPGTD – FPFTD) = [Unlabeled DNA]n / (IEn50 +[Unlabeled DNA]n),  [2] 
where FPGTD, FPFTD, and n are the same as in Eq. S1; IE50 represents the 
concentration of unlabeled DNA needed to bind 50% of protein. 
Crystallization. Crystals of GabR were obtained by the hangingdrop method using 
protein at 5 or 10 mg/mL The initial sparse matrix screen was set up with the Gryphon 
crystallization robot (Art Robbins Instruments) to obtain initial crystallization hits, which 
were further optimized manually to obtain crystals with the best size and morphology. 
The optimized crystallization solution contained 33% (vol/vol) PEG400, 200 mM 
calcium acetate, and 200 mM imidazole, pH 7.5. The hanging drops were incubated at 20 
°C or room temperature. Crystals appeared in 5 d and grew to maximum size in 1–2 wk. 
Crystals with good morphology and size were picked directly from the hanging drops and 
flash-cooled in liquid nitrogen. The heavy metal derivatives were prepared by soaking 
crystals in 10 mM ethylmercury phosphate for 1 h before flash- cooling in liquid 
nitrogen. The heavy metal soaking condition also included 1 mM PLP. 
Data Collection and Processing. Single-wavelength anomalous dispersion 
(SAD) data were collected at beamlines 19-ID and 19-BM at Advanced Photon Source, 
Argonne National Laboratory. X-ray diffraction data for the mercury derivative of holo-





2 and 3) were collected at the wavelengths of 1.0039 and 0.9792 Å, respectively. The 
datasets were indexed, integrated, and scaled with either the HKL package 41 or iMosflm 
and Scala programs in the CCP4 program suite 42. The datasets were all scaled in the 
space group P212121 to resolutions of 3.1, 2.7, and 2.55 Å, respectively. The data 



















































(2) GabR-PLP, native (3) apo-GabR, 
native 
Wavelength (Å) 1.0039 0.9792 0.9792 
    Space Group P212121 P212121 P212121 
Resolution range 
(Å) 
30-3.1 (3.15-3.1) 50-2.71 (2.76-2.71) 49.3-2.55 
 Unit cell (a b c) 
(Å) 
98.1 101.1 211.2 97.2 101.3 211.2 99.9 101.4 213.2 
  Total unique 
reflections 
39106 57413 68270 
  Multiplicity 6.7 (6.8) 4.8 (3.8) 5.8 (5.6) 
Completeness (%) 100 (100) 99 (97.9) 95.8 (90.7) 
Linear Rmergea (%) 10.7 (71.6) 0.102 (ND) 11.7 (68.7) 
I/σ 21.9 (2.9) 18.7 (1.0) 9.4 (2.2) 
Average Wilson B-
factor 
67.7 59.9 38.7 
Rcrystb 0.2124 0.1947 
Rfreec 0.2556 0.2461 
Number of atoms 15247 15514 
Macromolecules 15108 15139 
Ligands 99 73 
Water 40 300 
RMSDd bonds (Å) 0.005 0.010 










Macromolecules 82.6 63.0 







The values for the highest resolution bin are in parentheses.  
aLinear Rmerge = Σ|Iobs-Iavg|/ ΣIav 
bRcryst = Σ|Fobs-Fcalc|/ ΣFobs 
cFive percent of the reflection data were selected at random as a test set and only these data were used to 
calculate Rfree. 
dRMSD, root mean square deviation. 
 ND, Not Determined/Calculated by the program 
 
Sequence and Structure Analyses. GabR homologs were identified in the 
sequence database using BLAST ; multiple sequence alignment using BLAST; conserved 
domain searches using CDD (4) 34; buried surface area from PDBePISA server 
(http://www.ebi.ac.uk/msd-srv/prot_int/cgi-bin/piserver); and structural similarity using 
DALI 43. Secondary structure superimpositions were done in Coot. Electrostatic surface 
potentials were calculated with PyMOL (The PyMOL Molecular Graphics System, 
version 1.5.0.4; Schrödinger). Figs. 3, 4, 6, and 9, and Figs. S2, S4, S5, S7, and S8 were 
drawn with PyMOL.  
Structure Solution, Model Building, and Refinement. Automated substructure 
solution by AutoSol in PHENIX 44 found 15 heavy atom peaks in the mercury dataset 
(Table 1, Dataset 1) and identified fourfold noncrystallographic symmetry (NCS) using 
superposition of the mercury sites. AutoBuild in PHENIX automatically built 80% of 
the residues. The initial phases were extended and refined to 2.7 Å using the native holo-





fourfold NCS averaging and density modification. The remainder of the model was built 
manually in Coot 45 guided by the structure of Thermococcus profundus multiple 
substrate aminotransferase [Protein Data Bank (PDB) ID code 1WST], a homolog 
obtained from the FFAS03 server (http://ffas.burnham.org/ffas-cgi/cgi/ffas.pl). Several 
loops accounting for gaps in the model were placed and refined by a combination of 
manual building and the fit_loops routine in PHENIX. Next, MR-SAD using the model 
and the mercury dataset identified five more mercury sites and led to even better maps. 
Several iterative rounds of manual model building and refinement using the maximum-
likelihood amplitude targets in PHENIX and Rosetta using simulated annealing (in the 
initial stages) and automatic NCS restraints were required to obtain the final model. The 
initial model (80% complete) had Rcryst and Rfree values of 0.393 and 0.484, 
respectively, for all data between 45.0 and 2.7 Å. The Rcryst and Rfree values of the final 
model (98% complete) are 0.229 and 0.265, respectively. The final model of the 
GabR−PLP complex consists of two homodimers of GabR in the asymmetric unit with 
470 residues out of 479 accounted for in each monomer. The final model also contains 1 
molecule of PLP per monomer, 16 molecules of ethylmercury, and 52 water molecules. 
The quality of the final model is summarized in Table S1. This model has been deposited 
in the PDB and is available with ID code 4N0B. The native dataset of apo-GabR (Table 
1, Dataset 3), which was processed to a resolution of 2.55 Å, was phased by molecular 
replacement using the final model of GabR as the input model. 





and 0.246, respectively. Other model statistics are summarized in Table S1. This model 
has been deposited in the PDB with ID code 4MGR. The density for PLP is lacking in 
this structure, as expected. We interpreted a difference density peak in the PLP-binding 
pocket as imidazole (Figure 10) because imidazole is a major component in the protein 
purification and crystallization buffer. 
GabR Enzyme Assay. Activity was measured using varying concentrations 
of GabR protein in an assay buffer containing 100mM Tris·HCl, 5 mM DTT, 100 mM 
KCl, 100 μM PLP, 20 mM GABA, 20 mM α-ketoglutarate, 500 μM NADP+, and 3 units 
of aldehyde dehydrogenase (ADH). In the coupled assay, ADH consumes the product of 
the first half-reaction (succinic semialdehyde) to produce succinate. The coupled reaction 
is measured spectrophotometrically (absorbance change at 340 nm) from the concomitant 














PLP AND GABA TRIGGER GABR-MEDIATED TRANSCRIPTION REGULATION 
IN BACILLUS SUBSILIS VIA EXTERNAL ALDIMINE FORMATION 
Research Significance 
The Bacillus subtilis protein GabR activates the biosynthesis of glutamate from γ-
aminobutyric acid (GABA) at the transcription level upon binding to pyridoxal-5’-
phosphate (PLP) and GABA. We herein report that the external aldimine formed between 
PLP and GABA is apparently responsible for triggering the GabR-mediated transcription 
activation.  A crystal structure of the GabR effector-binding/oligomerization (Eb/O) 
domain (residues 88-479) in complex with both PLP and GABA revealed the formation 
of a PLP-GABA Schiff base.  Details of the GABA binding site in the Eb/O domain 
structure suggest that binding monocarboxylic γ-amino acid such as GABA should be 
preferred over dicarboxylic acid ligands.  A reactive GABA analog, (S)-4-amino-5-
fluoropentanoic acid (AFPA), was used as a molecular probe to examine the reactivity of 
PLP in both GabR and a homologous aspartate aminotransferase (Asp-AT) from E. coli 
as control.  The comparison between the complex structures of Eb/O-PLP-AFPA and 
Asp-AT-PLP-AFPA revealed that GabR is incapable of facilitating further steps of the 
transamination reaction after the formation of the external aldimine.  Results of in vitro 




agonistic ligand capable of triggering GabR-mediated transcription activation via 
formation of an external aldimine with PLP 
Introduction 
Bacterial transcription regulators are often directly responsive to the changes in 
metabolite concentration 15, 16. GabR responds to the increase of GABA concentration in 
bacterial cells 25 and upregulates glutamate regeneration from GABA.  Belonging to the 
MocR/GabR subfamily in the GntR family of bacterial transcription regulators 16, 25. 
GabR-type regulators characteristically have a large C-terminal Eb/O domain, which is 
homologous to the type I aminotransferases 31, and a small N-terminal “winged-helix-
turn-helix” (wHTH) DNA-binding domain 26.  In B. subtilis, GabR represses its own 
transcription 24, 25.  With both PLP and GABA bound, GabR activates the transcription of 
two genes, gabT and gabD, which encode the enzymes GABA aminotransferase (GABA-
AT) and succinic semialdehyde dehydrogenase (SSA-DH) respectively, forming a 
pathway for glutamate regeneration from GABA 24, 25. 
Previously, we have reported the crystal structures of full-length GabR as a 
“head-to-tail” dimer 46, in which electron density supported the existence of PLP bound 
to K312 of the Eb/O domain in the form of an internal aldimine.  Although the PLP-
binding site of GabR is largely conserved compared to that of type I aminotransferases, 
no aminotransferase activity has been detected for GabR 46.  To our knowledge, the 
existence of PLP in MocR/GabR- type transcription regulators is the only case known in 
nature where PLP functions as an effector in transcription regulation, including the other 





47-49. A previous report on GabR has shown that a “second metabolite pair” of 
pyridoxamine-5’-phosphate (PMP) and succinic semialdehyde (SSA) could also cause 
transcription activation upon binding to GabR 24. The first half of the “Ping-Pong” 
transamination catalyzed by GABA-AT (Schemes 1 and 2) in fact converts PLP and 
GABA to PMP and SSA, reversibly 50. It was hypothesized that certain step(s) of the 
aminotransferase reaction might be required to trigger GabR-mediated transcription 
activation 24.  Such hypothesis has not been proven, and the chemical identity of the 
GabR-PLP-GABA complex that results in transcription activation remained unknown.  
Using X-ray crystallography, NMR spectroscopy and biological assays, an external 
aldimine species formed between PLP and GABA when both bound to the effector 
binding site of GabR has been identified and is apparently responsible for triggering 
GabR-mediated transcription activation. 
Crystallography of GabR Eb/O Domain and Asp-AT Complexed with Ligands 
Three complex structures with PLP-ligand adducts bound were obtained through 
co-crystllization. X-ray crystal structures were determined and refinment of all three 
complex structures converged with good statistics (Table 2).  The Schiff base adducts 
were built into the electron density maps (fo-fc) in the final rounds of refinement.  The 
formed adduct was confirmed by the simulated annealing omit difference maps (fo-fc) 
generated in Phenix 51. The final models for EB/O-PLP-GABA, EB/O-PLP-AFPA and 
Asp-AT-PLP-AFPA have been deposited in the Protein Data Bank (PDB) with accession 





Eb/O domain (residues 88-479), expressed, purified and co-crystallized with PLP and 
GABA.  The complex structures Eb/O-PLP-GABA and Eb/O-PLP-AFPA were solved 
with molecular replacement and refined at 2.23 Å resolution and 2.25 Å resolution, 
respectively. The complex structure of Asp-AT-PLP-AFPA was solved and refined at 
1.53 Å resolution.  The overall structure of the Eb/O domain retains the same “head-to-
tail” homodimer architecture as those in the full-length GabR and type I 
aminotransferases (Figure 25).  
Figure 25.  Head-to-tail-dimers of the full-length GabR  (PDB code: 4N0B), Eb/O 
domain of GabR and Asp-AT. Bound PLP’s are shown in spheres. a) In the full length 
GabR, the Eb/O domains are in red, the flexible linker regions are in orange, and the 
DNA-binding domains are in blue.  b) An overlay of two dimeric structures of the GabR 
Eb/O domain in complexes with GABA (magenta) and AFPA (green).  c) The dimeric 










Table 2.  Data collection and refinement statistics for GabR Eb/O domain 
Protein GabR-EBO/GABA GabR-EBO/AFPA Asp-AT/AFPA 
Data processing 
Space group C2221 C2221 C2221 
Cell dimension    
         α, β, γ (°) 90.0; 90.0; 90.0 90.0; 90.0; 90.0 90.0; 90.0; 90.0 
         a, b, c (Å) 92.4; 128.9; 65.1 96.6; 127.5; 67.6 84.9; 154.9; 79.3 
Resolution (Å) 49.2 - 2.23 50.8 - 2.25 29.0-1.53 
aRmerge (%) 7.5 (46.4)b 8.3 (64.4)b 6.8 (68.7)b 
I/σ (I) 29.3(4.7)b 12.6(1.2)b 34.0(1.7)b 
Completeness (%) 99.8(97.9)b 96.2(78.4)b 98.2(83.4)b 
Multiplicity   5.5 (4.9) b 3.1 (2.5) b 12.2 (5.6) b 
No. Reflections 248492 132836 1914313 
No. Unique Reflections 19166 19311 147549 
Refinement 
cRwork/dRfree (%) 17.44/21.07 18.82/23.70 14.88/16.55 
No. of Atoms    
     Protein  2921 2292 3465 
     Ligand 22 24 32 
     Water 136 182 510 
B-factors(Å2)    
     Protein  40.41 42.24 23.72 
     Ligand (Lowest/Highest) 28.60/41.18 24.80/43.97 13.05/27.80 
eRMSD (from ideal values)    
          Bond length (Å) 0.005 0.003 0.007 
          Bond angle (°) 0.862 0.604 1.128 
Ramachandran plot    
Most Favored (%) 96.69 96.40 97.17 
Allowed (%) 3.04 3.32 2.61 
Outliers (%) 0.28 0.28 0.22 
 
a Rmerge = Σ|Iobs-Iavg|/ ΣIavg    
b The values for the highest resolution bins are in parentheses.    





d Five percent of the reflection data was selected at random as a test set, and only these data were used to 
calculate Rfree.    
e RMSD, root mean square deviation 
 
 
Details of the Effector Binding Site in the GabR Eb/O Domain and Schiff Base 
Formation between PLP and GABA 
In the effector-binding pocket of the Eb/O domain, the omit map difference 
electron density (fo-fc) revealed the existence of a Schiff base formed between PLP and 
GABA Figure 26a).  Three basic residues, R207, R430 and H114, from the same subunit 
interact with the carboxylate of the GABA moiety.  In a complex structure of GABA-AT-
PLP-aminooxyacetate (AOA) (Figure 26a), the PLP-AOA adduct mimicks the PLP-
GABA external aldimine, whose carboxylate interacts with one of the conserved arginine  
 
Figure 26. PLP and GABA bound to the truncated Eb/O domain.  a) The simulated 
annealing omit map (fo-fc) is shown around the PLP-GABA Schiff base at 3σ. b) Eb/O-
PLP-GABA in comparison to GABA-AT with aminooxyacetate (AOA) bound to PLP 
mimicking the PLP-GABA external aldimine  (green, PDB code: 1SFF). 





residues (R141) 52.  Compared with the homologous type I aminotransferases such as 
GABA-AT (Figure 26B), GabR is missing one (R141 in GABA-AT) of the two 
conserved arginines, which are involved in binding to dicarboxylic acid substrates 37, 52, 
such as L-glutamate or 2-ketoglutarate, in the second-half of a typical 
 This observed structural difference suggests that GabR has evolved to preferentially 
recognize monocarboxylic acids, such as GABA, and orient the ligand in favor of 
forming a Schiff base with PLP.  
 
Scheme 1. The Mechanism of First Half of the GABA-AT Reaction. 
 
Interestingly, the preserved basic residues in GabR are not aligned with GABA-





the aminooxyacetate (AOA)-PLP adduct, which mimics the GABA-PLP in the E. coli 
GABA-AT structure, binds to the active site in an anti conformation, the PLP-GABA 
Schiff base in GabR is in a gauche conformation (Figure 3b).  The dihedral torsional 
angle of C2-C1-O-N in the PLP-AOA “structural mimic” is measured to be 156.7° (13.3° 
off from an ideal anti-conformation) in UCSF Chimera. In the complex structure of 
Eb/O-PLP-GABA, the GABA moiety displays a gauche conformation (Figure 27).    
 
Figure 27.  GABA Moiety Displays a Gauche Conformation. (a) The GABA bound in the 
Eb/O domain is in a gauche conformation.  The PLP-GABA external aldimine is shown 
in stick and ball form.  The Cγ atom is placed (hidden) behind the Cβ atom, in the same 
orientation as the Newman projection for the dihedral torsional angle Cα-Cβ-Cγ-N in the 
PLP-GABA.   A Newman projection of a PLP-GABA Schiff base is shown in a gauche 
conformation. (b) The aminooxyacetate (AOA)-PLP imine bound in E. coli GABA-AT 
(PDB code: 1SFF) mimicking the PLP-GABA Schiff base was shown in ball and stick 
form.  The O atom is placed (hidden) behind the C1 atom in the same orientation as the 
Newman projection for the dihedral torsional angle C2-C1-O-N in the PLP-AOA.  A 






The dihedral torsional angle of Cα-Cβ-Cγ-N in PLP-GABA Schiff base was measured to 
be 77.3° (17.3° off from an ideal gauche conformation) in UCSF Chimera. Compared to 
the anti conformation, the gauche conformation is of higher energy and a relatively minor 
conformation for GABA molecule dissovled in an aqueous environment in the cell. 
Herein, we speculate that GabR’s preference for a gauche conformation could be an 
evolutionary outcome to sense the GABA’s concentration buildup instead of detecting 
the basal GABA level inside the cell.  Alternatively, we speculate that the chemical strain 
could be released and provide extra energy for GabR’s action after or during transcription 
activation. 
In all PLP-dependent enzymes, a conserved lysine forms an internal aldimine with 
PLP in a resting form and acts as a key catalytic residue during catalytic reactions, such 
as in the first half of the “Ping-Pong” transamination 31 (Scheme 1).  The conserved K312 
46(Figure 28) was previously proven to be essential for GabR’s function, although the 
catalytic capacity to facilitate transamination was never detected for GabR 24.  In the 
Eb/O-PLP-GABA complex structure (Figure 2a), Y281 is observed to block K312 from 
accessing the PLP-GABA Schiff base, preventing the reformation of the internal aldimine 
as well as further transamination-like catalysis, in which the freed catalytic lysine would 
deprotonate the carbon adjacent to the nitrogen atom of GABA (Scheme 1) 33, 37.  As a 
result, GabR is unlikely to catalyze the first half of the transamination reaction shown in 
Scheme 1.  As we previously reported 46, in the absence of GABA, Y281 is found in a 





obstruction by Y281 supersedes the previous speculation that GabR’s inability to 














Figure 28.  Comparison of the external aldimine vs. internal aldimine in GabR.  Schiff 
bases, K312, and Y281 are shown in stick form.  Labels and carbon atoms for internal 
aldimine (PDB code: 4N0B) are in black and grey, respectively.  Labels and carbon 
atoms for Eb/O-PLP-GABA are in magenta.  Labels and carbon atoms for Eb/O-PLP-
AFPA are in cyan. 
 
External Aldimine as the Final Adduct of GabR-Mediated Reaction 
The Eb/O-PLP-GABA complex structure at 2.23 Å resolution could not allow us 
to distinguish between external aldimine and ketimine (Scheme 1) for the chemical 
identity of the PLP-GABA Schiff base observed.  Therefore, we used a mechanism-based 





irreversibly inactivate PLP-dependent aminotransferases 53, as a molecular probe.  A 
previously proposed inactivation mechanism of an aminotransferase, mammalian GABA-
AT, by AFPA is shown in Scheme 2.  Once a typical aminotransferase reaction 
progresses beyond the external aldimine 1 stage, the AFPA moiety loses the fluorine 
group, resulting in a reactive intermediate.  Eventually, AFPA inactivates the PLP-
dependent aminotransferase via a ternary adduct, in which the AFPA moiety is covalently 
linked to both PLP and the catalytic lysine, or alternatively forms external aldimine 3.  
The catalytic lysine freed after the formation of the external aldimine 1 plays a critical 
role in assisting the irreversible inactivation of the PLP enzyme.  The formation of the 
proposed ternary adduct should provide evidence that the reaction between AFPA and 
PLP can progress beyond the external aldimine 1, reaching quinonoid or ketimine 








Scheme 2.  Proposed Reaction Mechanism of AFPA.  The green dashed box (1) shows 
the final adduct in the GabR Eb/O domain; the red dashed box (2) shows the expected 








Figure 29. Fluorine NMR Spectra.  a) Fluorine NMR showing a triplet of doublets (J1 = 
25.3 Hz, J2 = 21.4 Hz).  b) Proton-decoupled fluorine NMR spectrometry that shows a 
singlet. 
 
In contrast, the intacted fluorine group of AFPA should indicate that the reaction 





homolog of the GabR Eb/O domain, has been used successfully as a model enzyme to 
study mechanism-based inactivators of PLP-dependent enzymes 54-56. Due to the 
desirable crystallographic behavior of Asp-AT in various co-crystallization conditions, 
we chose it as a control for the co-crystallization experiment with AFPA.   
Both the GabR Eb/O domain and Asp-AT were co-crystallized with PLP and 
AFPA.  The structure of the Eb/O-PLP-AFPA complex (refined at 2.25 Å resolution) 
confirms the formation of external aldimine with the fluorine atom intact in the final 
adduct (Figure 30)  To validate the existence of the fluorine atom, extra rounds of 
refinement were done after deletion of the fluorine atom; the omit map difference density 
(fo-fc) strongly supports the presence of the fluorine atom in the complex. Residue Y281 
is observed to be in the same position as that in Eb/O-PLP-GABA complex structure 
(Figure 27), preventing the access of K312 to the PLP-AFPA Schiff base, which 
otherwise could potentially push the reaction further along the proposed inactivation 
pathway (Scheme 2).  
Furthermore, the AFPA-treated protein sample was subjected to NMR studies to 
eliminate the possibility of an alternative adduct (adduct 3 in Scheme 2, via pathway b in 
Scheme 2).  Pathway b and adduct 3 were never previously proven in the studies of the 
AFPA inactivation.  However, it is chemically plausible that a hydroxyl or water could 
react with the reactive intermediate and replace the eliminated fluorine group; the 
resulting adduct 3 would be structurally similar to the external aldimine proposed here 





PLP-AFPA, it is impossible to distinguish adduct 3 from adduct 1 even with the omit 
map difference density (fo-fc) validation shown (as green mesh) in Figure 30a.  Fluorine 
NMR spectrometry was hence employed to eliminate this hypothetical possibility.  The 
results are shown in Figure 29.  Figure S29a is the fluorine NMR spectrum that shows a 
triplet of doublets (J1 = 25.3 Hz, J2 = 21.4 Hz), since the fluorine atom is split by its two 
neighboring hydrogen atoms, then split again by another hydrogen atom on the adjacent 
carbon in the external aldimine form.  Figure S1b represents the proton-decoupled  
fluorine NMR spectrum that shows a singlet, because the fluorine atom and the protons 
are decoupled. As concluded, the fluorine atom remains intact in the same environment 
as intact AFPA, even after treatment with a saturated amount of GabR protein.   
As a positive control, the structure of the Asp-AT-PLP-AFPA complex (refined at 
1.53 Å resolution) showed that the proposed ternary adduct 3 (has formed via pathway a 
in Scheme 2 (Figure 30b), indicating that the catalytic actions of the conserved lysine 
have occurred in Asp-AT but not in the GabR Eb/O domain. On the basis of structural 
information and NMR results, it was concluded that the external aldimine 1 is the final 
chemical species when both PLP and AFPA are bound to the GabR Eb/O domain. This 
suggests that the observed Schiff base in the Eb/O-PLP-GABA complex structure is also 
an external aldimine.  
For aminotransferases in general, the external aldimine intermediate can be 
transiently observed spectroscopically 57.  However, mutation of a catalytic residue 58 or 





trap a stable external aldimine in an aminotransferase. GabR is, to our knowledge, the 
first reported protein capable of forming a stable external aldimine between PLP and 
GABA for its function in transcription regulation. Only mild global conformational 
changes are introduced in the PLP-bound Eb/O domain upon binding to GABA and 
formation of the external aldimine. A least squares structural comparison revealed that 
the Eb/O domains of the GabR-PLP dimer (PDB: 4N0B) aligned well with those of the 
Eb/O-PLP-GABA complex or the Eb/O-PLP-AFPA complex, with RMSD values for Cα 
atoms around 1.12 Å and 1.13 Å, respectively. Conformational changes could be more 
pronounced in the linker region between Eb/O and wHTH domains, and within the 
wHTH domains in the full-length dimeric GabR; these conformational changes likely 
contribute to the triggering of transcription activation.  
Functional Significance of External Aldimine Formation 
To extrapolate the functional interpretation from the GabR Eb/O domain to the 
full length GabR, both in vivo and in vitro assays were conducted to compare the 
biological effects of GABA and AFPA.  When examining GabR-mediated activation in 
vivo using a gabT-lacZ fusion 25(Figure 31a), both GABA and AFPA triggered GabR-
mediated transcription activation in B. subtilis cells In vitro, GabR, PLP, RNA 
polymerase, and the gabT promoter-containing DNA fragments were mixed with 
radioactively labeled nucleotides as described previously 24.  The gabT transcript was 
formed upon addition of either GABA or AFPA (Figure 31b).  In contrast to in vivo 





potency than did GABA.  The GabR-PLP-AFPA complex may be a better transcriptional 
activator than the GabR-PLP-GABA complex.   However, the bacterial cellular uptake of 
GABA may be more efficient than that of AFPA, resulting in a more pronounced 
biological effect in vivo upon the addition of GABA. 
 
Figure 30.  Biological effects of GABA and AFPA.  a) The gabT-lacZ expression is 
monitored by absorbance at 420nM produced by the lacZ reaction using ONPG over 
time.  b) Self-developed film indicating the newly synthesized gabT mRNA.  Lane 1: 
Control without GABA or AFPA.  Lanes 2-7: GABA added at concentration of 0.625, 
1.25, 2.5, 5, 10 & 20 mM, respectively.  Lanes 8-13: AFPA added with concentration of 
0.625, 1.25, 2.5, 5, 10 & 20 mM, respectively. 
Conclusions 
We have shown that PLP bound to the GabR Eb/O domain reacts with the effector 
GABA to form a stable external aldimine, which apparently triggers the transcription 
from the gabT promoter in B. subtilis.  This conclusion offers an explanation for the 
previous results that the effector pair of PMP and SSA can also trigger GabR-mediated 





(Scheme 1), SSA and PMP can potentially form a Schiff base, presenting a structure 
similar to the PLP-GABA external aldimine 24. However, SSA and PMP may not work as 
an actual effector pair in vivo.  With an evolutionarily modified PLP/GABA binding site, 
the GabR Eb/O domain is capable of preferentially binding to GABA and forming an 
external aldimine.  To perform the role of a transcription regulator, GabR employs Y281 
to subdue the Eb/O domain’s catalytic potential by stabilizing the external aldimine 
formed and preventing its further modification. 
In summary, these studies were submitted to the Proceedings of the National 
Academy of Sciences of the United States of America (PNAS) for publication: Rui Wu, 
Ruslan Sanishvili, Boris R. Belitsky, Jose I. Juncosa, Hoang V. Le, Helaina J.S. Lehrer, 
Michael Farley, Richard B. Silverman, Gregory A. Petsko, Dagmar Ringe, and Dali Liu. 
(2015) 
Materials and Methods 
Materials.  Chemicals for the assays were purchased from Fisher Scientific 
(Pittsburgh, PA) and Sigma-Aldrich (St. Louis, MO); Cloning vectors were obtained 
from Integrated DNA Technologies (Coralville, IA). Escherichia coli BL21 (DE3) cells 
was purchased from New England BioLabs (Ipswich, MA). Bacterial growth media and 
antibiotics were obtained from Fisher Scientific and Sigma-Aldrich. Crystallization 
screen solutions and other crystallization supplies were purchased from Hampton 
Research (Aliso Viejo, CA) and Emerald Bio (Bedford, MA). All chemicals were of the 





Truncation & Cloning of GabR Eb/O Domain.  The sequence coding for GabR-
Eb/O domain was amplified by PCR using previously cloned full-length GabR (in pETite 
vector from Lucigen) as the template 46, the specific oligonucleotides as primers (forward 
primer designed as GAAGGAGATATACATATGATCGACCAGAGCGATTGGATA 
and the reverse primer designed as 
GTGATGGTGGTGATGATGATCCCCTGTAACGGGGATTTT), and Phusion HF 
DNA polymerase, following the manufacture’s instructions. The thermocycler program 
used included an initial denaturation for 120 s at 95 °C; 35 cycles of 95 °C for 30 s, 50 °C 
for 60 s, and 72 °C for 60 s; and a final extension of 72 °C for 5 min. The PCR product 
was inserted into a pETite vector (Lucigen) for recombinant expression of GabR Eb/O 
domain protein with a C-terminal His6-tag. 
Protein Expression and Purification.  Full-length GabR protein and L-aspartate 
aminotransferase from E. coli were expressed and purified as described 24.  The GabR 
Eb/O domain was overexpressed in E. coli and purified using a similar method. 
Transformed E. coli BL21 (DE3) cells were grown in 1L of LB supplemented with 50 
µg/ml kanamycin at 37 °C and 250 rpm until OD600 nm reached ~ 0.6. Protein expression 
was induced by the addition of 0.5 mM isopropyl-beta-D-1-thiogalactopyranoside 
(IPTG). Cells were incubated at 25 °C and harvested after 16 h by centrifuging at 4800 
rpm and 4 °C for 10 min. The cell paste was resuspended in the lysis buffer containing 1 
x PBS and 10 mM imidazole, pH 8.0 followed by sonication. The resulting suspension 





loaded onto a 10 ml His-Trap column (GE Life Sciences, Piscataway, NJ) containing 
Ni2+ and previously equilibrated with lysis buffer. Elution of the retained proteins was 
achieved with a linear imidazole gradient (25 column volume, 10 mM-485 mM). 
Fractions containing truncated EB/O domain were pooled, concentrated to 2 mL, and 
loaded onto a 16/60 Superdex 200 size exclusion column (GE Life Sciences) that was 
previously equilibrated with 84% elution buffer. Fractions containing enzyme were 
pooled, concentrated, and used freshly after exchanging into suitable buffers for the 
crystallization and biological assays. The wild type Asp-AT was overexpressed and 
purified with the protocol used by Onuffer and Kirsch 60. 
Crystallization of the GabR-Eb/O and X-ray Diffraction Data Collection.  After 
the initial crystallization screen and optimization, the GabR-Eb/O domain was 
crystallized via hanging drop methods at 25 °C. The hanging drops were prepared with 1 
µL of 12 mg/mL pre-incubated protein with inhibitor solution and 1 µL of the reservoir 
solution that contained 0.1 M Tris (pH 8.5) buffer and 20 % ethanol. Crystals were 
harvested in about 10 days. For cryo-cooling, crystals were transferred to the reservoir 
solution with 20 % glycerol as cryo protectant, and were flash-cooled by plunging in 
liquid nitrogen.  The cocrystallization of Asp-AT and AFPA were conducted according to 
previous studies 54, 55 The diffraction data were collected at GM/CA@APS beamlines 
23ID-B and 23ID-D at Advance Photon Source (Argonne National Laboratory, Argonne, 





recorded on 4x4 tiled CCD detectors (Rayonix, Evanston, IL) with 300×300 mm2 
sensitive are. All data were indexed, integrated, scaled and merged using HKL2000 41.  
Phasing, Model Building, and Refinement.  Diffraction data were phased with 
molecular replacement using the program Phaser 61in the CCP4 software suite 42.  
Previously solved full-length GabR structure 46, truncated to contain residues 107-479, 
was used as the search model. Rigid body refinement followed by restrained refinement 
was carried out in Refmac5. Model building was conducted using the program COOT 45.  
Iterative rounds of model building and refinement generated the final coordinates. 
In Vivo and in Vitro Assays for GabR-Dependent Transcription Activation.  The 
in vivo assay was conducted as previously described 24, using GABA or AFPA as 
effectors (0.625 – 20 mM).  In vitro GabR-dependent RNA polymerase reactions were 
performed as previously described 24.  The PCR-fragment (50nM) contained the gabR-
gabT regulatory region. The total reaction was carried in transcription buffer containing: 
40 mM Tris-HCl, 100 mM KCl, 10 mM MgCl2, 5% glycerol, 0.1 mM EDTA, 1 mM 
DTT, 0,1 mg/mL of BSA with four units of RNasin, 150 µM ATP, CTP, and GTP, 20 
µM UTP, 0.5 to 1 µl Ci of 32P-labeled UTP, and 0.02-0.04 unit of E. coli RNA 
polymerase. The reaction was incubated at 37 oC for 15 min and terminated by additional 
of 4 µL of the 20 mM EDTA, 95% formamide dye solution. The samples were 
subsequently heated at 80 oC for 5 min. The samples were then analyzed without further 
purification using 7 M urea / 5-6% polyacrylamide DNA sequencing gels. GABA was 





Nuclear Magnetic Resonance (NMR) Spectroscopy.  The protein (100 mg) was 
treated with AFPA. The molar ratio of the protein and AFPA was 2:1 to minimize free 
AFPA in the solution. The sample was concentrated to a volume of 0.4 mL by 
centrifugation. Deuterium oxide (0.15 mL) was added, and the solution was transferred to 
a 5 mm standard NMR tube. Fluorine NMR and proton-decoupled fluorine NMR spectra 
were taken at the Northwestern IMSERC facility on an Agilent DD2 500 MHz 
spectrometer with an Agilent 5 mm HFX probe at 26 oC. 19F NMR δ 229.87 (td, J1=25.3 
Hz, J2=21.4 Hz); proton-decoupled 19F NMR δ 229.87 (s). 
Structural Analysis and Figure Making. All structural analyses were conducted in 
COOT 45 and UCSF Chimera 53.  Structure comparison of the PLP/amino acid binding 
site was conducted in two steps (Figure 2b & Figure 6): First, the overall structural 
comparison/overlap was conducted in UCSF Chimera using the Needleman-Wunsch 
algorithm.  Second, manual adjustments were done by overlapping the pyridine ring of 
the PLP to achieve better pattern matching for the conserved key residues in the 








CONCLUSIONS AND FUTURE INVESTIGATIONS 
Full length GabR and Its Overall Structure 
In conclusion, the studies presented herein have as provided useful information to 
elucidate the transcription regulatorty mechanism of GabR, gain insight into the 
functionality of a unique MocR subfamily member, gain insight into the regulation 
pathway of the GABA shunt pathway, and provided some detailed molecular and 
chemical information for future anti-vurilance drug discovery.  
The obtained X-ray crystal structures of full length GabR provided information on 
the domain arragements of MocR subfamily’s transcriotion. To our best knowledge, these 
structures are the first X-ray crystal structures revealed in the GntR/MocR family. In 
addition, we also bead model obtained from the small angle X-ray scattering (SAXS) 
from protein solution sample (Figure 31), and structure impose indicated a high 
agreement between the bead model and the X-ray crystal structure (Figure 32). These 
suggested that the head-to-tail homodimer is probably physciology and in the functional 
geometry before transcription initiation. More detailed structure analysis provides offer 
more information:  
(1) To allow us to propose a model for the DNA and protein complex, further to 
spectulated how the interaction between DNA and GabR could position the regulatory 




       Figure 31. Small Angle X-ray Scattering (SAXS) bead model of full length GabR. 
Figure 32. Small Angle X-ray Scattering (SAXS) bead model of full length GabR 
superimpose with X-ray crystal structure of full length GabR. 
 
             (2) The reveal of the effector/s (GABA and PLP) binding pocket in effector 
binding and/or regulatory domain offer us a bold hypothesis that nature may recycled the 





transcription initation.  
(3) The linker region between the DNA binding domain and the effectors binding 
and /or regulatory domain shown to be the first case in GntR transcription regulator super 
family. The long linker suggestes a rather dramatic confirmation changes could happen 
upon binding to the effectos during the initiation of the transcription.  
Effector Binding Domain and Related Biological Function 
Although these structures have provided much needed answers in terms of static 
image before GabR associate with the effector GABA. There are still more details that 
need to be addressed to elucidate how effector triggers the transcription initiation. 
Further studies reveavled several Eb/O domain structures in complex with 
GABA, and molecular probe molecule AFPA. These two structures paved the way 
toward understanding how GabR functions. Our results suggest that upon binding to 
effector (GABA) or effectors analog (APFA), the internal aldimine would undergo a 
reaction with coming effector to form external aldimine. Using multiple approaches, such 
as: NMR, in vivo transcripton assay, in vitro transcription assay, we were able to 
determine that the external aldimine is a critical chemical species that triggers the 
transcription initation.  
GabR and DNA Complex 
One of the disadvantage of having only the Eb/O domain is no structural 
information could support during the initiation of the transcription if there is a 





the DNA binding domain have re-located upon binding to effectors. This will hopefully 
be addressed in the near future. Meanwhile a SAXS bead modeal of the GabR/DNA 
complex (Figure 33 and Figure 34) shed some light on how the DNA and GabR would 
interact. Noteably, the DNA fragment is at the bented confirmation from the 
interpretation from the SAXS bead model. Looks apparent to us this bented geometry 
somehow facilitate the transcription initiation, more specifically maybe facilitating RNA 













Figure 34. The fittng model of Small Angle X-ray Scattering (SAXS) bead stcuture of 






THE CRYSTAL STRUCTURE OF NITROSOMONAS EUROPAEA SUCROSE 
SYNTHASE REVEALS CRITICAL CONFORMATIONAL CHANGES AND 
INSIGHTS INTO THE SUCROSE METABOLISM IN PROKARYOTES 
Research Significance 
In this chapter we report the first crystal structure of a prokaryotic sucrose 
synthase from the non-photosynthetic bacterium Nitrosomonas europaea. The obtained 
structure was in an open form, whereas the only other available structure from the plant 
Arabidopsis thaliana was in a closed conformation. Comparative structural analysis 
revealed a “hinge-latch” combination, which is critical to transition between the open and 
closed forms of the enzyme. The N. europaea sucrose synthase shares the same fold as 
the GT-B family of the retaining glycosyltransferases. In addition, a triad of conserved 
homologous catalytic residues in the family showed to be functionally critical in the N. 
europaea sucrose synthase (Arg567, Lys572, Glu663). This implies that sucrose synthase 
shares not only a common origin with the GT-B family, but also a similar catalytic 
mechanism. The enzyme was proven to prefer transferring glucose from ADP-glucose 
rather than UDP-glucose like the eukaryotic counterparts. This predicts that these 
prokaryotic organisms have a different sucrose metabolic scenario from plants. 







In plants, sucrose (Suc) is a major photosynthetic product and plays a key role not 
only for carbon partition but also in sugar sensing, development, and regulation of gene 
expression 62-64. It was first thought that Suc metabolism was a characteristic of plants but 
it was later found in other oxygenic photosynthetic organisms 65, 66. In the last decade, 
Salerno and coworkers demonstrated the importance of Suc for carbon and nitrogen 
fixation in filamentous cyanobacteria 67, 68. More recently, genomic and phylogenetic 
analyses revealed the existence of Suc-related genes in non-photosynthetic prokaryotes 
such as proteobacteria, firmicutes, and planctomycetes 65, 66, 69. It has been suggested that 
these organisms acquired the genes of Suc metabolism by horizontal gene transfer 65, 66, 
69. However, analysis of the enzymes encoded by such genes is currently lacking. 
Nitrosomonas europaea is a chemo-litho-autotrophic bacterium that obtains 
energy by oxidizing ammonia to hydroxylamine and nitrite in presence of oxygen 70. It is 
a member of the β-proteobacteria group with a putative photosynthetic ancestor 71. N. 
europaea has potential for many biotechnological applications, including bioremediation 
of water contaminated with chlorinated aliphatic hydrocarbons 72 or ammonia, in 
combination with Paracoccus denitrifi 70. N. europaea displays some metabolic 
resemblance to photosynthetic organisms, but with marked differences. For instance, it 
possesses all the coding genes for enzymes of the Calvin-Benson cycle, but with two 
exceptions that could be replaced by other glycolytic enzymes 73. All the genes coding for 
enzymes from the tricarboxylic acid cycle were found in N. europaea 73; however, 





The evidence from genomic studies suggests that N. europaea can synthesize Suc 73; 
however, the biochemical properties of enzymes from Suc metabolism have not been 
characterized. Generally, in plants, Suc is synthesized from UDP-glucose (UDP-Glc) and 
fructose-6-phosphate (Fru-6P) in a reaction catalyzed by Suc-6-phosphate synthase (EC 
2.4.1.14), followed by removal of the phosphate group by Suc-6-phosphatase (EC 
3.1.3.24). The disaccharide can be degraded to Glc and Fru by invertases (EC 3.2.1.26) or 
cleaved by UDP to form UDP-Glc and Fru by Suc synthase (SucSase, EC 2.4.1.13) 63, 64. 
However, some plant SucSases have a certain degree of substrate promiscuity 75-82, and 
Thermosynechococcus elongatus prefers ADP 77. For that reason, a general reversible 
reaction could be written as:  
NDP + Suc ⇌ NDP-Glc + Fru 
Besides its physiological role, SucSase catalyzes a reversible reaction and its activity can 
be measured in both directions in vitro. In filamentous cyanobacteria, the products 
derived from Suc cleavage contribute to other biological processes, such as 
polysaccharides synthesis 83. Therefore, understanding the catalysis and the regulation of 
SucSase is of great significance. Recently, Zheng et al. 84 reported the crystal structure of 
the Arabidopsis thaliana SucSase (AthSucSase) in complex with UDP and fructose in a 
closed conformation. This enzyme is a homotetramer composed of four identical subunits 
of ~90 kDa and belongs to group 4 of the GT-B retaining glycosyltransferase family 
(http://www.cazy.org/GlycosylTransferases.html) 85. The reaction mechanism for this 
enzyme family has not been elucidated. But, it has been suggested that it favors the SNi-





Although several cyanobacterial 69, 77, 80 and plant 75, 78, 87-90 SucSases have been 
characterized, the enzyme from non-photosynthetic bacteria has never been studied and 
no structural information of any SucSase from bacterial sources is available. In this work 
we report the recombinant expression and biochemical characterization of N. europaea 
SucSase (NeuSucSase) and its crystal structure. We also determined the catalytic 
implications of highly conserved residues and the specificity for nucleotide substrates.  
Sequence Analysis 
To know how NeuSucSase relates to other SucSases from divergent organisms we 
constructed a phylogenetic tree using 117 amino acid sequences retrieved from the NCBI 
database (Figure 35, Table 3, and Figure 37). The tree comprised seven major branches, 
containing the sequences from cyanobacteria (group I; 21 sequences), proteobacteria 
(groups II and III; 17 sequences), the moss Physcomitrella patens subsp. patens (group 
IV; 4 sequences), and vascular plants (groups V, VI, and VII; 75 sequences) (Figure 35). 
The shape of the tree shown in Figure 35 is similar to the one published by Kolman et al. 
69. Group I is subdivided in two branches, containing the sequences encoded by the susA 
(cyan) and susB (orange) genes (Figure 35) 69. Most sequences from proteobacteria are 
















Figure 35.  Phylogenetic tree of SucSases. Group I contains sequences from 
cyanobacteria and is divided in two major branches, susA (cyan) and susB (orange) 
proteins; groups II and III (pink) contain sequences from proteobacteria; group IV 
contains the sequences from the moss P. patens (violet); and groups V, VI, and VII, 
which contain the sequences from vascular plants are further divided in two branches, 
dicots (green) and monocots (blue). Numbers for major branches are the bootstrap values 
obtained during tree reconstruction, as described in the “Materials and Methods” section. 
Neu, N. europaea; Ath, A. thaliana SucSase 1; Nos, Nostoc sp. PCC 7120 susA; Tel, T. 
elongatus. proteobacteria); though, the sequences from δ-proteobacterium MLMS-1 and 









































Organism Phylum Type Annotation 
     
158339122 Acaryochloris marina MBIC11017 cyanobacteria  sucrose synthase 
75908500 Anabaena variabilis ATCC 29413 cyanobacteria  sucrose synthase 
209523126 Arthrospira maxima CS-328 cyanobacteria  sucrose synthase 
284053161 Arthrospira platensis str. Paraca cyanobacteria  sucrose synthase 
218440696 Cyanothece sp. PCC 7424 cyanobacteria  sucrose synthase 
220907171 Cyanothece sp. PCC 7425 cyanobacteria  sucrose synthase 
332712456 Lyngbya majuscula 3L cyanobacteria  sucrose synthase 
254416162 Microcoleus chthonoplastes PCC 7420 cyanobacteria  sucrose synthase 
334117431 Microcoleus vaginatus FGP-2 cyanobacteria  sucrose synthase 
159031025 Microcystis aeruginosa PCC 7806 cyanobacteria  unnamed protein product 
119512682 Nodularia spumigena CCY9414 cyanobacteria  sucrose synthase 
186682280 Nostoc punctiforme PCC 73102 cyanobacteria  sucrose synthase 
17232477 Nostoc sp. PCC 7120 cyanobacteria  sucrose synthase 
22298591 Thermosynechococcus elongatus BP-1 cyanobacteria  sucrose synthase 
75909957 Anabaena variabilis ATCC 29413 cyanobacteria  sucrose synthase 
220909283 Cyanothece sp. PCC 7425 cyanobacteria  sucrose synthase 
332708740 Lyngbya majuscula 3L cyanobacteria  sucrose synthase 
119510624 Nodularia spumigena CCY9414 cyanobacteria  sucrose synthase 
298489784 Nostoc azollae 0708 cyanobacteria  sucrose synthase 






17228554 Nostoc sp. PCC 7120 cyanobacteria  sucrose synthase 
     
     
168009716 Physcomitrella patens subsp. patens streptophyta moss predicted protein 
168029793 Physcomitrella patens subsp. patens streptophyta moss predicted protein 
168035060 Physcomitrella patens subsp. patens streptophyta moss predicted protein 
168058907 Physcomitrella patens subsp. patens streptophyta moss predicted protein 
297795665 Arabidopsis lyrata subsp. lyrata streptophyta eudicot hypothetical protein 
297805240 Arabidopsis lyrata subsp. lyrata streptophyta eudicot hypothetical protein 
297812265 Arabidopsis lyrata subsp. lyrata streptophyta eudicot hypothetical protein 
297814081 Arabidopsis lyrata subsp. lyrata streptophyta eudicot hypothetical protein 
297818772 Arabidopsis lyrata subsp. lyrata streptophyta eudicot hypothetical protein 
297842089 Arabidopsis lyrata subsp. lyrata streptophyta eudicot hypothetical protein 
15219457 Arabidopsis thaliana streptophyta eudicot sucrose synthase 6 
42568160 Arabidopsis thaliana streptophyta eudicot sucrose synthase 5 
22331535 Arabidopsis thaliana streptophyta eudicot sucrose synthase 4 
15235300 Arabidopsis thaliana streptophyta eudicot sucrose synthase 3 
15239816 Arabidopsis thaliana streptophyta eudicot sucrose synthase 2 
15242073 Arabidopsis thaliana streptophyta eudicot sucrose synthase 1 
151176306 Beta vulgaris streptophyta eudicot sucrose synthase 1 
14530225 Beta vulgaris streptophyta eudicot sucrose synthase 
38425095 Beta vulgaris streptophyta eudicot sucrose synthase 
6682841 Citrus unshiu streptophyta eudicot sucrose synthase 
6683114 Citrus unshiu streptophyta eudicot sucrose synthase 
115310620 Coffea arabica streptophyta eudicot sucrose synthase 






4468153 Craterostigma plantagineum streptophyta eudicot sucrose synthase 
4468151 Craterostigma plantagineum streptophyta eudicot sucrose synthase 
324984223 Gossypium barbadense streptophyta eudicot sucrose synthase 
324984221 Gossypium barbadense streptophyta eudicot sucrose synthase 
324984229 Gossypium hirsutum streptophyta eudicot sucrose synthase 
258489633 Gossypium hirsutum streptophyta eudicot sucrose synthase 1 
3915046 Medicago sativa streptophyta eudicot sucrose synthase 
4584690 Medicago truncatula streptophyta eudicot sucrose synthase 
345286419 Orobanche ramosa streptophyta eudicot sucrose synthase 2 
345286417 Orobanche ramosa streptophyta eudicot sucrose synthase 1 
3915037 Pisum sativum streptophyta eudicot sucrose synthase 2 
3766299 Pisum sativum streptophyta eudicot sucrose synthase 
3377764 Pisum sativum streptophyta eudicot nodule-enhanced susy 
313770771 Populus trichocarpa streptophyta eudicot sucrose synthase 7 
313770769 Populus trichocarpa streptophyta eudicot sucrose synthase 6 
313770767 Populus trichocarpa streptophyta eudicot sucrose synthase 5 
313770765 Populus trichocarpa streptophyta eudicot sucrose synthase 4 
313770763 Populus trichocarpa streptophyta eudicot sucrose synthase 3 
313770761 Populus trichocarpa streptophyta eudicot sucrose synthase 2 
313770759 Populus trichocarpa streptophyta eudicot sucrose synthase 1 
255550319 Ricinus communis streptophyta eudicot sucrose synthase 
255551835 Ricinus communis streptophyta eudicot sucrose synthase 
255564236 Ricinus communis streptophyta eudicot sucrose synthase 
255570671 Ricinus communis streptophyta eudicot sucrose synthase 






304651490 Solanum lycopersicum streptophyta eudicot sucrose synthase isoform 4 
304651488 Solanum lycopersicum streptophyta eudicot sucrose synthase isoform 3 
3660531 Solanum lycopersicum streptophyta eudicot sucrose synthase 
31455440 Solanum tuberosum streptophyta eudicot sucrose synthase 4 
28629438 Solanum tuberosum streptophyta eudicot sucrose synthase 2 
29289943 Solanum tuberosum streptophyta eudicot sucrose synthase 
225431790 Vitis vinifera streptophyta eudicot hypothetical protein 
225437428 Vitis vinifera streptophyta eudicot hypothetical protein 
225444613 Vitis vinifera streptophyta eudicot hypothetical protein 
225466221 Vitis vinifera streptophyta eudicot hypothetical protein 
62865493 Bambusa oldhamii streptophyta monocot sucrose synthase 
17980241 Bambusa oldhamii streptophyta monocot sucrose synthase 
17980243 Bambusa oldhamii streptophyta monocot sucrose synthase 
326531526 Hordeum vulgare subsp. vulgare streptophyta monocot predicted protein 
326504012 Hordeum vulgare subsp. vulgare streptophyta monocot predicted protein 
241896730 Hordeum vulgare subsp. vulgare streptophyta monocot sucrose synthase 
3980298 Hordeum vulgare subsp. vulgare streptophyta monocot sucrose synthase 2 
239984690 Hordeum vulgare subsp. vulgare streptophyta monocot sucrose synthase 
115450038 Oryza sativa Japonica Group streptophyta monocot Os02g0831500 
115452927 Oryza sativa Japonica Group streptophyta monocot Os03g0340500 
115453437 Oryza sativa Japonica Group streptophyta monocot Os03g0401300 
115457664 Oryza sativa Japonica Group streptophyta monocot Os04g0309600 
115466896 Oryza sativa Japonica Group streptophyta monocot Os06g0194900 
115473359 Oryza sativa Japonica Group streptophyta monocot Os07g0616800 






242063616 Sorghum bicolor streptophyta monocot hypothetical protein 
242035533 Sorghum bicolor streptophyta monocot hypothetical protein 
242035817 Sorghum bicolor streptophyta monocot hypothetical protein 
162458268 Zea mays streptophyta monocot sucrose synthase 2 
162460681 Zea mays streptophyta monocot sucrose synthase 2 
162460741 Zea mays streptophyta monocot sucrose synthase 1 
     
     
114331077 Nitrosomonas eutropha C91 β-proteobacteria  sucrose synthase 
82703384 Nitrosospira multiformis ATCC 25196 β-proteobacteria  sucrose synthase 
30249199 Nitrosomonas europaea ATCC 19718 β-proteobacteria  sucrose synthase 
94264333 delta proteobacterium MLMS-1 δ-proteobacteria  sucrose synthase 
94266940 delta proteobacterium MLMS-1 δ-proteobacteria  sucrose synthase 
95929190 Desulfuromonas acetoxidans DSM 684 δ-proteobacteria  sucrose synthase 
297569306 Desulfurivibrio alkaliphilus AHT2 δ-proteobacteria  sucrose synthase 
298528445 Desulfonatronospira thiodismutans ASO3-1 δ-proteobacteria  sucrose synthase 
77166514 Nitrosococcus oceani ATCC 19707 γ-proteobacteria  sucrose synthase 
292493898 Nitrosococcus halophilus Nc4 γ-proteobacteria  sucrose synthase 
300115586 Nitrosococcus watsonii C-113 γ-proteobacteria  sucrose synthase 
350552412 Thiorhodospira sibirica ATCC 700588 γ-proteobacteria  sucrose synthase 
350574485 Thiorhodovibrio sp. 970 γ-proteobacteria  sucrose synthase 
220933364 Thioalkalivibrio sulfidophilus HL-EbGr7 γ-proteobacteria  sucrose synthase 
255021595 Acidithiobacillus caldus ATCC 51756 γ-proteobacteria  sucrose synthase 
198283392 Acidithiobacillus ferrooxidans ATCC 53993 γ-proteobacteria  sucrose synthase 






Figure 36. Alignment of sucrose synthases from Table 3. 
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114331077          ----------------------MTTIDTFTTCTLQNRDAVYTLLRRYFSTNRPLLLQSDLRDELLQLEKDCE-----RSDMLHEFVFHLQEGVFSSPWAY  
30249199           ----------------------MTTIDTLATCTQQNRDAVYTLLRRYFTANRTLLLQSDLREGLLQTEQDCG-----QSDMLRAFVFRLQEGIFSSPWAY  
82703384           ------------------------MLHKFEAWAADHRGDMYTLLRRWFELERPLLLHSDLGAVFNALSAEQAS--LLADSQVREIVNTLQEAVCRPPIVY  
198283392          ------------------------MPDNLRRCISQNPHCVAGLLRYLFNLQRPFLLYTDLQKAIGDFAADYGS--DADLVVLQEFFSRLQEAVLAEPWIY  
344199811          ------------------------MSDDLRRCINQNAHCVSGLLRHLFNLQRPFLLYTDLQKAISDFAADYGS--DADLVMLQEFFSRLQEAVLAEPWIY  
255021595          ------------------------MIEALRQQLLDDPRSWYAFLRHLVASQRDSWLYTDLQRACADFREQLPEGYAEGIGPLEDFVAHTQEVIFRDPWMV  
77166514           -------------------------MKELANFVGQHKEIVYLLLRRYLALQRPFLLRSDLVDEFDLFCKENDEGALLQDSPLATIIQAAQEAAVDPEWIY  
300115586          -------------------------MNELANFVGQHKEIIYLLLRRYLALQRPFLLRSDLVDEFDLFCKEDEGGALLQDSPLATIIQTVQEAAVDPEWIY  
292493898          --------------------------MELVDFVGKHRDVVYLLLRRYLALQKPFLLRSDLIDEFDNFCDEKEVGSVLRNSPLAAMIQAVQEAAVDPEWIY  
350552412          ------------------------MLETLQAFISRHREPAYLLLRRYFSENRCFLLRNELQDGLQALMADKN-LPELAHTPLGEMIRDAQEAVLSAPWVY  
220933364          ------------------------MTQPTRDALELHREAAYLLLRRYLALGRPFLLRSELQDGFQALCLERD-EPGLAESPLADLVGQAQEAVLAAPWVC  
350574485          --------MSEIFLEQRQEQSTGSLVPELIAFVREQRNLTHRVFHWLIGLQRPFLLHSDVADALAHLCRD---DPELGPTVLARALEQCQEVTLTPSWIY  
95929190           ------------------------MITELKTLFSEHRRTLYLLCQQFYTHEDSPFLLRSDLHQLFDLFIQTEQGQLLKDSAVEELFCSLQEASKNEPWIY  
298528445          ----------------------MIDVEELDGLDPELRKSLYLFLREMIRKEK-PFLLRSELQDMLADFFEDEEHGRHESALVFEVFRYTQVATIRNPWVY  
297602308          -----------MASKLSFKRMDSIAETMPDALRQSRYQMKRCFQRYVSKGKRLLKNQQLMEELEKS-LDDKVENEKLVEGFLGYIICSTQEAVVLPPFVA  
115457664          -----------MASKLSFKRMDSIAETMPDALRQSRYQMKRCFQRYVSKGKRLLKNQQLMEELEKS-LDDKVEKEKLVEGFLGYIICSTQEAVVLPPFVA  
326504012          ----------MASAKLSFKRMDSVAESMPDALRQSRYQMKRCFQRYVSRGRRLLKNQQLMEELDRS-LDDELEKEKLVEGFLGYIICSTQEAVVLPPFVA  
115450038          -------------MAVGLRRSDSIADMMPEALRQSRYQMKRCFQRYVSQGKRLMKRQQLLDELDKS-VDDKADKDQLLQGFLGYVISSTQEAAVLPPFVA  
326531526          ---------MASSSSMPLRRSDSVADMMPEALRQRRYQMKRCFQSYVSKGRRLMKNQQLMEELETSEGDDKVEKARLAEGFLGYVICSTQEAVVLPPLVA  
242063616          --------------------------MMPEALRQSRYHMKRCFQRFVSQGSRLMKQQHLLEELHGGGSADNN-KQLAADGFLGHVISCTHEAVVLPPYVA  
42568160           ----------------MEMTSGSLGNGIPEAMGQNRGNIKRCLEKYIENGRRVMKLNELMDEMEIV-INDVTQRRRVMEGDLGKILCFTQAVVIPPN-VA  
297805240          ------------------MPSGSLGNGIPEAIGQNRGNIKRCLEKYIENGRRVMKLNELMDEMEIV-INDVMQRRRVMEGDLGKILCFTQEAVVIPPNVA  
313770765          --------------MATLKRSDSIADNMPEALKQSRYHMKKCFAKYIEKGRRTMKLQQLLDEMENV-IDDQVERTRVLEGLLGDIWFSIQEAVVNPPYVA  
313770767          --------------MATLKRSDSIADNMPEALKQSRYHMKRCFAKYIEKGRRTMKLQQLLDEMENV-IDDQVERTRVLQGLLGDIWFSIQEAVVNPPYVA  
255584097          ----------MAASGATLKRSDSIADNMPEALKQSRYHMKKCFSKYVQKGRRIMKLQNLLDEMEDV-IDDKIERTKVLEGLLGDIWYSTQEAVVNPPYVA  
225466221          -----------MASKPTLKRADSMAENMPDALRQSRYHMKRCFARYIGKGKRLMKLNHLMDEMEAV-IDDKNERTQVLEGVLGFILCSTQEAVAIPPHVI  
313770769          -----------MASQTALQRSETITESMPEALRQSRYHMKKCFSRFVAPGKRLMKRQHLMDEVDES-IQDKNERQKVLEGLLGYILSCTQEAAVIPPFVA  
313770771          -----------MASAPVLKRSETIAESMPDALRQSRYHMRICFSRFVAPGRRLMKRQHIMDEVDKS-IQDKNERQKVLEGLLGYILSSTQEAAVVPPFVA  
255570671          -----------MASGPVIKRSETIAESMPDALRQSRYHMKRCFSSLAASGNRLLKHHNIMEEVEKS-IQDKGERKKVLEGLLGYILSSTQEAAVIPPYVA  
15219457           ---------MSSSSQAMLQKSDSIAEKMPDALKQSRYHMKRCFASFVGGGKKLMKREHLMNEIEKC-IEDSRERSKILEGLFGYILTCTQEAAVVPPFVA  
297842089          ---------MSSSSQAMLQRSDSIADKMPDALKQSRYHMKRCFASFVGGGKKLMKRKHLMNEIEKC-IEDSRERSKILEGLFGYILTCTQEAAVVPPFVA  
115466896          -------------MAAKLARLHSLRERLGATFSSHPNELIALFSRYVNQGKGMLQRHQLLAEFD-ALIEA---DKEKYA-PFEDILRAAQEAIVLPPWVA  
17980243           -------------MAAKLTRLHSLRERLSATFSSHPNELIALFSRYVHQGKGMLQRHQLLAEFD-ALIAA---DKEKYA-PFEDILRAAQEAIVLPPWVA  
162460741          -------------MAAKLTRLHSLRERLGATFSSHPNELIALFSRYVHQGKGMLQRHQLLAEFD-ALFDS---DKEKYA-PFEDILRAAQEAIVLPPWVA  
239984690          -------------MAAKLTRLHSLRERLGATFSSHPNELIALFSRYVHQGKGMLQRHQLLAEFD-ALFES---DKEKYA-PFEDILRAAQEAIVLPPWVA  
162460681          --------MGEGAGDRVLSRLHSVRERIGDSLSAHPNELVAVFTRLKNLGKGMLQPHQIIAEYN-NAIPEAEREKLKDG-AFEDVLRAAQEAIVIPPWVA  
242035533          --------MGEAAGDRVLSRLHSVRERIGDSLSAHPNELVAVFTRLKNLGKGMLQPHQIIAEYN-SAIPEAEREKLKDG-AFEDVLRAAQEAIVIPPWVA  
62865493           --------MGEAAGDRVLSRLHSVRERIGDSLSAHPNELVAVFTRLVNLGKGMLQPHQIIAEYN-NAIPEAEREKLKDG-AFEDVLRAAQEAIVIPPWVA  
17980241           --------MGETAGDRVLSRLHSVRERIGDSLSAHPNELVAVFTRLVNLGKGMLQPHQIIAEYN-NAIPEAERDKLKDG-AFEDVLRAAQEAIVIPPWVA  
115453437          --------MGEAAGDRVLSRLHSVRERIGDSLSAHPNELVAVFTRLVNLGKGMLQAHQIIAEYN-NAISEADREKLKDG-AFEDVLRSAQEGIVISPWVA  
115473359          --------MGETTGERALTRLHSMRERIGDSLSAHTNELVAVFSRLVNQGKGMLQPHQIIAEYN-AAIPEGEREKLKDS-ALEDVLRGAQEAIVIPPWIA  
3980298            --------MGETAGERALSRVHSVRERIGHSLSAHTNELVAVFSRLVNQGKGMLQPHQITAEYN-AAIPEAEREKLKNT-PFEDLLRGAQEAIVIPPWVA  






297812265          ----------MANAERMITRVHSQRERLNETLVSERNEVLALLSRVEAKGKGILQQNQIIAEF--EALPEETQKKLEGG-PFFDLLKSTQEAIVLPPWVA  
22331535           ----------MANAERVITRVHSQRERLDATLVAQKNEVFALLSRVEAKGKGILQHHQIIAEF--EAMPLETQKKLKGG-AFFEFLRSAQEAIVLPPFVA  
297818772          ----------MANAERVITRVHSQRERLDATLIAQKNEVLALLSRVEAKGKGILQYHQIIAEF--EAMPLETQKKLQGG-AFFEILRSAQEAIVLPPFVA  
313770759          ------------MAERALTRVHSIRERVDETLKAHRNEIVALLTRIEGKGKGILQHHQIVAEF--EAIPEDTRKTLAGG-AFAEVLRSTQEAIVVPPWIA  
313770761          --------------MSVLTRVQSIRERLDETLKTHRNEIVALLTRIEGKGKGILQHHQIIAEF--EAIPEEIRKILAGG-AFSEVLRSTQEAIVLPPWVA  
255550319          ------------MAERVITRVHSIRERLDETLAANRNEIVALLTRIEGKGKGILQHHQIIAEF--EAIPEDIRKNLLDS-VFGEVLRSTQEAIVLPPWVA  
324984223          ------------MANPVITRVHSLRERLDETLLAHRNEILALLSRIEGKGKGILQHHQIILEF--EAIPEENRKKLADG-AFFEVLKASQEAIVLPPWVA  
258489633          ------------MANPVITRVHSLRERLDETLLAHRNEILALLSRIEGKGKGILQHHQIILEF--EAIPEENRKKLADG-AFFEVLKASQEAIVLPPWVA  
324984221          ------------MADRVITRVHSLRERLDETLLAHRNEILALLSRIEGKGKGILQHHQIILEF--EAIPEENRKKLANG-AFFEVLKASQEAIVLPPWVA  
324984229          ------------MADRVITRVHSLRERLDETLLAHRNEILALLSRIEGKGKGILQHHQIILEF--EAIPEENRKKLANG-AFFEVLKASQEAIVLPPWVA  
6683114            ------------MAERALTRVHSLRERLDETLSAHRNEILALLSRIEGKGKGILQNHQLIAEF--ESISEENRKHLTEG-AFGEVLRATQEAIVLPPWVA  
4584690            ------------MATERLTRVHSLKERLDETLTANRNEILALLSRLEAKGKGILQHHQVIAEF--EEIPEDSRQKLTDG-AFGEVLRSTQEAIVLPPWVA  
3915046            ------------MATERLTRVHSLKERLDETLTANRNEILALLSRLEAKGKGILQHHQVIAEF--EEIPEESRQKLTDG-AFGEVLRSTQEAIVLPPWVA  
3766299            ------------MATDRLTRVHSLRERLDETLTANRNEILALLSRIEAKGKGILQHHQVIAEF--EEIPEENRQKLTDG-AFGEVLRSTQEAIVLPPWVA  
3377764            ------------MATDRLTRVHSLRERLDETLTANRNEILALLSRIEAKGKGILQHHQVIAEF--EEIPEENRQKLTDG-AFGEVLRSTQEAIVLPPWVA  
225444613          ------------MADGVLTGVHSLRARVDETLTAHRNEILSFLSRIEGHGKGILQPHQLLAEF--EALPEVNRKKLSDG-PFGDILKSIQEAIVLPPWIA  
3660531            ------------MAERVLTRVHRLRERVDATLAAHRNEILLFLSRIESHGKGILKPHELLAEF--DAIRQDDKDKLNEH-AFEELLKSTQEAIVLPPWVA  
31455440           ------------MAERVLTRVHSLRERVDATLAAHRNEILLFLSRIESHGKGILKPHELLAEF--DAIRQDDKNKLNEH-AFEELLKSTQEAIVLPPWVA  
304651488          ------------MAQRVLTRVHSLRERLDATLDAHRNEILLFLSRIESHGKGILKPHQLLAEF--ESIQKEDKDKLNDH-AFEEVLKSTQEAIVLPPWVA  
28629438           ------------MAERVLTRVHSLRERLDATLAAHRNEILLFLSRIESHGKGILKPHQLLAEF--ESIHKEDKDKLNDH-AFEEVLKSTQEAIVLPPWVA  
115310618          ------------MAERVLTRVHSLRERLDATLAAHRNDVLLFMSRLETHGKGILKPHQLLAEF--EEINKDGKQKIHDH-AFEEVLKSTQEAIVLPPWVA  
345286417          ------------MAERVLTRVHSLRERLDATLAAHRNEILLFLSRVEAHGKGILKPHQLVAEF--EAICQADKAKLQDH-AFQEVLKSTQEAIVLPPWVA  
38425095           -------------MASRLTRVPSLKERLDETLTAQRNEIISFLSKIASHGKGILQPHEVLSEF--EAVAD--KHKLADG-PFGEVLRHTQETIVLPPWIT  
15235300           ------------MANPKLTRVLSTRDRVQDTLSAHRNELVALLSRYVDQGKGILQPHNLIDELESVIGDDETKKSLSDG-PFGEILKSAMEAIVVPPFVA  
297814081          ------------MANPKLTRIISTRDRVQDTLSAHRNELVALLSRYVDQGKGILQPHNLIDELESVIGDDATKQSLSDG-PFGEILKSAMEAIVVPPFVA  
6682841            ------------MAAPKLSRIPSIRERVEDTLSVHRNELVSLLSRYVAQGKGILQPHVLIDELDNIFGDDEGRQNLRDG-PFSEVIKSAQEAIVLPPFVA  
255564236          ------------MAAPKFARIPSMRERVEDTLSAHRNELVSLLCRYVDQGKGILQPHTLIDEFDNVVGDGESRQMLRNG-PFGEVLKSAQEAIVLPPFVA  
313770763          ------------MANPKLERIPSMRERVQDTLSANRNVLVSLLSRYVEQGKGILHPNNLIDELDNIVCDDAARLSLKDG-PFSEVLKAAQEAIVLPPFVA  
3915037            -----------MSTHPKFTRVPSIRDRVQDTLSAHRNELISLLSRYVAQGKGILQPHNLIDELDNILGEDHATLDLKNG-PFGQIINSAQEAIVLPPFVA  
225437428          ------------MVTPKLGRSPSIRDRVEDTLSAHRNELVALLSRYVAQGNGILQPHHLIDELDNIVGDDVGRQKLSDG-PFGQILKSTQEAIILPPFVA  
162458268          ------------MSAPKLDRNPSIRDRVEDTLHAHRNELVALLSKYVNKGKGILQPHHILDALDEVQGS--GGRALAEG-PFLDVLRSAQEAIVLPPFVA  
242035817          ------------MSAPKLDRNASIRDRVEDTLHAHRNELVALLSKYVNKGKGILQPHHILDALDEVQGS--GVRALAEG-PFLDVLRSAQEAIVLPPFVA  
115452927          ------------MSGPKLDRTPSIRDRVEDTLHAHRNELVALLSKYVSQGKGILQPHHILDALDEVQSS--GGRALVEG-PFLDVLRSAQEAIVLPPFVA  
241896730          ------------MAAPKLDRTPSIRERVEDTLHAHRNELVALLSKYVSKGKGILQPHRILDTLDEVQVS--GGSALAEG-PFLDVLRSSQEAIVLPPFVA  
304651490          ------------MSNPKLSRIPSMRERVEDTLSAHRNQLVALLSRYVAQGKGILQPHHLIDELNNAVCDDTACEKLKEG-PFCEILKSTQEAIVLPPFVA  
29289943           ------------MSNPKFTRVPSMRERVEDTLSAHRNQLVALLSRYVAQGKGILQPHHLIDEFNSAVCDDTACEKLKEG-PFCEILKSTQEAIVLPPFVA  
115310620          ------------MATIKLQKLPSIRERVEDTLSAHRNELVALLSRYVAQGKGMLQPHHLIDELDNIVVDETACKKLSEG-PFSEVLRSAQEAIVLPPFVA  
4468153            ------------MATPKLTKIPSMRERVEVTLAAHRNELVSLLSRYVAQGKGLLQSHHLIDELENIILDDDAKKKLSDG-PFSEVLRSAQEAIVLPPFVA  
345286419          ------------MSNPKLTKITSMREGVEDTLSAHRNQLVSLLSRYVAQGKGILQPHHLIDELDNIIDDDSCRAKLNDG-PFGEVLKTAQEAIVLPPFVA  
4468151            -----------MTTHEKAPASPCMRERVEETLADHRDELISLLSRYTSRGKCLLQSHQLMDELEDAIAEDPANKKLSDG-CFNEVLSSAQEAIVLPPFVI  
151176306          -------------MAPKLTRIPSMRERVEDTLSVHRNELVSLLSKYVAQGKCLLQPHHLIDGLESVIGEDKGKQILSDG-PFSEVLRSAQEAIVVPPFVA  
14530225           -------------MAPKLTRIPSMRERVEDTLSVHRNELVSLLSKYVAQGKCLLQPHHLIDGLESVIGEDKGKQILSDG-PFSEVLRSAQEAIVVPPFVA  
15239816           ---------------MPTGRFETMREWVYDAISAQRNELLSLFSRYVAQGKGILQSHQLIDEFLKTVKVDGTLEDLNKS-PFMKVLQSAEEAIVLPPFVA  
297795665          ---------------MPTGRFETMREWVHDAISAQRNELLSLFSRYVAQGKGILQSHQLIDEFLKTVKVDGTTEDLNKS-PFMKVLQSAEEAIVLPPFVA  
225431790          --------------MPHRYDGQSMRERFQETLSAHRNELVSLFTGYVAQGKGILQPHHMIDELDKVVGKDEGMQKLRDS-PFSKVLKSAQEAIVLPPFVA  
255551835          ------------------MPLSSFRDRVHDILSVYRVELVSLLTRHVAEGKGILQTHDLLCELDNVVVDDEAMEKLRRS-PFVEVLQSTQEAIVLPPFVA  






168035060          -----MAANGVAPKKPVLQRLNSIQERVQSAVQEHRNVIIDLLSRYVKQGRTHLQPHHIVDELN-SLTEADRVTEIKDS-AFGLLLLNCQEAIVLPPWLG  
168058907          ----------MSQPRPTLRRLTSLKERVESSLQEHRNELLHLLQGYVAQGRSILQPHHLQDQLA-AVHDA---AHIQDT-AIGKLLQNCQEAMVSPPWVG  
168029793          -------MDGIATQAGALPRMTSMNKKIQGSLDDHRNENLRILSKLTAKRKALMQPHEVIDELN-KAAEESGSLKIMDG-PLARVFSLCQEAIVLAPWVG  
94266940           ----------------------MYDDLGSFIDEAEIPLLREFLLSLPPSEPPLLLRNDVLQAFQQFCEAHSEVDEPLG---CWRFLRKVQEILQADDLLV  
94264333           ----------------------MYDDLGSFIDEAEIPLLREFLLSLPPSEPPLLLRNDVLQAFQQFCESHPEVDDPLG---CWRFLRKVQEILQADDLLV  
297569306          ----------------------MENDLGCFVDEQDVAPLREFLLSLQRPEPPLLLRNDILLAFQQFAGQRPAAEGDLAG--AWRFLRKVQEVLLADDLLI  
254416162          ----------------------MLNLIQNVLDCEERNDLRQFASQLKQSGPRYLLRNDILSDFSKYCADQEKPDYFYHSSNLGRLIYYTQEIILDQESLY  
332712456          ----------------------MLNLIQDVLESDEKSDLRHFTSQLKTAEPRYLLRNEILAAFNEYCTKHKKSEYFYHSSHLGKLIYYTQEIILEDESLC  
17232477           ----------------------MSELMQAILDSEEKHDLRGFISELRQQDKNYLLRNDILNVYAEYCSKCQKPETSYKFSNLSKLIYYTQEIIQEDSNFC  
75908500           ----------------------MSELMQAILDSEEKNDLRAFISELRLQDKNYLLRNDILNVYSEYCSKCQKSETSYKFSNLGKLIYYTQEIIQEDSNFC  
186682280          ----------------------MSELLQAVLDSEERSDLRSFLSELRQQEKKYLLRNDILNVYSEYCSKSQKPEAYYTTSELGKLIYYTQEIIQEDSNFC  
119512682          MQGGGVSFVLPVKNANLMLGVPMSELIQAILDSEEKSDLRSFASQLRQEEKNYLLRNDILNVFIDYCSKSEKSETSAASSRLGKLIYYTQEIIQEDSSLC  
334117431          ----------------------MSELFQAVIASDEKTELRQFVSDLRALGNKYLLRNDIVNAFAAYCTKYEKPEQFHQSSLLSKLIYYVQEIILEDGSLC  
218440696          ----------------------MSGLIETVLNSEEKIVLWQFIGELRTSDKRYLLRNDIVCAFEDFCKRNGNSQ-KIDSSPLGQMIHYTQEIILEEESIC  
159031025          ----------------------MAELIEAIANSNEKKDLQQFLHQLRQLEKPYLLRNDLLTAFADYCQRLDKPASFRQSSLLAKLIYYTQETILESESFC  
220907171          ----------------------MSELITAVLASEERRELKEFLLQLQRQDNRYLLRNEILAAFSQYGEEAGKPKEFFHSSQLGKLINFTQEIILEDESFC  
22298591           ---------------------MTCVLLKAVVESDERADLRQFSRILQLGEKRYLLRNDILDAFADYCRDQERPVPPPSESRLSKLVFYTQEIIVDNESLC  
158339122          ----------------------MSQLIQAVLNSDEKTDLRQFASEVHNQPERYLLRNDILSVFDTFCEKYEKTPAFQLSSRLQKLIYYTQEILVEDENLY  
284053161          ----------------------MSELIQNVIESDEKQDLRQFYSELRISEKRYLLRNDILQAFADYCLKFQKAAHFVDSSHLSKLIYYTQEIILENESIC  
209523126          ----------------------MSELIQNVIDSDEKQDLRQFASELRISEKRYLLRNDILQAFADYCLKFQKSDHFVHSSNLSKLIYYTQEIILENESIC  
17228554           ---------------------MHELFHPIFANGEEKAALQQLIIALDASGKRYFLRNEILHTFSQYCQQAQKPTYFYYSSSVGKLIQYTHEIVLAEDGTW  
75909957           ---------------------MHELFHPIFANGEEKAALQQLIIALDSSGKRYFLRNEILHTFSQYCQQAQKPTYFYYSSSVGKLIQYTHEIVLAEDSTW  
186685043          ----------------------MYELVQAVFNGDEKTALHQLIYTLSASGKRYLLRNEILQAFADYCHESQKPAYFYHSSSIGKLIQYTHEIIIEEESTW  
119510624          ----------------------MHELFETVLNKDEKITLRQFISELSDTDKRYFLRNEILHNFAEFCHQYQKPTYFYYSSSIGRLIHNTHEMILDEQGTW  
298489784          ----------------------MYELFQAVLTSDEKTALRQFLLILHDFDKCYFLRNEILQAFTNYCHQSEKPTYFYHSSSLGTLIHYTHEIIIEDENTW  
220909283          ----------------------MRDLVESVLTSDEKIDLARFLDRLIQQGKQYFLRNEILQHFSSYCREAEKAAHFYYASYLGKLLHYTHELILEEGAVW  
332708740          ----------------------MSSLLRAVLQSNEKADLRQFISQLRSEQERYFLRNQILQAFDNYCTTHDKPAYFKRTSSIAELLNYTHEIILEEKNLW  
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114331077          FVLRPGIAELEFVRMHQEHLMPEKITINEFLGFKE-TVTKG-EA--IESILEVDFGPFNRAFPKLRESRSIGQGVIFLNRQLSSEMFT-RIE--AGSTRL  
30249199           LALRPEIAKWEFMRIHQEHLIPEKLTISEFLKFKE-TVVKG-EA--TESVLEVDFGPFNRGFPRLKESRSIGQGVIFLNRKLSSEMFS-RIE--AGHTSL  
82703384           MAAREEAGCWWYARLHLDRLIPEAVTVSEYLAFKE-LLVNPEGA--NEPVLEIDFAPFNRGSPKLKEIRSIGQGVIFLNKQLAGGLFG-QLG--LGSDKL  
198283392          LAWRPSPGRWTYLRMHWEQLHLETLAPSDYLAFKE-RQVLPAND--QEPILTVDFEDFRAAPYHLQDEDTIGQGLIYMNRRLAGRLFG-NIK--TGRQSI  
344199811          LAWRPSPGRWTYLRLHREQLNLETLTAGDYLAFKE-RQVLPAND--QEPVLTVDFEDFRAVSYRLHDEATIGQGLMYMNRRLAGQLFG-DIK--AGRQSI  
255021595          FAWRPRPGRWIYVRIHREQLALEELSTDAYLQAKE-GIVGLGAE--GEAVLTVDFRDFRPVSRRLRDESTIGDGLTHLNRRLAGRIFS-DLA--AGRSQI  
77166514           LSVRPRIANWEYYRIHTEVMQIETVPVSQFLEFKERLVLGPTQP--QSWPLKIDMGPFNREFPRLRETRSIGRGMDFLNRHLSNQLFN-ELE--TGGQYL  
300115586          LSVRPRIANWEYYRIHTEVMHIETVTVSQFLEFKERLVLGTSQP--QSWPLKIDMGPFNREFPRLKETRSIGRGMDFLNRHLSNQLFN-ELE--TGGQYL  
292493898          LSIRPGIASWEYYRIHAEVIQIETVTISQFLEFKARLVLGPQQD--EPWPLKVDMGPFNREFPRLSETRSIGRGMDFLNRHLSSQLFK-ELE--TGGQCL  
350552412          FAVRPRVGRWWYLRLHVDDLYPDSVEASEFLGFKERLISAQAG---TERPLEFDIEPFDRGFPKLRESRSIGRGMEFLNRKLSSQLFD-GGD--QGLEKL  
220933364          LALRPRIGRWQFLRIHADDLSVEDLGVSEFLAIKERLVCPAPR---HGRPLEFDIEPFNREFPRLRETRSIGRGVEFLNRKLSSQLFD-RAN--GGLDKL  
350574485          LALRRRVARWEFVRLHIETMDAQPVSVAEYLAFKERTATGGPE---DPWGLEIDMSPFYRDQFKLREEGSIGRGVEFLNRRLSSRLFE-ELG--KGDRRL  
95929190           LAARSTIGHWNYYRLHSEEIEIDEIDVSEYLEFKERLVGYEAPS--DEYLLELDMTPFNREFPKLQEARSIGRGVEFLNRHLSSKLFV-EKR--EGSRKI  
298528445          LAVRPEIAKWQYFRFHVEDVLFDEIGASDYLKFDEMQVNNSTQV--DEFLLEIDLEPFNREFPKLNEYTYIGKGVDFLNRHLSGQFFQ-DKK--RGHEKL  
297602308          FAVRMNPGIWEYVKVHSDDLSVEGITPSEYLKFKETLYDEKWAKDDNS--LEVDFGALDLSTPHLTLPSSIGNGLQFVSKFMSSKLG--GKP--ESMKPL  






326504012          FAVRMNPGIWEYVKVHADDLSVEGITPSEYLKFKDTLYDEKWAKDDNS--LEVDFGALDLSTPRLTLPSSIGNGMQFVSKFMSSKLN--GKP--ESMKPL  
115450038          FAVRMNPGIWEFVKVHSANLSVEQMTPSDYLKNKEALVDDKWGAYDDDSQLEVDFGALDLSTPHLTLPSSIGKGAHLVSRFMSSKLT--DNK-----KPL  
326531526          FAVRTNPGVWEFIRVHSGDLSVEQITPADYLKCKETLYDEKWARDDNS--LEVDFGALDLSTPHLALPSSIGNGMQFISRFMSSKLS--GKP--ESMKPL  
242063616          LAVRRNPGVWEYITVHSGDLTVQQITPSDYLKRK-----EILFLYDNSSQLEVNLGALDLSTPRLTLPCSIGNGMHLVSRFLSSRLGGGGGR--TKNKAL  
42568160           FAVRGTPGNWQYVKVNSSNLSVEALSSTQYLKLKEFLFDENWANDENA--LEVDFGALDFTLPWLSLSSSIGNGLSFVSSKLGGRLN-------DNPQSL  
297805240          FAVRGNPGIWQYTKVNSSNLSVEALSSTQYFKLKELLFDENWANDENA--LEVDFGALDFTLPWLSLPSSIGNGVSFVSSKLGSRLN-------DNPQSL  
313770765          FSIRPSPGFWEYVKVNSANLSVEGITVTDYLKFKEMIYDENWAKDANA--LEVDFGAFDFSVPHLTLSSSIGNGLGFVSKFVTSKLSG--RL--ENAQPL  
313770767          LSIRPSPGFWEFVKVNSADLSVEGITATDYLKFKEMIYDENWAKDANA--LEVDFGAFDFSVPHLTLSSSIGNGLGFVSKFATSKLSG--RL--ESAQPL  
255584097          FAIRPSPGFWEFVRVNSADLAVDGINVSEYLKFKEMIFEESWAKDVNT--LEVDFGAFDFSMPKLTLSSSIGNGHNFVSKFITSKLNG--RP--ENAQPL  
225466221          FSIRSNPGFWEYVKVSSDDLSVEAITAADYLKFKEMVFDENWAKDDNA--LELNFSAFDFPMPRLTLSSSIGNGVSLVSKFMTSKLNG--NS--QSAQPL  
313770769          FAVRPNPGFWEYVKVNAEDLSVEGISVSEYLQLKEMVFDEKWANNENA--LELDFGAMDFSTPRLTLSSSIGNGVNYMSKFMSSKLSG--SS--EAAKPL  
313770771          FAVRPNPGFWEYVKVNAEDLSVDGISVSEYLQFKEMIFDEKWASNENA--LEVDFGAMDFSTPRLTLSSSIGNGLNYMSKFMSSKLRG--NS--DAAKPL  
255570671          FAVRPNPGFWEYVKVNADDLNVDGISPSEYLQFKEMVFDEKWAKDENA--LEIDFGAIDFSIPRLNLSSSIGNGMSFISKFMSSNLCG--SY--SSAKPL  
15219457           LAARPNPGFWEYVKVNSGDLTVDEITATDYLKLKESVFDESWSKDENA--LEIDFGAIDFTSPRLSLSSSIGKGADYISKFISSKLGG--KS--DKLEPL  
297842089          LAARPNPGFWEYVKVNSGDLTVDEITANDYLKLKESVFDESWSKDENA--LEIDFGAIDFTSPRLSLSSSIGKGADYISKFISSKLGG--KS--GRLEPL  
115466896          LAIRPRPGVWDYIRVNVSELAVEELSVSEYLAFKEQLVDGHTN---SNFVLELDFEPFNASFPRPSMSKSIGNGVQFLNRHLSSKLFQ--DK--ESLYPL  
17980243           LAIRPRPGVWDYIRVNVSELAVEELSVSEYLEFKEQLVDGHTN---SNFVLELDFEPFNASFPRPSMSKSIGNGVQFLNRHLSSKLFQ--DK--ESLYPL  
162460741          LAIRPRPGVWDYIRVNVSELAVEELSVSEYLAFKEQLVDGQSN---SNFVLELDFEPFNASFPRPSMSKSIGNGVQFLNRHLSSKLFQ--DK--ESLYPL  
239984690          LAIRPRTGVWDYIRVNVSELAVEELTVSEYLAFKEQLVDEHAS---SKFVLELDFEPFNASFPRPSMSKSIGNGVQFLNRHLSSKLFQ--DK--ESLYPL  
162460681          LAIRPRPGVWEYVRVNVSELAVEELRVPEYLQFKEQLVEEGPN---NNFVLELDFEPFNASFPRPSLSKSIGNGVQFLNRHLSSKLFH--DK--ESMYPL  
242035533          LAIRPRPGVWEYVRVNVSELAVEELRVPEYLQFKEQLVEEGPN---NNFVLELDFEPFNASFPRPSLSKSIGNGVQFLNRHLSSKLFH--DK--ESMYPL  
62865493           LAIRPRPGVWEYVRVNVSELAVEELRVPEYLQFKEQLVEGSTN---NNFVLELDLEPFNASFPRPSLSKSIGNGVQFLNRHLSSKLFH--DK--ESMYPL  
17980241           LAIRPRPGVWEYVRVNVSELAVEELRVPEYLQFKEQLVEGSTN---NNFVLELDFEPFNASFPRPSLSKSIGNGVQFLNRHLSSKLFH--DK--ESMYPL  
115453437          LAIRPRPGVWEYVRVNVSELAVELLTVPEYLQFKEQLVEEGTN---NNFVLELDFEPFNASFPRPSLSKSIGNGVQFLNRHLSSKLFH--DK--ESMYPL  
115473359          LAIRPRPGVWEYLRINVSQLGVEELSVPEYLQFKEQLVDGSTQ---NNFVLELDFEPFNASFPRPSLSKSIGNGVQFLNRHLSSKLFH--DK--ESMYPL  
3980298            LAIRPRPGVWEYVRVNVSELGVEELSVLRYLQFKEQLANGRTD---NNFVLELDFGPFNASFPRPSLSKSIGNGVQFLNRHLSSKLFH--DK--ESMYPL  
15242073           LAVRPRPGVWEYLRVNLHALVVEELQPAEFLHFKEELVDGVKN---GNFTLELDFEPFNASIPRPTLHKYIGNGVDFLNRHLSAKLFH--DK--ESLLPL  
297812265          LAVRPRPGVWEYIRVNLHALVVDELQPAEFLHFKEELVDGVKN---GDFTLELDFEPFNASFPRPTLNKYIGNGVEFLNRHLSAKLFH--DK--ESLLPL  
22331535           LAVRPRPGVWEYVRVNLHDLVVEELQASEYLQFKEELVDGIKN---GNFTLELDFEPFNAAFPRPTLNKYIGDGVEFLNRHLSAKLFH--DK--ESLHPL  
297818772          LAVRPRPGVWEYVRVNLHDLVVDELQASEYLQFKEELVDGIRN---GNFTLELDFEPFNAAFPRPTLNKYIGNGVEFLNRHLSAKLFH--DK--ESLHPL  
313770759          LALRPRPGVWEYIRLNVQALVVEELRVAEYLHFKEELVDGGCN---GNFVLELDFEPFNASFPRPTLSKYIGNGVEFLNRHLSAKLFH--DK--ESLHPL  
313770761          LAVRPRPGVWEYVRVNVQALVVEELRVAEYLHFKEELVDGGSN---GNFVLELDFEPFSASFPRPTLSKYIGNGVEFLNRHLSAKLFH--DK--ESLHPL  
255550319          LAVRPRPGVWEYIRVNVHALVVEELRVAEYLHFKEELVDGSQN---GNFVLELDFEPFNASFPRPTLSKYIGNGVEFLNRHLSAKLFH--DK--ESLHPL  
324984223          LAVRPRPGVWEYIRVNVHALVVEELTVAEYLHFKEELVDGSSN---GNFVLELDFEPFNSSFPRPTLSKSIGNGVEFLNRHLSAKLFH--DK--ESMHPL  
258489633          LAVRPRPGVWEYIRVNVHALVVEELTVAEYLHFKEELVDGSSN---GNFVLELDFEPFNSSFPRPTLSKSVGNGVEFLNRHLSAKLFH--DK--ESMHPL  
324984221          LAVRPRPGVWEYIRVNVHALVVEELTVAEYLHFKEELVDGSSN---GNFVLELDFEPFNSSFPRPTLSKSIGNGVEFLNRHLSAKLFH--DK--ESMHPL  
324984229          LAVRPRPGVWEYIRVNVHALVVEELTVAEYLHFKEELVDGSSN---GNFVLELDFEPFNSSFPRPTLSKSIGNGVEFLNRHLSAKLFH--DK--ESMHPL  
6683114            LAVRPRPGVWEYIRVNVHALVVEELLVAEYLHFKEELVDGGSN---GNFVLELDFEPFNASFPRPTLSKSIGNGVEFLNRHLSAKLFH--DK--ESMHPL  
4584690            LAVRPRPGIWEYLRVNVHALVVENLQPAEFLKFKEELVDGSAN---GNFVLELDFEPFTASFPRPTLNKSIGNGVQFLNRHLSAKLFH--DK--ESLHPL  
3915046            LAVRPRPGIWEYLRVNVHALVVENLQPAEFLKFKEELVDGSAN---GNFVLELDFEPFTASFPRPTLNKSIGNGVHFLNRHLSAKLFH--DK--ESLHPL  
3766299            LAVRPRPGVWEYLRVNVHALVVENLQPAEFLKFKEELVDGSAN---GNFVLELDFEPFTASFPRPTLNKSIGNGVQFLNRHLSAKLFH--DK--ESLHPL  
3377764            LAVRPRPGVWEYLRVNVHALVVENLQPAEFLKFKEELVDGSAN---GNFVLELDFEPFTASFPRPTLNKSIGNGVQFLNRHLSAKLFH--DK--ESLHPL  
225444613          FAVRPRPGVWEYIRVNVSALVVEELLVPEYLHFKEELVDGSCN---GNFVLELDFEPFTASVPRPTLSKSIGNGVEFLNRHLSAKMFH--DK--DSMQPL  
3660531            LAIRLRPGVWEYVRVNVNALVVEELSVPEYLQFKEELVDGASN---GNFVLELDFEPFTASFPKPTLTKSIGNGVEFLNRHLSAKMFH--DK--ESMAPL  
31455440           LAIRLRPGVWEYIRVNVNALVVEELSVPEYLQFKEELVDGASN---GNFVLELDFEPFTASFPKPTLTKSIGNGVEFLNRHLSAKMFH--DK--ESMTPL  
304651488          LAIRLRPGVWEYVRVNVNALSVEELTVPEFLQFKEELVNGTSS---DNFVLELDFEPFTASFPKPTLTKSIGNGVEFLNRHLSAKMFH--DK--ESMTPL  






115310618          LAIRLRPGVWEYVRVNVHALVVEELTVPEYLHFKEELVDGSKN---GNFVLELDFEPFTASFPKPTLTKYIGDGVEFLNRHLSAKMFH--DK--ESMAPL  
345286417          LAIRLRPGVWEYVRVNVNALVVEELTVPQYLHFKEELVNGAAN---GNFVLELDFEPFTASFPKPTLTKSIGNGVEFLNRHLSAKMFH--DR--ESMTPL  
38425095           LAVRPRPGIWEYIRVNVDALAVEELTPSQFLHVKEELVDGSTN---GNFVLELDFEPFTASFPRPTLSKSIGNGVEFLNRHLSAKMFH--DK--ESMRPL  
15235300           LAVRPRPGVWEYVRVNVFELSVEQLTVSEYLRFKEELVDGPNS---DPFCLELDFEPFNANVPRPSRSSSIGNGVQFLNRHLSSVMFR--NK--DCLEPL  
297814081          LAVRPRPGVWEYVRVNVFELSVEQLTVSEYLRFKEELVDGPNS---DPFPLELDFEPFNANVPRPSRSSSIGNGVQFLNRHLSSVMFR--NK--DCLEPL  
6682841            IAVRPRPGVWEYVRVNVYELSVEQLSVSEYLHFKEELVDAAFN---ERFVLELDFEPFNATFPRPNRSSSIGNGVQFLNRHLSSSMFR--NK--DCLEPL  
255564236          IAIRPRPGIWEYVRVNVHDLSVEQLDVSQYLRFKEELVDGSSN---DPYVLELDFEPFNADVPKPHRSSSIGNGVQFLNRHLSSIMFR--NK--DCLEPL  
313770763          VSIRPRPGVWEYVRVDVSQLNVEELTVSQYLRFKEELVDGPSN---DPYVLELDFEPFNAAFPRPTRSSSIGNGVQYLNRHLSSNMFR--NK--DTLEPL  
3915037            IAVRPRPGVWEYVRVNVFELSVEQLSVSEYLSFKEELVEGKSN---DNIILELDLEPFNASFPRPTRSSSIGNGVQFLNRHLSSNMFR--NK--DCLEPL  
225437428          IAVRPRPGVWEYVRVNVHELSVDQLSVSEYLRFKEELVDGMFN---DYYVLELDFEPFNASFPRPNRSSSIGNGVQFLNRHLSSIMFR--NK--ESLEPL  
162458268          IAVRPRPGVWEYVRVNVHELSVEQLTVSEYLRFKEELVDGQHN---DPYVLELDFEPFNVSVPRPNRSSSIGNGVQFLNRHLSSIMFR--NR--DCLEPL  
242035817          IAVRPRPGVWEYVRVNVHELSVEQLTVSEYLRFKEDLVDGQHN---DPYILELDFEPFNASVPRPNRSSSIGNGVQFLNRHLSSIMFR--NR--DCLEPL  
115452927          IAVRPRPGVWEYVRVNVHELSVEQLTVSEYLRFKEELVDGQYN---DPYILELDFEPFNASVPRPNRSSSIGNGVQFLNRHLSSIMFR--NK--DCLEPL  
241896730          IAVRPRPGVWEYVRVNVHELNVEQLSVSEYLRFKEELVDGQHN---NPYVLELDFEPFTALIPRPSRSSSIGNGVQFLNRHLSSILFR--NR--DCLEPL  
304651490          IAVRPRPGVWEYVRVNVYDLSVEQLTVPEYLRFKEELVDGEDHN--HLFVLELDFEPFNASVPRPSRSSSIGNGVQFLNRHLSSNMFR--SN--ESLDPL  
29289943           IAVRPRPGVWEYVRVNVYDLSVEQLTIPEYLRFKEELVDGEDN---NLFVLELDFEPFNASVPRPSRSSSIGNGVQFLNRHLSSNMFR--SK--ESLDPL  
115310620          IAVRPRPGVWEYVRVNVYELSVDQLSISEYLHLKEELVDGRSE---DHLVLELDFEPFNATFPRPTRSSYIGNGVQFLNRHLSSIMFR--NK--DSLEPL  
4468153            LAVRPRPGVWEFVRVNVYQLSVDELTISEYLRFKEELVDGGID---DNFVLELDFEPFNASFPRPTRSSYIGNGVQFLNRHLSSIMFR--NK--DCLEPL  
345286419          IAIRPRPGVWEFVRVNVYELSVDELTVSEYLRFKEALVDGQHD---DHYVLELDFEPFNATFPRPTRSSSIGNGVQFLNRHLSSIMFR--NK--ESLDPL  
4468151            LAVRPRPGVWAYVRVNMQELSIDELTVSEYLCFKEELVDGRGF---DPYVLELDFEPFNATFPRPSRSSSIGNGVQFLNRHLSSIMFR--NK--DSLEPL  
151176306          IAVRPRPGVWEYVRVNVSELNVEQLTVSEYLHFKEELVDGKAD---DHYVLELDFEPFNESVPRPTRSSSIGNGVQFLNRHLSSSMFR--NK--DCLEPL  
14530225           IAVRPRPGVWEYVRVNVSELNVEQLTVSEYLHFKEELVDGKAD---DHYVLELDFEPFNESVPRPTRSSSIGNGVQFLNRHLSSSMFC--NK--DCLEPL  
15239816           LAIRPRPGVREYVRVNVYELSVDHLTVSEYLRFKEELVNGHAN---GDYLLELDFEPFNATLPRPTRSSSIGNGVQFLNRHLSSIMFR--NK--ESMEPL  
297795665          LAIRPRPGVREYVRVNVYELSVDHLTVSEYLRFKEELVNGHAN---GDYLLELDFEPFNATLPRPTRSSSIGNGVQFLNRHLSSIMFR--NK--ESMEPL  
225431790          IAIRPRPGVWEYIRVNVYELNVDQLSVSEYLQFKEELVDGQIK---GNYVLELDFEPFNATFPRPTRSSSIGNGVQFLNRHLSSIMFR--NK--ESLEPL  
255551835          MAIRPRPGVWEYVRVNVYELSVDHLNVSEFLRFKEDLADGECD---ESYVLELDFEPFNATFPRPTRSSSIGNGVQFLNRHLSSVMFR--QK--ESLEPL  
168009716          FAVRPRPGIWEYVRINVEELTLEELSVSEYLSFKEQLAN-GTEY--DPFVLELDFAPFNANFPHMTRPSSIGHGVQFLNRHLSSKLFH--TP--DSMEPL  
168035060          LAVRPRPGIWEYLRINVEELILEELSVSEYLGFKEQLANSTDVR--DPFLLELDMAPFNSNFPRMTRPSSIGHGVEFLNRHLSLKLFQ--TA--DGIEPL  
168058907          FAVRPRPGIWEYVRINVEELIVEELSVSEYLGFKEQLSLGSDSI--DLYVLELDFEPFNAHFPRMTRPSSIGHGVQFLNRHLSSKLFQ--NP--ESMEPL  
168029793          LALRPRPGLWEYMRINVEEMIVEELTTSEYLSFKECLADENRCN--DLYVLELDIEPFNVGFPRMTRPQSIGNGVQFLNRHLSSRLFR--DA--DSMEPL  
94266940           IVYRHRRANCLIFAINGQSDKLLKLSVGDFLAIKERLLRPELPP--QQRTLNLNLAPFYDYGPTLKDPNTIGQGIKFLNRHMSGRLANHPEK---WNRFL  
94264333           IVYRHRRANCLIFAINGQSDKLLKLSVGDFLAIKERLLRPELPP--QQRTLNLNLAPFYDYGPTLKDPNTIGQGIKFLNRHMSGRLANHPEK---WNRFL  
297569306          ILYRHRRASCRIFALSEDDDRLIPVTLIDFLAIKERLIRPNLPP--QQRTLAINLAPFYDYGPTLKDPNTIGQGIKFLNRHMSGNLSNHPEK---WNRSL  
254416162          LIIRPKIAEQEAF-QVLEDLTVEPITIQTLLDVRDRFVNHYRPN--EGDVLELDFKPFYDYSPIIRDSKNIGKGVQFLNRFLSSKLFQDPRQ---WQESL  
332712456          LIIRPKIAAKRAF-RLFEDLRAQEVTPEELLDIGDRFVNRYNPK--VGEVLQLDFQPFYDYSPLIRDPKNIGKGVRFLNRYLSSKLFQDPEQ---WLESL  
17232477           FIIRPKIAAQEVY-RLTADLDVEPMTVQELLDLRDRLVNKFHPY--EGDILELDFGPFYDYTPTIRDPKNIGKGVQYLNRYLSSKLFQDSQQ---WLESL  
75908500           FIIRPNIAAQEVY-RLTADLDVEPMTVQELLDLRDRLVNKFHPH--EGDLLELDFGPFYDYTPTIRDPKNIGKGVQYLNRYLSSKLFQDSQQ---WLESL  
186682280          FIIRSKIASQEVY-WLTSDLSIEPMTVQDLLDLRDRLVNKFHPN--DGDLLELDFGPFYDYTPIIRDPKNIGKGVQFLNRYLSSKIFQDSKQ---LLENL  
119512682          FIIRPKIASQEVY-RLTEDLNVEPMSVQELLDLRDRFVNKYHPL--EGDLLELDFGPFYDYTPVIRDPKNIGKGVQFLNRYLSSKIFQDSKQ---LLDSL  
334117431          VLLRPKIASMEIV-RVADDLTVEQMTVQELLDVRDRFVNHFHPQ--EGDILELDFGPFYDYSPTIRDPKNIGKGVQFLNRYLSSKLFQDARQ---WQETL  
218440696          IVYRPKIARQEVY-RLREDTPIEHLSVQQLLDVRDHFVNQFHPD--EGDVFEIDFEPFYDYSPTIRDSKNIGKGVRFLNRYMSSKLFQDPRQ---WLETL  
159031025          LVVRPQIALSQAF-RLTDDLTCEPISVQELLDLRDRLVHRSHPE--EGDLLELDFRPFYDYSPIIRDAKNIGKGVQFLNRFLSSRLFQAEQTGEQWLQSA  
220907171          LVLRPNIASQSVF-RITSDLAVEEMRVKELLTVRDRLVQRHHPE--EGELLELDFQPFYDYSPTIRDAKNIGKGMQLLTRYLSSKLFQDPQE---WTQVL  
22298591           WIVRPRIAQQEVCRLLVEDLTIVPMTIPELLDLRDRLVNHYHPN--EGDVFEIDVQPFYDYSPIIRDAKNIGKGVEFLNRYLSSKLFQDPRQ---WQQNL  
158339122          LIIRPKIASEEAYRLDPRELVYEQIQIDELLDLRDRFVGHYHPQ--EGDILEIDFRPFYDYSPVIRDPKNIGRGVQYLNRYLSSKMFEGPQQ---WLFSL  
284053161          LIVRPQIATQERF-RLRPDLSVDVMSVQELLDLRDHFVDHHHPH--DGNVFAIDFGPFYDYSPQLRDSKNIGKGVRYLNRYLSSKLFQDSNQ---WLESL  






17228554           FVVRPRIASQEVWRLTSDLAKFDSMSIDAFLDVSDRLVNAYEP-----NILEIDLNSFYEASPSISDPRNIGQGLAFLNRYLCSQIATDPQY---WVELV  
75909957           FVVRPRIANQEVWRLTSDLAKFDSMPIDAFLDVSDRLVNAYEP-----NILEIDLSSFYEASPSISDPRNIGQGLAFLNRYLCSQIATDPQY---WVELV  
186685043          FVIRPKIANQEVWRLTANLDSFEQMTQQALLDVRDRLVNRYQP-----GILEIDLHPFYEDSPRIDDPRNIGQGLAYLNRYLCNQLLTDPEY---WVEML  
119510624          FVVRPRIGSQQMWRLQADFSGFEPMTPQAWLDVSDRLVNRYQP-----HILEIDFQPFAEESTRITDPRNIGQGLAFLNRYLCDQLSNDTHY---WLEVI  
298489784          FVVRPRIASQEVWRLTADFTHFDLMTPKAFLDVSDRLVNRYQP-----HILEIDLHPFYQTSPRISDPREIGQGLTFLNHYLCNQFVSDPQY---WLETF  
220909283          LLVRSTINDQQIWQISTDLNRYGRMSPHDLLEVRDRLVNRSQS-----SILEINVHPFYNMAYAVEDPRNIGQGLAFLNHYLCNQVSIDRTR---WLDVL  
332708740          LLLRTRVASQEIYRLAADLTSFEPMPVEELLSLRDRWVKRYFPE--KGGLLEIDVGPFYKNTPTIRDPRKIGNGLEFLNRYLSSQLFADSEQ---WLEEL  
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114331077          LHFLGVHTID----------GQQLMFTSNSHNINMVRSQLRQALEMLEAVDGTTPWAELSSDMSKIGFAPGWGHNAARVAETMNMLMDILEAPSPSALEA  
30249199           LHFLGVHAIE----------GQQLMFSNNSHDIHAVRNQLRQALEMLETLDGTTPWIELAPKMNQLGFAPGWGHNANRVAETMNMLMDILEAPSPSALEE  
82703384           LHFLTVHSMD----------GKQLMLGGNFADVPALRSGLRRALSMLEKYPDDTEWKDVAEPLGGIGFAPGWGNCVGRVSETMSLLVDILEAPSPQILES  
198283392          LDFLAVHKLN----------GQSLMVHDQPPDFEALR----QTVQYLATLPKTKPWTEFAAEMTYRGFAPGWGDTAGRVRETMRLLMDLLDAPSAEGLQA  
344199811          LDFLAVHKLN----------GQSLMVHDQPPDFEALR----RTVQYLATLPKTQAWTEIAAEMTHRGFAPGWGDTVGRVRETMRLLMDLLDAPSAEGLQA  
255021595          LEFLSLHRLD----------GQNLMLSNGNTDFDSLR----QTVQYLGTLPRETPWAEIREDMRRRGFAPGWGNTAGRVRETMRLLMDLLDSPSPAALES  
77166514           LSFLSVHHCR----------GQPLMLNDRIQDVQGLRCALRLAMDFLGGFQEAAEWDAVGHKLQEFGFERGWGRTAARIQDSFSLLMDILEAPEPGNLEH  
300115586          LSFLSVHHCR----------GQPLMLNDRIQDVRGLRRALRLAMDFLGSFQEAAEWDAVGHKLQELGFERGWGRTAVRMQDSFSLLMDILEAPEPGNLEH  
292493898          LNFLSVHHCR----------GQPLMLNDRIQDLRGLRRALRRAVDFLGGFPKAAEWEAVGHKLQELGFERGWGGTVAQMEDSFSLLMDILEAPDPGNLER  
350552412          FHFLHEHCCE----------GQILMINERVRNVNELRGVIRRCEKLLNGYARHTPWAEVAPLLRDVGLEPGWGSDVGRILETLRLLSDLLEAPSPETLER  
220933364          FRFLREHRCD----------GRLLMINDRIRDVDALRVAIRDAEQRLARLKRDTPWADFAHPLQDLGFEPGWGRDAGRVQETLRLLSELLEAPSPESLER  
350574485          LNFLRMHSHR----------GQVLMLNDTITDVAGLRNALRQALLPLRRRAASTPYEELAPDLRPLGFEPGWGCDAARVRNTMGLLLDILEAPSPQTIEE  
95929190           LDFLRVHQHR----------STQLMLNGMIEDVPGLQAALRKGVKFLKNCDEDTCWDDVAPTMMSYGFQPGWGRTLEDILEMFHMLMDILEAPDPQNLEK  
298528445          FEFLRLHQIE----------GKQLMLNGHIETVSGLRSALRKALTFLKKQDPSQKWSGISRHMQTLGFQPGWGKDVERVRENLELLREILEAPTPNILAS  
297602308          LDYLLTLNYR----------GEKLMINDTIDTVSKLQTALLLAEVFVSGLPKYTPYLKFEQRFQEWGLEKGWGDTAERCKETLNCLSEVLQAPDPTNMEK  
115457664          LDYLLTLNYR----------GEKLMINDTIDTVSKLQTALLLAEVFVSGLPKYTPYLKFEQRFQEWGLERGWGDTAERCKETLNCLSEVLQAPDPTNMEK  
326504012          LDYLLALNYR----------GEKLMVNDTIDTVNKLQTALLLAEVFVSGLPKFTPYLKFEQRFQEWGLEKGWGENAERCKETLNFLSEVLQAPDPINMEK  
115450038          LDYLLALSHR----------GDKLMINDILDTVDKLQTALLLAEVYVAGLHPDTNYSEFEQKFQEWGLEKGWGDTAETCKETLSSLSEVLQAPDPINMEK  
326531526          LDYLLALNYR----------GEKLMISDSLDTADKLQTALLLAEVFVASLEKSTPYQQFEQKFQEWGLEKGWGDTAETCRETLNFLSEVLQAPDPINMEK  
242063616          LDYLLALRYYRRRPGDQQQINNKLLISDTLDTVGKLQAALLLAQAFVSEQHPDTPYQQMAHRFQEWGLEKGWGDTAEACGHTLACLAEVLQAPDPASIHR  
42568160           VDYLLSLEHQ----------GEKLMMNETLNTARKLEMSLILADVFLSELPKDTPFQAFELRFKECGFEKGWGESAGRVKETMRILSEILQAPDPQNIDR  
297805240          VDYLLSLEHQ----------GEKLMMNETLNTARKLEMSLILADVFLSELPKDTPFQAFELRFKEWGFEKGWGESAGRVKETMRILSEILQAPDPHNIDR  
313770765          VDYLLSLNRQ----------GEKLMINETLGTVGKLQMALIVAEVYLSGLAKDTPYQNFEISFKEWGFEKGWGDTAERVKETMRCLSEVLQAPDPMNMEK  
313770767          VDYLLSLNHE----------GEKLMINETLSSVRKLRMALIVAEAYLSGLPKDTQYQNFETSFKAWGFEKGWGNTAERVKETMRCLSEVLQAPDPLNMEN  
255584097          VDYLLSLTHH----------GEKLMINENLSTVAKLQMALIVAEVYLSGLAGDTPYQNFELSFKEWGFEKGWGDTAERAKETMRSLSEVLQAPDPVNMEK  
225466221          VDYLLSLNHQ----------GEKLMITNTLNTPTKLQMALIVAEVFVSALPKDTPYPSFELRFKEWGFEKGWGNTAERVKETMRSLSEALEAPDPMNMEK  
313770769          LDYLLALNHQ----------GENLMINQTLDTVAKLQEALIVAEVVVSAFPKDTPYQDFQQRLRELGFETGWGDTAERVKETMRLLSESLQAPYPMKLQL  
313770771          LDYLLALDHQ----------GENLMINQALDSVSKLQAALIVAEVVVSAFPKDAPYQDFQQSLKRLGFEKGWGDTAERVKETMRMLSESLQAPEPVKLEL  
255570671          LDYLLALNYQ----------GEELMINEKLDTVAKLQKALTGAEDVLSVFSKEAAYKNVQQSLKEMGFEKGWGNTAERVKETMRLLSESLQAPDPAKLEL  
15219457           LNYLLRLNHH----------GENLMINDDLNTVAKLQKSLMLAVIVVSTYSKHTPYETFAQRLKEMGFEKGWGDTAERVKETMIILSEVLEAPDNGKLDL  
297842089          LNYLLRLNHH----------GENLMINDDLNTVAKLQKSLMLAVIVVSTYPKHTPYETFALRLKEMGFEKGWGDTAERVKETMVMLSEVLEAPDNVKLDL  
115466896          LNFLKAHNHK----------GTTMMLNDRIQSLRGLQSSLRKAEEYLMGIPQDTPYSEFNHRFQELGLEKGWGDCAKRVLDTIHLLLDLLEAPDPANLEK  
17980243           LNFLKAHNHK----------GTTMMLNDRIQSLRGLQSALRKAEEYLMSFPQDTPYSEFNHRFQELGLEKGWGDTAKRVLDTIHLLLDLLEAPDPANLEK  
162460741          LNFLKAHNYK----------GTTMMLNDRIQSLRGLQSSLRKAEEYLLSVPQDTPYSEFNHRFQELGLEKGWGDTAKRVLDTLHLLLDLLEAPDPANLEK  
239984690          LNFLKAHNYK----------GTTMMLNDRIQSLRGLQSALRKAEEYLISIPEDTPSSEFNHRFQELGLEKGWGDTAKRVHDTIHLLLDLLEAPDPASLEK  






242035533          LNFLRAHNYK----------GMTMMLNDRIRSLSALQGALRKAEEHLSTLQADTPYSEFHHRFQELGLEKGWGDCAKRAQETIHLLLDLLEAPDPSTLEK  
62865493           LNFLRAHNYK----------GMTMMLNDRIRSLSALQGALRKAEEHLSGLSADTSYSDFHHRFQELGLEKGWGDCAKRAQETIHLLLDLLEAPDPSTLEK  
17980241           LNFLRAHNYK----------GMTMMLNDRIRSLSALQGALRKAEEHLSGLSADTPYSDFHHRFQELGLEKGWGDCAKRAQETIHLLLDLLEAPDPSTLEK  
115453437          LNFLRAHNYK----------GMTMMLNDRIRSLSALQGALRKAEEHLSGLSADTPYSEFHHRFQELGLEKGWGDCAKRSQETIHLLLDLLEAPDPSTLEK  
115473359          LNFLRAHNYK----------GMTMMLNDRIRSLDALQGALRKAEKHLAGITADTPYSEFHHRFQELGLEKGWGDCAQRVRETIHLLLDLLEAPEPSALEK  
3980298            LNFLRAHNYK----------GMAMMLNDRIRSLGTLQGALRKAETHLSGLPADTPYSEFHHRFQELGLEKGWGDCAQRASETIHLLLDLLEAPDPSSLEK  
15242073           LKFLRLHSHQ----------GKNLMLSEKIQNLNTLQHTLRKAEEYLAELKSETLYEEFEAKFEEIGLERGWGDNAERVLDMIRLLLDLLEAPDPCTLET  
297812265          LKFLRRHSHQ----------GKNLMLSEKIQNLNTLQHTLRKAEEYLAELKPETPYEEFEAKFEEIGLERGWGDNAERVLDMIRLLLDLLEAPDPCTLET  
22331535           LKFLRLHSHE----------GKTLMLNNRIQNLNTLQHNLRKAEEYLMELKPETLYSEFEHKFQEIGLERGWGDTAERVLNMIRLLLDLLEAPDPCTLEN  
297818772          LKFLRLHSHE----------GKTLMLNDRIQNLNTLQHNLRKAEEYLMELKPETPYSEFDHKFQGIGLERGWGDTAVRVLDMIRLLLDLLEAPDPCTLGN  
313770759          LAFLKVHCHK----------GKNMMLNDRIRNLDSLQYVLRKAEEFLSTLKPDTPYSQFEHKFQEIGLERGWGDTAERVLEMIRLLLDLLEAPDPCTLET  
313770761          LAFLKVHCHK----------GKNMMLNDRIHNLDSLQYVLRKAEEYLSSLKPETPYSQFEHKFQEIGLERGWGNTAERVLQMIQLLLDLLEAPDPCTLET  
255550319          LEFLKVHCHK----------GKNMMLNDRIQNLNSLQYVLRKAEEYLVTLPAKTPYSEFEHKFQEIGLERGWGDTAERVLEMIRLLLDLLEAPDPCTLET  
324984223          LEFLRVHCHK----------GKNMMLNDRIQNLNALQHVLRKAEEYLGTLPPETPCAEFEHRFQEIGLERGWGDTAQRVLEMIQLLLDLLEAPDPCTLEK  
258489633          LEFLRVHCHK----------GKNMMLNDRIQNLNALQHVLRKAEEYLGTLPPETPCAGFEHRFQEIGLERGWGDTAQRVLEMIQLLLDLLEAPDPCTLEK  
324984221          LEFLRVHCHK----------GKNMMLNDRIQNLNALQHVLRKAEEYLGTLPPETPCAEFEHRFQEIGLERGWGDTAERVLEMIQLLLGLLEAPDPCTLEK  
324984229          LEFLRVHCHK----------GKNMMLNDRIQNLNALQHVLRKAEEYLGTLPPETPCAEFEHRFQEIGLERGWGDTAERVLEMIQLLLDLLEAPDPCTLEK  
6683114            LEFLRVHCHK----------GKNMMLNDRIQNLNSLQHVLRKAEEYLTTVAPETPFSELALRFQEIGLERGWGDTAERALEMIQLLLDLLEAPDPCTLET  
4584690            LEFLRLHSYK----------GKTLMLNDRIQNPDSLQHVLRKAEEYLSTIDPETPYSEFEHRFQEIGLERGWGDTAERVLESIQLLLDLLEAPDPCTLET  
3915046            LEFLRLHSYK----------GKTLMLNDRIQNPDSLQHVLRKAEEYLSTIDPETPYSEFEHRFQEIGLERGWGDTAERVLESIQLLLDLLEAPDPCTLES  
3766299            LEFLRLHSYK----------GKTLMLNDRIQNPDSLQHVLRKAEEYLGTVAPDTPYSEFEHRFQEIGLERGWGDTAERVLESIQLLLDLLEAPDPCTLET  
3377764            LEFLRLHSYK----------GKTLMLNDRIQNPDSLQHVLRKAEEYLGTVAPDTPYSEFEHRFQEIGLERGWGDTAERVLESIQLLLDLLEAPDPCTLET  
225444613          LDFLRTHQYK----------GKTMMLNDRIQNLDTLQFVLRKAEEYLSSQAPETPYPEFEHKFQEIGLERGWGDTAERVLEMIHLLLDLLEAPDPCTLEQ  
3660531            LEFLRAHHYK----------GKTMMLNDRIHNSNTLQNVLRKAEEYLIMLPPETPFFEFEHKFQEIGLEKGWGDTAERVLEMVCMLLDLLEAPDSCTLEK  
31455440           LEFLRAHHYK----------GKTMMLNDRIQNSNTLQNVLRKAEEYLIMLSPDTPYFEFEHKFQEIGLEKGWGDTAERVLEMVCMLLDLLEAPDSCTLEK  
304651488          LEFLRVHHYN----------GKSMMLNDRIQNLYTLQKVLRKAEEYLTTLSPETSYSSFEHKFQEIGLERGWGDTAERVLEMICMLLDLLEAPDSCTLEK  
28629438           LEFLRVHHYK----------GKTMMLNDRIQNLYTLQKVLRKAEEYLTTLSPETSYSAFEHKFQEIGLERGWGDTAERVLEMICMLLDLLEAPDSCTLEK  
115310618          LDFLRVHQYK----------GKTMMLNDRIKDLNTLQAVLRKAEEYLTTLSADTPYSEFEHKFQEIGLERGWGDTAERVLEMICMLLDLLGAPDSCTLEK  
345286417          LDFPRMHSYK----------GKTMMLNDRIRNLNSLQAVLRKAEEYLSTLPPETPFEDFEHKFQEIGLERGWGDNAQRVSGMISMLLDLLEAPDSCTLER  
38425095           LDFLRMHHYK----------GKTIMLNDRIQNLDSLQAVLRKAEEFLTTIPADTPYSEFDHKFQEIGLERGWGDNAERVMDMIQLLLDLLEAPDSCTLEK  
15235300           LDFLRVHKYK----------GHPLMLNDRIQSISRLQIQLSKAEDHISKLSQETPFSEFEYALQGMGFEKGWGDTAGRVLEMMHLLSDILQAPDPSSLEK  
297814081          LDFLRVHKYK----------GHPLMLNDRIQSISRLESQLNKAEDHISKLSQETPFSEFEYALQGMGFEKGWGDTAGRVLEMMHLLSDILQAPDPSTLEK  
6682841            LDFLRAHKYK----------GHLLMLNDRIQSISRLQSSLSKAEDHLSKLPPDTPFSQFEYVLQGMGFEKGWGDTAEHVLEMMHLLLDILQAPDPSTLEK  
255564236          NDFLRAHKYK----------GHALMLNDRIQNISKLQSALAKAEEYVSKLPPDVPFSEFEYTLQGLGFERGWGDTAARVSEMMHLLLDILQAPDPSTLEK  
313770763          LDFLRVHKYK----------GHALMLNDRIKSVSRLQSALLKAEEYISKLPSETLYTEFEYTFQGMGFERGWGDTAARVLEMMHLLLDILQAPDPSTLET  
3915037            LDFLRVHTYK----------GHALMLNDRIQSISKLQSALVKAEDHLSKLAPDTLYSEFEYELQGTGFERGWGDTAARVLEMMHLLLDILQAPDPSTLET  
225437428          LDFLRVHKYK----------GQVIMLNDRIQSISRLQSALVKADDHLTKLPPETPFGEFEYEFQGMGFERGWGDTAQRVLEMIHLLLDILQAPDPSTLET  
162458268          LDFLRGHRHK----------GHVMMLNDRIQSLGRLQSVLTKAEEHLSKLPADTPYSQFAYKFQEWGLEKGWGDTAGHVLEMIHLLLDIIQAPDPSTLEK  
242035817          LDFLRGHRHK----------GHVMMLNDRVQSLGRLQSVLTKAEEYLSKLPAETPYAQFAYKFQEWGLEKGWGDTAEHVLEMVHLLLDIIQAPDPSTLEK  
115452927          LDFLRGHRHK----------GHVMMLNDRIQSLGRLQSVLTKAEEHLSKLPADTPYSQFAYKFQEWGLEKGWGDTAGYVLEMIHLLLDVLQAPDPSTLET  
241896730          LDFLREHRHK----------GHVMMLNDRIQSVGRLQSVLTKAEENLSKLPAETPYSQFANQFQEWGLEKGWGDTAEHVLEMIHLLLDILQAPDPSTLET  
304651490          LDFLRGHNHK----------GNVLMLNERIQRISRLESSLNKADDYLSKLPPDTPYTDFEYALQEMGFEKGWGDTANRVLETMHLLSDILQAPDPSTLET  
29289943           LDFLRGHNHK----------GNVLMLNERIQRISRLESSLNKADDYLSKLPPDTPYTEFEYALQEMGFEKGWGDTAKRVLETMHLLSDILQAPDPSTLET  
115310620          LDFLRAHKHK----------GHVLMLNDRIQRISRLESALSKAEDYLAKLPQDTPYSDFEYALQELGFERGWGDTAARVLNMMHLLSDILQAPDPSTLET  
4468153            LEFLRAHKHK----------GHIMMLNDRIQHIPRLESALARAEDHLSKLPPDTPYSEFEYTLQGLGFERGWGDTAERVLEMMHLLSDILQAPDASTLET  
345286419          LDFLRVHRHK----------GHVLMLNDRVQRISRLESQLAKAEDYVSKLPLDTPYSEFEYALQGMGFERGWGDTAARVLEMMRLLSDVLHAPDPSTLET  






151176306          LDFLRVHKHK----------GVVMMLNDRIQTIQRLQSALSKAEDYLIKLPADTPYSEFEFVIQGMGFERGWGDTAERVLEMMHLLLDILQAPDPSTLET  
14530225           LDFLRVHKHK----------GVVMMLNDRIQTIQRLQSALSKAEDYLIKLPADTPYSEFEFVIQGMGFERGWGDTAERVLEMMHLLLDILQAPDPSTLET  
15239816           LEFLRTHKHD----------GRPMMLNDRIQNIPILQGALARAEEFLSKLPLATPYSEFEFELQGMGFERGWGDTAQKVSEMVHLLLDILQAPDPSVLET  
297795665          LEFLRTHKHD----------GRSMMLNDRIQNIPILQGALARAEEFLSKLPLATPYSEFEFELQGMGFERGWGDTAQKVSEMVHLLLDILQAPDPSVLET  
225431790          LDFLRAHKHD----------GHVMMLNDRIQNISRLQSALARAEEYLSKLPPLTPYSEFEFELQGMGFEKGWGDTAQRVSEMVHLLLEILQAPDPSTLET  
255551835          LEFLRTHKHD----------GHALMLNDRIQNLSSLHYALARAEEHLSKFPPNTPFSEFEFDLQSMGFERGWGDRAERVSEMVHLLMDILQAPDPASLES  
168009716          FEFLRMHTYR----------GQTLMLNDRIASLVRLRPQLVKAEEALSKLPEKTPFADFAHQLQGLGLEKGWGNSAGRALETIKMLQDLLQAPDPDTLEK  
168035060          FQFLRMHTYR----------GQTLMLNDRITSLRRLRPQLVKADDILSKLPEDTPFTDFAHKLQELGLEKGWGNTAGRVVETIKLLEDLLQAPDPDTLEK  
168058907          FQFLRLHTYR----------GETLMLNERIATFSRFRPQLVRAEEALSKLPEDTPFSSFAHRLQELGLEKGWGNTAGRVLQTLKLLLDLLQAPDPDTLEK  
168029793          VEFMRVHKYK----------DQTLLLNESITNVVRLRPALIKAEEYLIKLPNDQPLKDFYSKLQELGLERGWGDTAGRVLEMIHLLLDLLQAPDPDILEK  
94266940           YEFLKLHQLH---------GIQLLLDGERVRNPVQLEDALAAALDFLERCHWPDDLERIRQRLRRLGFLDGWGDSLPRILETMHMLQDILEQPDEANLEE  
94264333           YEFLKLHQLH---------GIQLLLDGERVRNPVQLEDALAAALDFLERCHWPDDLERLRQRLRRLGFLDGWGDSLPRILETMHMLQDILEQPDEANLEE  
297569306          YEFLKLHQLH---------GTQLLLDGSLVRSPEELEEALSSAMDFLERCRYPDDLARISQRLGRLGFLAGWGNSLPRMLETMHMLQDILEQPDEANLEE  
254416162          FNFLSLHEVQ---------GTQLLIN-GRIKSQQQLSDQVKLALGFVSDRAEDEPYESFRFKLQDMGFEAGWGNTASRVRETLEILDELIDSPDHQGLEE  
332712456          YGFLKVRHFH---------GNQLLIN-ERIHNHQQLSEQVKLALEFVSDRPDSESYDKFRFKLQEMGFEPGWGNTASRVRETLAMLDELIDEPDDRALEQ  
17232477           FNFLRLHNYN---------GIQLLIN-HQIQSQQQLSQQVKNALNFVSDRPNDEPYEQFRLQLQTMGFEPGWGNTASRVRDTLNILDELIDSPDPQTLEA  
75908500           FNFLRLHNYN---------GIQLLIN-YQIQSQQQLSQQVKKALNFVSDRPHDEPYEQFRLQLQAMGFEPGWGNTASRVRDTLNILDELIDSPDPLTLEA  
186682280          LNFLRLHHYN---------GVQLLVN-DRIQSQQQLSEQVKKAIGFVNNRPDDEPYEQFRFQLQSMGFEPGWGNTAARVRETLNILDELIDSADPQTLEA  
119512682          LNFLRLHQYN---------GVQLLIN-DRITTQQQLSTQIKKAITFVSDRPKDEPYEKFRFELQMIGFEPGWGNTAKRVGDTLDILDELIDSPDPQTIEA  
334117431          FNFLRLHRYN---------GVQLLIN-DRIKSQEQLSEQVKKALTFVSDLSEEEGYERFRLVLQMMGFEAGWGNTAARVHETLGILDELIDSPDPQTLEA  
218440696          FNFLSLHCYN---------GITLLIN-GRIKNQHQLSEQVKDAIFFLNQFSDEIPFEDFRYEFQSMGFEPGWGNTAGRVKETLSILDELIDSPDDQVLEA  
159031025          FQFLRMHQYN---------GITLLIN-DRIGNQRQLSQQVKAALDFLESYPSEEPYSNLRFELQSLGFEPGWGNTASRMRESLELLDGLIDAPDHQSLEA  
220907171          FQFLSLHRYD---------GNQLLIS-ERIKNQHQLSMQVKQALHLVNSQPPQALFSDFRFELQNLGFEPGWGNTAARVKETLELLDSLIDSPDPHSLET  
22298591           FNFLRIHRYN---------GYQLLIN-ERIRSPQHLSEQVKQALVVLSDRPPTEAYSEFRFELQNLGFEPGWGNTVARVRDTLEILDQLLDSPDHQVLEA  
158339122          FSFLKLHSYN---------GTQLLIN-QRIQSPEHLSECVKQAISLVGGLPPEQPYPEFRFNFQELGFEPGWGNTAARVLETLEMLDELIDSPDDQVLEA  
284053161          YQFLSLHSYN---------GLQLLIN-DRITNQNQLSYAIKKAISLLNKRSPKEPYEKFRFELQEIGFEPGWGNTARRALETLEILDELLDSPDHQVLEA  
209523126          YQFLSLHSYN---------GLQLMIN-DRITNQNQLSHAIKKAISLLNKRSPKEPYENFRFELQEIGFEPGWGNTARRALETLEMLDELLDSPDHQVLEA  
17228554           YLALRGLQYD---------GINLMIG-DAIPSGIHLAKQIHAAIKFLSALPPEEPYEKFYIELQKLGFEPGWGNTAQRILETITLLDKLIDSPQPAVLEA  
75909957           YLALRGLQYD---------GINLMIG-DAIPSGIHLAKQIHAAIKFLSDLPPEEPYEKFYIELQALGFEPGWGNTAERILETITLLDRLIDSPQPAVLEA  
186685043          FQALQGLQHD---------GIRLLLS-DRIPSGIHLAKQIKLALKLVNERSPHEPYEKFSLDLQELGFEPGWGNTAARVSETLELLDRLIYSPEPGILEA  
119510624          FQALYQLTYD---------QKPLLIS-DRIPSGIHLVKQIKQALKFLNQQPPEEPYANFRPHLQELGFEPGWGNTSGRISETLELLEQLIDNPQPAILEA  
298489784          FQALQGIQFN---------GMKVLIS-DRIHSGIQFAKLIKPAITLLSELPPDEPYAQFRSHLQELGLEAGWGNNAGRVRETLELLQRLIDTPQTYILEA  
220909283          FRVLCGHEYD---------GLSLLIN-EQIGSGEDLYKQVQQALWFIRQRPGDEPWEQLHYYLEKLGFAPGWGDRASRVEETLELLQYLMDSPAPPILEA  
332708740          LKNLQAHHYD---------HTPLLLN-NRIDSTTQLFEKLKEALTLVGELPAHTPYEKFRFELQVLGFEAGWGNTAGRVRETLELLERLMDAPDHAVLEA  
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114331077          FLARIPMISRLLILSPHGYFGQDNVLGLPDTGGQVVYILDQVRALEQEMRDRLQLQGVQ---VEPKILIVTRLIPDAGDTTCNQRLEKVSGCTNTWILRV  
30249199           FLACIPMISRLLILSPHGYFGQDNVLGLPDTGGQVVYILDQVRALEKEMHDRLQLQGVQ---VEPKILIVTRLIPDAGDTTCNQRLEKVSGCTNTWILRV  
82703384           FLARIPMISKLLILSPHGYFGQDNVLGLPDTGGQVVYILDQVRALEREMSERLILQGID---AAPKILIGTRLIPDAGDTLCHQPLEKIHGTQNSWIVRV  
198283392          FIDRIPMISKILIVSIHGWFAQDKVLGRPDTGGQVVYILDQARALEQEMRQRLARQGVD---IVPRILIATRLIPNADGTTCDQRLEPVHGADNVQILRV  
344199811          FIDRIPMISKILIVSIHGWFAQDKVLGRPDTGGQVVYILDQARALEQEMRQRLARQGVD---IVPRILIATRLIPNADGTTCDQRLETVHGVDNVQILRV  
255021595          FLDRIPMISRILIVSIHGWFAQDKVLGRPDTGGQVVYILDQARALEREMRNRLRQQGVD---VEPRILIATRLIPESDGTTCDQRLEPVVGAENVQILRV  
77166514           FLARIPMIFNIVILSPHGYFGQGNILGLPDTGGQVVYILDQVRALEKEMHRQLKEQGLD---VAPQILVVTRLIPEAQGTRCDQRLESIVGTENAAILRV  
300115586          FLARIPMIFNIAILSPHGYFGQGNILGLPDTGGQVVYILDQVRALEKEMRRQLKEQGLD---VTPQILVVTRLIPEARGTRCDQRLESIVGTENAAILRV  






350552412          FLARIPMIFSLLILSPHGFFGQANVLGRPDTGGQVVYILDQVRALEREMRSRLQAQGLH---IEPRILVVTRLIPEAQGTSCDQPVERINGTRNAQILRV  
220933364          FLARIPMIFSLLILSPHGFFGQAGVLGLPDTGGQVVYILDQVRALEREMRDRLAEQGLD---IEPRIRVVTRLIPEARGTSCDQPEEAVSGTENARILRV  
350574485          FLGRIPMIFSIAILSPHGWFGQSNVLGRPDTGGQVVYILDQVRALEREMRARLAEQGID---IDPEVIVITRLIPESEGTTSDQRIEPIAGTQNARILRV  
95929190           FLGRIPMIFSIVVVSPHGYFGQENVLGLPDTGGQVVYILDQVRALEKEMKEQIYRQGLD---IEPSIVVLTRLIPHCGDTSCNQPEEQIAGTSNATIVRV  
298528445          FLSRIPMIFKLVIVSPHGYFGQSNVLGRPDTGGQIVYILDQVRALEKEMRRQIKEQGLE---IEPEIVVLTRQIPEAGDTTCNQRQEDIVGTSNARILRV  
297602308          FFSRVPSIFNIVIFSIHGYFGQEKVLGLPDTGGQVVYILDQVRAMEEELLQRIKQQGLH---VTPKILVLTRLIPDAKGTKCNVELEPVENTKYSHILRV  
115457664          FFSRVPSIFNIVIFSIHGYFGQEKVLGLPDTGGQVVYILDQVRAMEEELLQRIKQQGLH---VTPKILVLTRLIPDAKGTKCNVELEPVENTKYSHILRV  
326504012          FFSRVPSIFNIVVFSIHGYFGQEKVLGLPDTGGQVVYILDQVRSMEEELLQRIKLQGLH---ITPKILVLTRLIPDSKGTKCNVELEPVENTKYSHILRV  
115450038          FFSTVPCVFTVVIFSIHGYFGQEKVLGMPDTGGQVVYILDQVRALEDELLQRIKQQGLN---ATPKILVLTRLIPEAKGTKCNVELEPIENTKHSNILRV  
326531526          FFSRVPSVFNIVIFSIHGYFGQEKVLGLPDTGGQVVYILDQVRALEEELLQRIKRQGLN---VTPKILVLTRLIPDAKGTKCNVELEPVEHTKHSSILRV  
242063616          FFSRVPSVFDVVIFSVHGYFGQHKVLGMPDTGGQVVYILDQVRALEEELLQRIKGQGLT---FTPNILVLTRLIPEAKGTTCNVELEPIENTRHSSILRV  
42568160           FFARVPRIFNVVIFSVHGYFGQTDVLGLPDTGGQVVYILDQVKALEDELLQRINSQGLN---FKPQILVVTRLIPDAKKTKCNQELEPIFGTKYSNILRI  
297805240          FFARIPRIFNVVIFSVHGYFGQTDVLGLPDTGGQVVYILDQVKALEDELLHRINSQGLN---FKPQILVVTRLIPDAKNTKCNQELEPIFGTKHSNILRI  
313770765          FLSRLPTVFNVVIFSPHGYFGQADVLGLPDTGGQVVYILDQVKALEEELLLRIKQQGLN---VKPQIVVATRLIPDARGTTCNLEFEAIDGTKYSNILRV  
313770767          FFSRLPTVFNVVIFSPHGYFGQADVLGLPDTGGQVVYILDQVKALEDELLLRIEQQGLN---IKPQIVVVTRLIPEARGTKCNQELESINGTKHSNILRV  
255584097          FLSRVPTIFNVVIFSPHGYFGQANVLGLPDTG-----------------------------------GQVTRLIPDARGTKCNQELEAINGTKHSNILRV  
225466221          FLSRLPTIFNVVIFSPHGYFGQSDVLGLPDTGGQVVYILDQVRALEEELLLRIKLQGLN---VKPQILVVTRLIPDARGTKCNQEWEPIDNTKHSTILRI  
313770769          LFSRIPNMFNIVIFSPHGYFGQSDVLGLPDTGGQVVYILDQVRALEEELLLKIKHQGLG---VKPRILVVTRLIPNAGGTKCNQEVEPIFGTQHSHIVRV  
313770771          LFSRIPNVFNIVIFSPHGYFGQSDVLGLPDTGGQIVYILDQVRALEEELLLKIRQQGLS---VKPQILVITRLIPHAGGTKCNQEVEPIFGTKHSHIVRV  
255570671          LFSRLPNMFNIVIFSPHGYFGQADVLGLPDTGGQVVYILDQVRALEEELLLRIKQQGLT---MKPQILVVTRLIPDAKGTKCNQEVEPIIGTKHSNILRI  
15219457           LFSRLPTVFNVVIFSVHGYFGQQDVLGLPDTGGQVVYILDQVRALEEELLIRINQQGLG---FKPQILVVTRLIPEARGTKCDQELEAIEGTKHSHILRV  
297842089          LFSRLPTLFNVVIFSVHGYFGQQDVLGLPDTGGQVVYILDQVRPLEEELLIRINQQGLG---FKPQILVVTRLIPEARGTKCDQELEAIEGTKHSHILRV  
115466896          FLGTIPMMFNVVILSPHGYFAQSNVLGYPDTGGQVVYILDQVRALENEMLLRIKQQGLD---ITPKILIVTRLLPDAVGTTCGQRVEKVIGTEHTDILRV  
17980243           FLGTIPMTFNVVILSPHGYFAQSNVLGYPDTGGQVVYILDQVRALENEMLLRIKQQGLD---ITPKILIVTRLLPDAVGTTCGQRLEKVIGTEHTDILRV  
162460741          FLGTIPMMFNVVILSPHGYFAQSNVLGYPDTGGQVVYILDQVRALENEMLLRIKQQGLD---ITPKILIVTRLLPDAAGTTCGQRLEKVIGTEHTDIIRV  
239984690          FLGTIPMMFNVVILSPHGYFAQSNVLGYPDTGGQVVYILDQVRALENEMLLRIKQQGLD---ITPKILITR-LLPDAVGTTCGQRLEKVIGTEHTDILRV  
162460681          FLGTIPMVFNVVILSPHGYFAQANVLGYPDTGGQVVYILDQVRAMENEMLLRIKQCGLD---ITPKILIVTRLLPDATGTTCGQRLEKVLGTEHCHILRV  
242035533          FLGTIPMVFNVVILSPHGYFAQANVLGYPDTGGQVVYILDQVRAMENEMLLRIKQCGLD---ITPKILIVTRLLPDATGTTCGQRLEKVLGTEHCHILRV  
62865493           FLGTIPMVFNVVILSPHGYFAQANVLGYPDTGGQVVYILDQVRAMENEMLLRIKQQGLN---ITPRILIVTRLLPDATGTTCGQRLEKVLGTEHTHILRV  
17980241           FLGTIPMVFNVVILSPHGYFAQANVLGYPDTGGQVVYILDQVRAMENEMLLRIKQQGLN---ITPRILIVTRLLPDATGTTCGQRLEKVLGTEHTHILRV  
115453437          FLGTIPMVFNVVIMSPHGYFAQANVLGYPDTGGQVVYILDQVRAMENEMLLRIKQQGLN---ITPRILIVTRLLPDATGTTCGQRLEKVLGTEHTHILRV  
115473359          FLGTIPMVFNVVILSPHGYFAQANVLGYPDTGGQVVYILDQVRAMENEMLLRIKQQGLN---ITPRILIVTRLLPDAHGTTCGQRLEKVLGTEHTHILRV  
3980298            FLGTIPMVFNVVILSPHGYFAQANVLGYPDTGGQVVYILDQVRAMENEMLLRIKQQGLD---ITPKILIVTRMLPDAHGTTCGQRLEKVLGTEHTHILRV  
15242073           FLGRVPMVFNVVILSPHGYFAQDNVLGYPDTGGQVVYILDQVRALEIEMLQRIKQQGLN---IKPRILILTRLLPDAVGTTCGERLERVYDSEYCDILRV  
297812265          FLGRVPMVFNVVILSPHGYFAQDNVLGYPDTGGQVVYILDQVRALETEMLQRIKQQGLD---IKPRILILTRLLPDAVGTTCGERLERVYDSEYCDILRV  
22331535           FLGRIPMVFNVVILSPHGYFAQDNVLGYPDTGGQVVYILDQVRALETEMLQRIKQQGLN---ITPRILIITRLLPDAAGTTCGQRLEKVYGSQYCDILRV  
297818772          FLGRIPMVFNVVILSPHGYFAQDNVLGYPDTGGQVVYILDQVRALETEMLQRTKQQGLT---ITPRILIITRLLPDAAGTTCGQRLEKVYGSQYCDILRV  
313770759          FLGRIPMVFNVVIMSPHGYFAQDNVLGYPDTGGQVVYILDQVRALENEMLQRIKKQGLD---IIPRILIITRLLPDAVGTTCGQRLERVYGSEHCDILRV  
313770761          FLGRIPMVFNVVIMSPHGYFAQDNVLGYPDTGGQVVYILDQVRALESEMLLRIKQQGLD---ITPRILIITRLLPDAVGTTCGQRLEKVYGSEHCDILRV  
255550319          FLGRIPMVFNVVIMSPHGYFAQDNVLGYPDTG-----------------------------------GQITRLLPDAVGTTCGQRLEKVFGTEHSDILRI  
324984223          FLGRIPMVFNVVILTPHGYFAQDNVLGYPDTGGQVVYILDQVRALENEMLLRIKQQGLN---ITPRILIITRLLPDAVGTTCGQRLEKVYGTEYSDILRV  
258489633          FLGRIPMVFNVVILTPHGYFAQDNVLGYPDTGGQVVYILDQVRALENEMLLRIKQQGLN---ITPRILIITRLLPDAVGTTCGQRLEKVYGTEYSDILRV  
324984221          FLGRIPMVFNVVILTPHGYFAQDNVLGYPDTGGQVVYILDQVRALENEMLLRIKQQGLN---ITPRILIITRLLPDAVGTTCGQRLEKVYGTEHSDILRV  
324984229          FLGRIPMVFNVVILTPHGYFAQDNVLGYPDTGGQVVYILDQVRALENETLLRIKQQGLN---ITPRILIITRLLPDAVGTTCGQRLEKVYGTEHSDILRV  
6683114            FLGRIPMVFNVVILTPHGYFAQDDVLGYPDTGGQVIYILDQVRALEDEMLLRIKQQGLD---ITPQILIITRLLPDAVGTTCGQRLEKVYGTKYSDILRV  
4584690            FLDRIPMVFNVVILSPHGYFAQDDVLGYPDTGGQVVYILDQVRALESEMLSRIKKQGLD---IIPRILIITRLLPDAVGTTCGQRLEKVYGTEHCHILRV  






3766299            FLDRIPMVFNVVILSPHGYFAQDDVLGYPDTGGQVVYILDQVRALESEMLNRIKKQGLD---IVPRILIITRLLPDAVGTTCGQRLEKVYGTEHCHILRV  
3377764            FLDRIPMVFNVVILSPHGYFAQDDVLGYPDTGGQVVYILDQVRALESEMLNRIKKQGLD---IVPRILIITRLLPDAVGTTCGQRLEKVYGTEHCHILRV  
225444613          FLGRIPMVFNVVILSPHGYFAQDNVLGYPDTGGQVVYILDQVRAMETEMLLRIKQQGLD---ITPKIIIVTRLLPDAVGTTCNQRIEKVYGTEHSIILRV  
3660531            FLGRIPMVFNVVILSPHGYLAQENVLGYPDTGGQVVYILDQVPALEREMLKRIKEQGLD---IIPRILIVTRLLPDAVGTTCGQRLEKVYGTEHSHILRV  
31455440           FLGRIPMVFNVVILSPHGYFAQENVLGYPDTGGQVVYILDQVPALEREMLKRIKEQGLD---IIPRILIVTRLLPDAVGTTCGQRIEKVYGAEHSHILRV  
304651488          FLSRIPMVFNVVILSPHGYFAQENVLGYPDTGGQVVYILDQVPALEREMLKRIKEQGLD---IKPRILIVTRLLPDAVGTTCGQRLEKVFGTEHSHILRV  
28629438           FLSRIPMVFNVVILSPHGYFAQENVLGYPDTGGQVVYILDQVPALEREMLKRIKEQGLD---IKPRILIVTRLLPDAVGTTCGQRLEKVFGTEHSHILRV  
115310618          FLGRIPMVFNVVILSPHGYFAQENVLGYPDTGGQVVYILDQVPALEREMLKRIKEQGLD---VKPRILIITRLLPDAPGTTCGQRLEKVYGSEYSHILRV  
345286417          FLGRIPMVFNVVILSPHGYFAQENVLGYPDTGGQVVYILDQVPALEREMLKRIKEQGLD---ITPRILIVTRLLPDAVGTTCGQRLEKVFGAEHSHILRV  
38425095           FLGRIPMVFNVVILTPHGYFAQANVLGYPDTGGQVVYILDQVRALEHEMLLRIKQQGLD---IIPRILIVSRLLPDAVGTTCGQRLEKVFGTEHSHILRV  
15235300           FLGMVPMVFNVVILSPHGYFGQANVLGLPDTGGQVVYILDQVRALETEMLLRIKRQGLD---ISPSILIVTRLIPDAKGTTCNQRLERVSGTEHTHILRV  
297814081          FLGMVPMVFDVVILSPHGYFGQANVLGLPDTGGQVVYILDQVRALESEMLLRIKRQGLD---ITPRILIVTRLIPDAKGTTCNQRLERVSGTEHTHILRV  
6682841            FLGRLPMVFNVVILSPHGYFGQANVLGLPDTGGQVVYILDQVRALENEMLLRIKRQGLD---ISPKILIVTRLIPDAKGTTCNQRLERVSGTEHTHILRV  
255564236          FLGRIPMVFNVVILSPHGYFGQANVLGLPDTG-----------------------------------GQVTRLIPDAKGTTCNQRLERVSGTEYTHILRV  
313770763          FLGRVPMVFNVVILSPHGYFGQANVLGLPDTGGQIVYILDQVRALENEMLLRIQQQGLD---FKPKILIVTRLIPDSKGTSCNQRLERVSGTEHTHILRV  
3915037            FLGRVPMVFNVVILSPHGFFGQANVLGLPDTGGQVVYILDQVRALESEMLVRIKKQGLD---FTPRILIVTRLIPDAKGTTCNQRLERVSGTEYTHILRV  
225437428          FLGRIPMVFNVVILSPHGYFGQANVLGLPDTGGQVVYILDQVRALENEMLLRMQKQGLD---VTPRILIVTRLIPDAKGTTCNQRLERVSGTEHSHILRV  
162458268          FLGRIPMIFNVVVVSPHGYFGQANVLGLPDTGGQIVYILDQVRALENEMVLRLKKQGLD---VSPKILIVTRLIPDAKGTSCNQRLERISGTQHTYILRV  
242035817          FLGRIPMIFNVVVVSPHGYFGQANVLGLPDTGGQIVYILDQVRALENEMVLRLKKQGLD---FSPKILIVTRLIPDAKGTSCNQRLERISGTQHTYILRV  
115452927          FLGRIPMIFNVVVVSPHGYFGQANVLGLPDTGGQIVYILDQVRALENEMVLRLKKQGLD---FTPKILIVTRLIPEAKGTSCNQRLERISGTQHTYILRV  
241896730          FLGRIPMIFNVVIVSPHGYFGQANVLGMPDTGGQIVYILDQVRALENEMVLRLKKQGLD---VTPKILIVTRLIPDSKGTSCNQRLERISGTQHTYILRV  
304651490          FLGRLPMVFNVVILSPHGYFGQANVLGLPDTGGQVVYILDQVRALEAEMLLRIKQQGLN---FKPRILVVTRLIPDAKGTTCNQRLERISGTEYSHILRV  
29289943           FLGRLPMVFNVVILSPHGYFGQANVLGLPDTGGQVVYILDQVRALEAEMLLRIKQQGLN---FKPKILVVTRLIPDAKGTTCNQRLERISGTEYSHILRV  
115310620          FLGRVPMVFNVAILSVHGYFGQANVLGLPDTGGQIVYILDQVRALENEMLLRIKQQGLN---VTPRILIVTRLIPDAKGTTCNQRLERVSGTEYTSILRV  
4468153            FLGRIPMVFNVVILSIHGYFGQANVLGLPDTGGQIVYILDQVRALENEMIKRIKAQGLS---IIPQILIVTRLIPDAKGTSCNQRLEKISGCEHSHILRV  
345286419          FLGRVPMVFNVVILSVHGYFGQANVLGLPDTGGQIVYILDQVRALESETLQRIKKQGLQ---ITPRILVVTRLIPDAADTSCNQRLERLSGCEYSHILRV  
4468151            FLGQLPMVFNVVVLSIHGYFAQTDVLGLPDTGGQVVYVLDQVRAMENEMIKRIKNHGLN---ITPRILIVTRLIPEARGTKCDQRLEKIDGCEHSHILRV  
151176306          FLGRLPMVFNVVILSVHGYFGQAHVLGLPDTGGQIVYILDQVRSLEHEMLQRIKKQGLD---VTPRILIVSRLIPDAKGTTCNQRMEKVSGTEHASILRV  
14530225           FLGRLPMVFNVVILSVHGYFGQAHVLGLPDTGGQIVYILDQVRSLEHEMLQRIKKQGLD---VTPRILIVSRLIPDAKGTTCNQRMEKVSGTEHASILRV  
15239816           FLGRIPMVFNVVILSPHGYFGQANVLGLPDTGGQVVYILDQVRALENEMLLRIQKQGLE---VIPKILIVTRLLPEAKGTTCNQRLERVSGTEHAHILRI  
297795665          FLGRIPMVFNVVILSPHGYFGQANVLGLPDTGGQVVYILDQVRALENEMLLRIQKQGLE---VIPKILIVTRLIPEAKGTTCNQRLEKVSGTEHAHILRI  
225431790          FLGRIPMVFNVVIVSPHGYFGQANVLGLPDTGGQIVYILDQVRALENEMLLRIQKQGLD---VIPKILIVTRLIPDAKGTTCNQRLERISGTEHTHILRV  
255551835          FLGMLPMVFNVVIVSPHGYFGQANVLGLPDTG-----------------------------------GQVTRLIPHAKGTTCNQRLERISGTENTYILRV  
168009716          FLARIPMVFSVVIVSPHGYFGQEGVLGLPDTGGQVVYILDQVRALENEMLENLQLQGLD---IIPQIVILTRLIPNAIGTTCNQRIEKVTGSRFSHILRI  
168035060          FLARIPMVFSVVIVTPHGYFGQDGVLGLPDTGGQVVYILDQVRALENEMLENLQLQGLD---IVPKIVILTRLIPNAFGTTCNQRIEKVHGSRFSHILRI  
168058907          FLARIPMIFTVCIVSPHGYFGQAGVLGLPDTGGQVVYILDQVRALENQMLENLQLQGLD---FKP--QILTRLIPNANGTTVNQRIEKVSGTQHSRILRV  
168029793          FLARIPIVFSVAIISPHGYFGQSNVLGMPDTGGQVVYILDQVRAMEKEMLKNIKLQGLD---IEPQIVVVTRLIPNANGTTCNQRIEQIEGTKHSRILRV  
94266940           FLARIPMVSKVALISPHGWFGQDNVLGRPDTGGQVVYILDQARALEQFLAADLRSAG---LEIEPKILIITRLIPENEGTTADQRLEPVRDTANVAILRV  
94264333           FLSRIPMVSKVALISPHGWFGQDNVLGRPDTGGQVVYILDQARALEQFLAADLRSAG---LEIEPKILIITRLIPENEGTTADQRLEPVRDTANVAILRV  
297569306          FLSRIPMVSSVALISPHGWFGQENVLGRPDTGGQVVYVLDQAKALEDFLAQDLRDAG---LEIAPKILIVSRLIPENEGTSADQRLEKVYDTDDVWILRV  
254416162          FLSRIPMIFRIVLVSIHGWFGQEGVLGRPDTGGQVVYVLDQARSLEKQLQEDIKLAGLELLKVKPKVIILSRLIPNNDGTRCNERLEKVHGTDNAWILRV  
332712456          FLSRIPMIFRIVLVSVHGWFGQEGVLGRPDTGGQVVYVLDQAKSLEKQLQENLTLAG---LNIQPKVIILTRLIPNNDGTRCNERLEKIKGTENAWILRV  
17232477           FISRIPMIFRIVLVSAHGWFGQEGVLGRPDTGGQVVYVLDQAKNLEKQLQEDAILAGLEVLNVQPKVIILTRLIPNSDGTLCNQRLEKVYGTENAWILRV  
75908500           FISRIPMIFRIVLVSAHGWFGQEGVLGRPDTGGQVVYVLDQAKNLEKQLQEDAILAGLEVLNVQPKVIILTRLIPNSDGTLCNQRLEKVHGTENAWILRV  
186682280          FISRVPMIFRIVLVSAHGWFGQEGVLGRPDTGGQVVYVLDQAKSLEKQLQEDVLLAGLEKLNVEPKVIILTRLIPNSDGTLCNQRLEKVHGTENAWILRV  
119512682          FISRIPMIFRIVLVSAHGWFGQEGVLGRPDTGGQVVYVLDQAKNLEKQLQEDAQLAGLDGLNVEPKVIILTRLIPNSDGTLCNQRLEKVHGTENAWILRV  






218440696          FLSRVPMIFRIVLVSVHGWFGQEGVLGRPDTGGQVVYVLDQARSLEQQLKEDIILAGLDGYGIEPKVIILSRLIHNSDGTRCNQRLEKVHGTDNAWILRV  
159031025          FLSRIPMLFRIVLVSVHGWFGQEGVLGRPDTGGQVVYVLDQARSLEQQLREDIFLAGLEGLGIEPKIIILTRLLPNSEGTRCDQRLEKVYGTDNACILRV  
220907171          FLSRIPMIFRIALISPHGWFGQEGVLGRPDTGGQVVYVLDQARSLEQQLREEITLAGLEGLNVHPKVIILTRLIPNSDGTRCNQPLEKVYGTENVWILRV  
22298591           FVSRIPMLFRIALISPHGWFGQEGVLGRPDTGGQVVYILDQVKSLEKQMREDLELAGLGVLEAQPKIIVLTRLIPNAEGTLCNQRLEKIYGTNDAWILRV  
158339122          FISRIPMIFKIVLVSIHGYFGQEGVLGRPDTGGQVVYVLDQAKSLEKQLQEDLQFAGLDTLEVQPKLIILSRLIPNSEGTLCNQRLEKVHATDNVWILRV  
284053161          FLARIPMIFRIVLVSIHGWFAQEGVLGRPDTGGQIVYILDQARSLEMELEEELKLSGLSVLGVQPKVMILTRLIPHSDGTRCDQRLEKVYGTKNAWILRV  
209523126          FLARIPMIFRIVLVSIHGWFGQEGVLGRPDTGGQVVYILDQARSLEMELEEELKLSGLSVLGVQPKVMILTRLIPHSDGTRCHQRLEKVYGTKNAWILRV  
17228554           FVARVPAVFRVVLVSIHGWVAQEDVMGRDETLGQVIYVLEQARSLENKLQQEIKLAGLEVLGIQPHVIILTRLIPNCEGTYCNLRLEKLHNTENAWILRV  
75909957           FVARVPAVFRVVLVSIHGWVAQEDVMGRDETLGQVIYVLEQARSLENKLQQEIKLAGLEVLGIQPHIIILTRLIPHCEGTYCNLRLEKLHNTENAWILRV  
186685043          FVARVPAVFRVVLISIHGWVGQEDVVGRDETLSQVIYVLEQARSLENELREQIKLAGLDQLGIKPHVIILTRLIPNCEGTFCYLPLEKVQDTENAWILRV  
119510624          FVARVPAIFRVVLVSIHGWVGQQDVLGRDETLGQVIYVLEQARSLENKLQAEIKLAGLDLIGIQPHVIILTRLIPNCEGTECNLRLEKIHDTENAWILRI  
298489784          FVARIPAVFRVVLISIHGWVAQEDVLGRDETLGQVIYVLEQARSLENKLQQEIKLAGLDFLGIKPHVIILTRLIPNCESTFCDLRLEKVHNTENAWILRV  
220909283          FLARIPIVFRAVLVSIHGWVGQSGVMGRSETMSQVSYVLEQARQLEHELQSDIKRSGLDRLGIRPQVVILTRLIPHCEETLCYLPLEKLAETMNGWILRV  
332708740          FISRIPLIFRVVLVSVHGWVGQEGVLGLPDTAGQVAYVIDQARSLEQTIQNNIKLSGLDVLGVEPKVIVLTRLIPNCEGTQCNLRLEKIQGTSNGWILRV  
Clustal Consensus  :.  :*      :.: **:..*  ::*  :*                                          : .   *      * :       *:*:  
 
                           410       420       430       440       450       460       470       480       490       500          
                   ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
114331077          PFRKKNGEIIPQWISRFEIWPHLETFALD--VEREALAELGRRPDLIIGNYSDGNLVATLLSRRLGVTQCNIAHALEKTKYLHSDIYWQENEDKYHFSCQ  
30249199           PFRKHNGEIIPHWISRFEIWPHLEIFAGD--VEREALAELGGHPDLIIGNYSDGNLVATLLSRRLGVTQCNIAHALEKTKYLHSDIYWQENEDKYHFSCQ  
82703384           PFRKGSGEIVRHWISRFEIWPYLENFAHD--IEREALAQLSGRPDLIIGNYSDGNLVASLISKRIGVTQCNIAHALEQSKYLHSALYWRENEAQYHFNCQ  
198283392          PFRYANGEILPQWISRFNVWPWLERYADD--LERETLAEFGRRPDLIIGNYSDGNLVATILSARLNVTQCNIAHALEKSKYLYSDLYWRDHDASHHFACQ  
344199811          PFRYPNGEILPQWISRFNVWPWLERYADD--LERETLAEFGRRPDLIIGNYSDGNLVASMLSERLNVTQCNIAHALEKSKYLYSDLYWRDHDASHHFACQ  
255021595          PFRYPDGRIHPHWISRFKIWPWLERYAQD--LEREVLAELGSRPDLIIGNYSDGNLVATLLSERLGVTQCNIAHALEKSKYLYSDLHWRDHEQDHHFACQ  
77166514           PFRNAGGEVLPYWLSRFEVWPYLERYAMD--AEREMLAELEGSPDLIIGNYSDGSLVATLLSQRLRVTQCNIAHALEKAKYLYSDLYWRENDAQYHFACQ  
300115586          PFRNAAGEVLPYWLSRFEVWPYLERYAMD--VEREMLAELEGSPDLIIGNYSDGSLVATLLSQRLRVTQCNIAHALEKTKYLYSDLYWRENDAQYHFACQ  
292493898          PFRSAAGEALPYWLSRFEVWPYLERYAMD--VEREILAELEGSPDLIIGNYSDGNLVATLLAHRLRVTQCNIAHALEKTKYLYSDLYWRENDAQYHFSCQ  
350552412          PFRSKEGEIIPHWISRFEIWPYLERFADD--VEQTVRAELGTRPDLIIGNYSDGNLVATLLSARMQVTQCHIAHALEKTKYLYSDLYWKENEAQYHFSCQ  
220933364          PFRREDGEVVPQWISRFEIWPYLERFADE--VERTILADLGGRPDLIIGNYSDGNLVASLLSARLHVTQCNIAHALEKTKYLYSDLYWKDNDAQYHFATQ  
350574485          PFRNENGDILPHWISRFHIWPYLERFALD--AETELLAELGDRPDLIIGNYSDGNLVASLMSRRLGVSQCNIAHALEKTKYLFSDLYWRDNEDRYHFSCQ  
95929190           PFRNDQGEVINDWISRFKIWPHLERFSRE--SERKLLETIGARPDLIIGNYSDGNLVSFLLSRRLRVTQCTIAHALEKAKYLFSGLYWKEN-PEYNFQTQ  
298528445          PFRYPSGEIVPHWISRFHVWPFLERFALD--STQEVHSELKGRPDLIIGNYSDGNLVASLMSKKMNITQCNIAHALEKSKYLFSSQYWKDNEAQYRFSSQ  
297602308          PFKTEDGKDLRQWVSRFDIYPYLERYAQN--SCAKILDILEGKPDLIIGNYTDGNLVASLLSNKLCVTQGTIAHALEKTKYEDSDVKWREMDQKYHFSCQ  
115457664          PFKTEDGKDLRQWVSRFDIYPYLERYAQD--SCAKILDILEGKPDLIIGNYTDGNLVASLLSNKLCVTQGTIAHALEKTKYEDSDVKWREMDQKYHFSCQ  
326504012          PFKTEDGKDLRQWVSRFDIYPYLERYAQD--ASTKILDMLEGKPDLIIGNYTDGNLVASLMSSKLGVTQGTIAHALEKTKYEDSDVKWRELDQKYHFSCQ  
115450038          PFKTEDGKVLPQWVSRFDIYPYLERYAQD--SSVKILEILEGKPDLVIGNYTDGNLVASLLTSKLGVTQGTIAHALEKTKYEDSDIKWRELDHKYHFSCQ  
326531526          PFKTDDGKDLRQWVSRFDIYPYLERYAKD--SSVKILDILEGKPDMVIGNYTDGNLVASLLSSKLGVTQGTIAHALEKTKYEDSDVKWREMDHKYHFSCQ  
242063616          PFKTQDGQDLPHWVSRFDIYPYLERYAQ-------ILDILGRKPDLVIGNYTDGNLVAYLVSRKLGVTQGTIAHALEKTKYEDSDVKWREMDHKYHFSCQ  
42568160           PFVTENG-ILRRWVSRFDIYPYLERFTKD--ATTKILDILEGKPDLIIGNYTDGNLVASLMANKLGITQATIAHALEKTKYEDSDIKWKEFDPKYHFSSQ  
297805240          PFVTESG-ILRRWVSRFDIYPYLERFTKD--ATTKILDILEGKPDLIIGNYTDGNLVASLMANTLGITQATIAHALEKTKYEDSDIKWKEFDPKYHFSSQ  
313770765          PFRVENR-VLRQWVS----------RFDE--VTTKILDLMEGKPDLIIGNYTDGNFAATLMAGKLGITQATIAHALEKTKYENSDVKWKELESKYHFPCQ  
313770767          PFSIENK-VLRQWVS----------RFDD--VITKLLDLMQRKPDLIIGNYTDGNLAATLMASKLGITQATIAHALEKTKYENSDVKWKELDPKYHFSCQ  
255584097          PFTVENR-VLRQWVSRFDIYPYLEKFTQD--VADKILDLMDGKPDLIIGNYTDGNLAATLLANKLGITQATIAHALEKTKYEDSDIKWKELDPKYHFSCQ  
225466221          PFRTEKG-ILNQWVSRFDIYPYLERFTQD--ATAKIIEHMEGKPDLIIGNYTDGNLVASLMATKLGITQGTIAHALEKTKYEDSDVKWKELEPKYHFSCQ  
313770769          PFKTEKG-VLPQWVS----------RFDD--AADKVLEHMDSKPDLIIGNYSDGNLVASLMARKLSITLGTIAHALEKTKYEDSDVKWKELDAKYHFSCQ  
313770771          PFKTEKG-VLPQWVSRFDVYPYLERFAQD--AADKVREHMDCKPDLLIGNYSDGNLVASLMAQKLGTTLGTIAHALEKTKYEDSDAKWKELDPKYHFSCQ  






15219457           PFVTNKG-VLRQWVSRFDIYPYLERFTQD--ATSKILQRLDCKPDLIIGNYTDGNLVASLMATKLGVTQGTIAHALEKTKYEDSDAKWKELDPKYHFSCQ  
297842089          PFVTDKG-ILRQWVSRFDIYPYLERFTQD--ATSKILQRLDCKPDLIIGNYTDGNLVASLMATKIGVTQGTIAHALEKTKYEDSDAKWKELDPKYHFSCQ  
115466896          PFRSENG-ILRKWISRFDVWPFLETYTED--VANEIMREMQAKPDLIIGNYSDGNLVATLLAHKLGVTQCTIAHALEKTKYPNSDIYLDKFDSQYHFSCQ  
17980243           PFRTENG-ILRKWISRFDVWPFLETYTED--VANEIMREMQAKPDLIIGNYSDGNLVATLLAHKLGVTQCTIAHALEKTKYPNSDIYLDKFDSQYHFSCQ  
162460741          PFRNENG-ILRKWISRFDVWPYLETYTED--VSSEIMKEMQAKPDLIIGNYSDGNLVATLLAHKLGVTQCTIAHALEKTKYPNSDIYLDKFDSQYHFSCQ  
239984690          PFRTENG-IR-KWISRFDVWPYLETYTEVNDVANELMREMQTKPDLIIGNYSDGNLVATLLAHKLGVTQCTIAHALEKTKYPNSDIYLDKFDSQYHFSCQ  
162460681          PFRTENG-IVRKWISRFEVWPYLETYTDD--VAHEIAGELQANPDLIIGNYSDGNLVACLLAHKMGVTHCTIAHALEKTKYPNSDLYWKKFEDHYHFSCQ  
242035533          PFRTENG-IVRKWISRFEVWPYLETYTDD--VAHEIAGELQANPDLIIGNYSDGNLVACLLAHKMGVTHCTIAHALEKTKYPNSDLYWKKFEDHYHFSCQ  
62865493           PFRTENG-IVRKWISRFEVWPYLETFTDD--VAHEIAGELQANPDLIIGNYSDGNLVACLLAHKMGVTHCTIAHALEKTKYPNSDLYWKKFEDHYHFSCQ  
17980241           PFRTENG-IVRKWISRFEVWPYLETFTDD--VAHEIAGELQANPDLIIGNYSDGNLVACLLAHKMGVTHCTIAHALEKTKYPNSDLYWKKFEDHYHFSCQ  
115453437          PFRTENG-IVRKWISRFEVWPYLETFTDD--VAHEIAGELQANPDLIIGNYSDGNLVACLLAHKMGVTHCTIAHALEKTKYPNSDLYWKKFEDHYHFSCQ  
115473359          PFRTENG-TVRKWISRFEVWPYLETYTDD--VAHEISGELQATPDLIIGNYSDGNLVACLLAHKLGVTHCTIAHALEKTKYPNSDLYWKKFEDHYHFSCQ  
3980298            PFKTEDG-IVRKWISRFEVWPYLEAYTDD--VAHEIAGELQANPDLIIGNYSDGNLVACLLAHKLGVTHGTIAHALEKTKYPNSDLYWKKFEDHYHFSCQ  
15242073           PFRTEKG-IVRKWISRFEVWPYLETYTED--AAVELSKELNGKPDLIIGNYSDGNLVASLLAHKLGVTQCTIAHALEKTKYPDSDIYWKKLDDKYHFSCQ  
297812265          PFRTEKG-IVRKWISRFEVWPYLETYTED--AAVELSKELNGKPDLIIGNYSDGNLVASLLAHKLGVTQCTIAHALEKTKYPDSDIYWKKLDEKYHFSCQ  
22331535           PFRTEKG-IVRKWISRFEVWPYLETFTED--VAAEISKELQGKPDLIIGNYSDGNLVASLLAHKLGVTQCTIAHALEKTKYPDSDIYWKKLDEKYHFSCQ  
297818772          PFRTEKG-IVRKWISRFEVWPYLETFTED--VAAEISKELQGKPDLIIGNYSDGNLVASLLAHKLGVTQCTIAHALEKTKYPDSDIYWKKLDEKYHFSCQ  
313770759          PFRDGKG-MVRKWISRFEVWPYLETFTED--VAAEIAKELQGKPDLIIGNYSDGNIVASLLAHKLGVTECTIAHALEKTKYPDSDIYWKKFDEKYHFSCQ  
313770761          PFRDEKG-MVRKWISRFEVWPYLETYTED--VAAEIAKELQGKPDLIIGNYSDGNVVASLLAHKLGVTECTIAHALEKTKYPDSDIYWKKFDEKYHFSCQ  
255550319          PFRTEKG-IVRKWISRFEVWPYLETYTED--VATEIGKEFQGKPDLIIGNYSDGNIVASLLAHKLGVTECTIAHALEKTKYPESDIYWKKLDDKYHFSCQ  
324984223          PFRTEKG-IVRKWISRFEVWPYLETYTED--VAHEISKELQGKPDLIIGNYSDGNIVASLLAHKLGVTQCTIAHALEKTKYPDSDIYWKKLEDKYHFSCQ  
258489633          PFRTEKG-IVRKWISRFEVWPYLETYTED--VAHEISKELQGKPDLIIGNYSDGNIVASLLAHKLGVTQCTIAHALEKTKYPDSDIYWKKLEDKYHFSCQ  
324984221          PFRTEKG-IVRKWISRFEVWPYLETYTED--VAHEISKELQGKPDLIIGNYSDGNIVASLLAHKLGVTQCTIAHALEKTKYPDSDIYWKKLEDKYHFSCQ  
324984229          PFRTEKG-IVRKWISRFEVWPYLETYTED--VAHEISKELQGKPDLIIGNYSDGNIVASLLAHKLGVTQCTIAHALEKTKYPDSDIYWKKLEDKYHFSCQ  
6683114            PFRTEKG-VVRKWISRFEVWPYLETYTED--VAVEIAKELQGKPDLIIGNYSDGNIVASLLAHKLGVTQCTIAHALEKTKYPDSDIYWKNLDDKYHFSCQ  
4584690            PFRDTKG-IVRKWISRFEVWPYLETYTED--VAHELAKELQGKPDLIVGNYSDGNIVASLLAHKLGVTQCTIAHALEKTKYPESDIYWKKFEEKYHFSCQ  
3915046            PFRDEKG-IVRKWISRFEVWPYLETYTED--VAHELAKELQSKPDLIVGNYSDGNIVASLLAHKLGVTQCTIAHALEKTKYPESDIYWKKFEEKYHFSCQ  
3766299            PFRDQKG-IVRKWISRFEVWPYLETYTED--VAHELAKELQGKPDLIVGNYSDGNIVASLLAHKLGVTQCTIAHALEKTKYPESDIYWKKFEEKYHFSCQ  
3377764            PFRDQKG-IVRKWISRFEVWPYLETYTED--VAHELAKELQGKPDLIVGNYSDGNIVASLLAHKLGVTQCTIAHALEKTKYPESDIYWKKFEEKYHFSCQ  
225444613          PFRTEKG-IVRKWISRFEVWPYLETYTED--VAKELATELQTKPDFIIGNYSDGNIVASLLAHKLGVTQCTIAHALEKTKYPESDIYWKKLEDKYHFSCQ  
3660531            PFRTEKG-IVRKWISRFEVWPYMETFIED--VAKEISAELQAKPDLIIGNYSEGNLAASLLAHKLGVTQCTIAHALEKTKYPDSDIYWKKFDEKYHFSSQ  
31455440           PFRTEKG-IVRKWISRFEVWPYMETFIED--VAKEISAELQAKPDLIIGNYSEGNLAASLLAHKLGVTQCTIAHALEKTKYPDSDIYWKKFDEKYHFSSQ  
304651488          PFRTEKG-IVRKWISRFEVWPYMETFIED--VGKEITAELQAKPDLIIGNYSEGNLAASLLAHKLGVTQCTIAHALEKTKYPDSDIYLNKFDEKYHFSAQ  
28629438           PFRTEKG-IVRKWISRFEVWPYMETFIED--VGKEITAELQAKPDLIIGNYSEGNLAASLLAHKLGVTQCTIAHALEKTKYPDSDIYLNKFDEKYHFSAQ  
115310618          PFRTEKG-VVRKWISRFEVWPYMETFTED--VAKEVTAELQAKPDLVIGNYSEGNLVASLLAHKLGVTQCTIAHALEKTKYPDSDIYLSKFDEKYHFSCQ  
345286417          PFRTEKG-ILRKRISRFEVWPYMETFTED--VAKEITAELQSKPDLIIGNYSEGNLAASLLAHKLGVTQCTIAHALEKTKYPDSDIYLKNFDDKYHFSCQ  
38425095           PFRTEKG-IVRRWISRFEVWPYLETYTED--VANEIAGELQAKPDLIIGNYSDGNIVASLLAHKLGVTQCTIAHALEKTKYPNSDIYWKSFEEKYHFSCQ  
15235300           PFRSEKG-ILRKWISRFDVWPYLENYAQD--AASEIVGELQGVPDFIIGNYSDGNLVASLMAHRMGVTQCTIAHALEKTKYPDSDIYWKDFDNKYHFSCQ  
297814081          PFRSDKG-ILHKWISRFDVWPYLENYAQD--AASEIVGELQGVPDFIIGNYSDGNLVASLMAHRMGVTQCTIAHALEKTKYPDSDIYWKDFDNKYHFSCQ  
6682841            PFRSEKG-ILRQWISRFDVWPYLETFTED--VGSEITAELQGFPDFIIGNYSDGNLVASLLAYKMGITQCTIAHALEKTKYPDSDIYWKKFDEKYHFSCQ  
255564236          PFRSEKG-ILRKWISRFDVWPYLETLLS------EIVAELQGIPDFIIGNYSDGNLVASLLAYKMGVTQCTIAHALEKTKYPDSDIYWKKFDDKYHFSCQ  
313770763          PFRSEHG-ILRKWISRFDVWPYLETFAED--AASEIVAELQGIPDFIIGNYSDGNLVASLLAYKMGVTQCTIAHALEKTKYPDSDIYWKKFDDKYHFSCQ  
3915037            PFRSEKG-ILRKWISRFDVWPFLETFAED--VASEIAAELQCYPDFIIGNYSDGNLVASLLAYKMGVTQCTIAHALEKTKYPDSDIYWKKFEDKYHFSCQ  
225437428          PFRTDKG-ILRKWISRFDVWPYLETFAED--AASEIAAELQGVPELIIGNYSDGNLVASLLASKLGVTQCTIAHALEKTKYPDSDIYWKNFDDKYHFSCQ  
162458268          PFRNENG-ILKKWISRFDVWPYLETFAED--AAGEIAAELQGTPDFIIGNYSDGNLVASLLSYKMGITQCNIAHALEKTKYPDSDIFWKNFDEKYHFSCQ  
242035817          PFRNENG-ILKKWISRFDVWPYLETFAED--AAGEIAAELQGTPDFIIGNYSDGNLVASLLSYKMGITQCNIAHALEKTKYPDSDIYWKKFDEKYHFSCQ  






241896730          PFRNENG-ILRKWISRFDMWPYLEKFAED--AAGEISAELQGTPDFIIGNYSDGNLVASLLSYKMGITQCNIAHALEKTKYPDSDIYWKKFDEKYHFSCQ  
304651490          PFRTENG-ILHKWISRFDVWPYLEKFTED--VAGEMSAELQGVPDLIIGNYSDGNLVASLLAYKMGITQCTIAHALEKTKYPDSDIYWKKFEEKYHFSCQ  
29289943           PFRTENG-ILHKWISRFDVWPYLEKFTED--VAGEMSAELQGVPDLIIGNYSDGNLVASLLAYKMGVTQCTIAHALEKTKYPDSDIYWKKFEEKYHFSCQ  
115310620          PFRTEKG-ILRKWISRFDVWPYLETFTED--AANEISAELQGRPDLIIGNYSDGNLVASLLAHKLGVTQCTIAHALEKTKYPDSDIYWRKFEEKYHFSCQ  
4468153            PFRTEHG-VLRQWISRFDVWPYLEKFAED--AASEISAELRGVPDLIIGNYSDGNLVASLMAHKMGVTQGTVAHALEKXKYPNSDIYWKXYEDKYHFSCQ  
345286419          PFRTELG-VLHKWISRFDVWPYLEKFAED--AAGEIAAELQGVPDLIIGNYSDGNLVASSLSHKMGVTECTIAHALEKTKYPDSDLYWKKYEEKYHFSCQ  
4468151            PFRTEQG-ILKQWISRFDVWPYLEKFAED--AGKEIRAEMKAVPDLLIGNYSDGNLVASLLAYKMGVTQCTIAHALEKTKYPDSDIYWKKHEEKYHFSCQ  
151176306          PFRSEKG-ILRKWISRFDVWPYLENFTED--AAGEIIGELQGRPDLIIGNYSDGNIVASLLSHKMGVTQCNIAHALEKTKYPDSDIYWKRFEDKYHFSCQ  
14530225           PFRSEKG-ILRKWISRFDVWPYLENFTED--AAGEIIGELQGRPDLIIGNYSDGNIVASLLSHKMGVTQCNIAHALEKTKYPDSDIYWKRFEDKYHFSCQ  
15239816           PFRTEKG-ILRKWISRFDVWPYLETFAED--ASNEISAELQGVPNLIIGNYSDGNLVASLLASKLGVIQCNIAHALEKTKYPESDIYWRNHEDKYHFSSQ  
297795665          PFRTEKG-ILRKWISRFDVWPYLETFAED--ASNEISAELQGVPNLIIGNYSDGNLVASLLASKLGVMQCNIAHALEKTKYPESDIYWRNHEDKYHFSSQ  
225431790          PFRTENG-ILRKWISRFDVWPYLETFAED--ASNEIAAELQGVPDLIIGNYSDGNLVASLLSYKMGITQCNIAHALEKTKYPESDIYWRKFEDKYHFSSQ  
255551835          PFRTQNG-ILRKWISRFDVWPYLETFADD--ASNEIAAELQGVPDLIIGNYSDGNLVASLLSYKLGITQCNIAHALEKIKYPDSDIYWRKYEDKYHFASQ  
168009716          PFRHDGK-VLNNWISRFDVYPYLETYAQE--AAREISTDLAGPPDLIIGNYSDGNLVATLMCQQLGVTQCTIAHALEKTKYPDSDIYWKKFEEKYHFSCQ  
168035060          PFRNDGQ-ILKNWISRFDVYPYLETYAQE--AASEICADLSGPPDLIIGNYTDGNLVATLLCQHLGVTQCTIAHALEKTKYPDSDIYWKNFEEKYHFSCQ  
168058907          PFQHEGN-ILKNWISRFDVYPYLENYAQD--AAREVLGELQGRPDLIIGNYSDGNLVATLLSHYLDVTQCIIAHALEKTKYPDSDIYWKDFEEKYHFSCQ  
168029793          PFRNENG-ILHNWISRFDVYPFLENFVYD--VAQELTVELPGKPDFIIGNYTDGNLVASLLCHQLGVTQCNIAHALEKTKYPDSDIYWKKFEEKYHFSCQ  
94266940           PFRYPDLSVVPHWLSRFKLWPFLDQFAVD--VEEELRQEFAGRPDLLVGNYSDGNLVATRLSTSMGVIQCNIAHALEKSKYLFSDLYWHQFEADYHFSIQ  
94264333           PFRYPDLSVVPHWLSRFKLWPFLDQFAVD--VEEELRQEFVGRPDLLVGNYSDGNLVATRLSTSMGVIQCNIAHALEKSKYLFSDLYWHQFEADYHFSIQ  
297569306          PFRYPDNSVVPHWLSRFRIWPYLDQFAVD--AEEEIRRELGGRPDLLVGNYSDGNLVATRLSKNMGVIQCNIAHALEKSKYLFSDLYWDEFEPEYNFSIQ  
254416162          PFREFNPNYTQNWISRFEIWPYLETYAID--AEKELRAEFQGVPDFIVGNYSDGNLVAFLLSRRMDVTQCIVAHALEKSKYLFSNLYWQELEDQYHFSIQ  
332712456          PFREFNPKVTQDWISRFEIWPYLETYAID--AEKELLAEFQGRPDLIVGNYSDGNLVAFLLARRLKVTQCNIAHALEKSKYLFSNLYWQDSEQQYHFSLQ  
17232477           PLREFNPKMTQNWISRFEFWPYLETFAID--SERELLAEFQGRPDLIVGNYTDGNLVAFLLTRRMKVTQCNIAHALEKSKYLFSNLYWQDLEEKYHFSLQ  
75908500           PLREFNPKMTQNWISRFEFWPYLETFAID--SERELLAEFHGRPDLIVGNYTDGNLVAFLLARRMKVTQCNIAHALEKSKYLFSNLYWQDLEEKYHFSLQ  
186682280          PLRDFNPNMTQNWISRFEFWPYLETFAID--SERELRAEFQGTPDLIVGNYTDGNLIAFLLARRLKVTQCNVAHALEKSKYLFSNLYWQELEEKYHFSLQ  
119512682          PLRDFNPNMTQNWISRFEFWPYLETFAID--SEKELLAEFQGRPDLIVGNYSDGNLVAFLLARRMDVTQCNIAHALEKSKYLFSNLYWEELEDKYHFSLQ  
334117431          PFRQFNPKLTQNWISRFEIWPYLETYALD--SEKELLAEFQGKPDLIVGNYSDGNLVAFLLSRKLKTTQCNIAHALEKSKYLFSNLYWQESEDKYHFSLQ  
218440696          PFRDFNPNMTQNWISRFEIWPYLETYAID--AEKELYAQFHGRPDLIIGNYSDGNLVAFLLARRLDVTQFNIAHALEKSKYLFSNLYWQDLEHLYHFSIQ  
159031025          PFREFNPKLTQNWISRFEIWPYLETFALD--AEREILAEFQGRPDLIIGNYSDGNLVAFLLARKLKVTQCNIAHALEKSKYLFSNLYWQDLEEQYHFSLQ  
220907171          PFRSFNPKVTENWISRFEIWPYLETFAID--AEKALLAEFAGRPDLIVGNYSDGNLVAFLLSRRLGVTQGIIAHALEKSKYLFSNLYWQDLDDKYHFSLQ  
22298591           PFREFNPKVTQNWISRFEIWPYLETFAID--AERELRAEFGHVPDLIIGNYSDGNLVAFLLARRLKVTQCNIAHALEKSKYLFSNLYWQDLEDKYHFSLQ  
158339122          PFRELNPKYTQNWISRFEIWPYLETYAID--AERELLAEFRGLPDLIVGNYTDGNLVAFLLSRRLGVTQCNVAHALEKSKYLFSNLYWQDLEEQYHFSMQ  
284053161          PFREFNPNVTQNWISRFEIWPYLETFAID--AETEILAEFQGRPDLIVGNYSDGNLVAFLLSKRLNVIQCNVAHALEKSKYVFSDLYWQDMDDKYHFSLQ  
209523126          PFREFNPNVTQNWISRFEIWPYLETFSID--AETEILAEFQGRPDLIVGNYSDGNLVAFLLSKRLNVIQCNVAHALEKSKYVFSDLYWQNMEDKYHFSLQ  
17228554           PFGEFNPEITNNWISKFEIWPYLETFALD--AEKQLLAQFQGKPNLIIGNYSDGNLVAFLLARRLKVTHCNIAHSLEKPKNLFSNLYWQDSEEKYHFSVQ  
75909957           PFGEFNPAITNNWISKFEIWPYLETFALD--AEKQLLAQFQGKPNLIVGNYSDGNLVAFLLARRLKVTHCNIAHSLEKPKNLFSNLYWQNSEEKYHFSVQ  
186685043          PFGEFNPEITNNWISKFEIWPYLEQFAID--AEKELLTQFKGKPNLLVGNYSDGNLVASLLSRRMKVTQCNIAHSLEKPKYLFSNLYWQDLENQYHFSAQ  
119510624          PFGEFNSDITNNWISKYEIWPYLETFAQD--AEKELLTQFQGRPNLIVGNYSDGNLVASLISRSLKVTQCNIAHSLEKPKHLFSNLYWQDLEDNYHFSAQ  
298489784          PFRDFNPEIINNWISKFEIWPYLEKFAQD--AERELLTEFSGKPDLIVGNYSDGNLVASLLSSSLKIPQCNIAHSLEKPKHLFSNLYWQDLDEKYHFSAQ  
220909283          PFRECNPNVTDNWISKFEIWPYLENFAID--AEKVLLAQLGGRPQLIVGHYSDGNLVAYLLARRFKAIHCQVAHALEKPKYLFSDLYWQDWEAQYHFSAQ  
332708740          PFQEFNPKVTQNWISKFEIWPYLESFALD--SEKALLEEFQGSPDLIIGNYSDGSLVAFLLARRLNAIHGSIAHTMEKPKYLFSDLYWKDFESQYNFSIQ  
Clustal Consensus  *:           :*                        :   *::::*:*::*.. :  :   :      :**::*: *   *          :.*  *  
 
                           510       520       530       540       550       560       570       580       590       600          
                   ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
114331077          YTADLLAMNAADFIVTSTYQEIAGTREAEGQYESYRAFSMPGLYRVINGIDLFDPKFNIVSPGADAEVYFPYTDQ-SRRLHSLIPEIESMLFDNTANFPA  






82703384           YTADLIAMNSADFIITSTFQEIAGTEQTVGQYETYQNYTMPGLYRVVNGIDLFDPKFNIVSPGADAEVYFSYLDH-ERRLDALIPDIERLLYGDDPGVPC  
198283392          FTADLIAMNSSDIIVTSTYQEIAGNDREVGQYEGYQNYSLPGLYRVENGIDVFDTKFNIVSPGADAHYYFPYSAS-EARLRYLHDDIDALLFGEEPAADR  
344199811          FTADLIAMNSADIIVTSTYQEIAGNDHEVGQYEGHQNYSLPGLYRVENGIDVFDTKFNIVSPGADAHYYFPYSAS-EERLRYLHDDIDALLFGEEPAADR  
255021595          FTADLIAMNAADIIVTSTYQEIAGNDREIGQYEGHQDYTLPGLYRVENGIDVFDSKFNIVSPGADPRFYFSYART-EERPSFLEPEIESLLFGREPGADR  
77166514           FTGDLIAMNSADFIVTSTYQEIAGNKNSVGQYESYSAYTLPGLYQVIHGIDVFDPKFNIVSPGADGEVYFPYTDT-KRRLSGLRQEIEALIWGDERP-DA  
300115586          FTGDLIAMNSADFIITSTYQEIAGNKNSVGQYESYSAYTLPGLYQVIHGIDVFDPKFNIVSPGADGEVYFPYTDT-KRRLSGLRQEIEALVWGDDRS-DT  
292493898          FTADFIAMNSADFIITSTYQEIAGDRSSVGQYESYGAYILPGLYQVVQGIDVFDPKFNIVSPGADAEVYFPYRER-KRRLRGLRREIEELIWGNGRP-DA  
350552412          FTADLIAMNAADFIITSTYQEIAGTDHSVGQYESYSAFSMPGLYRVVKGIDVFDPKFNIVSPGADAEVYFSYKDS-ERRLHGLHDELQTLIFGTPSE-DM  
220933364          FTADLIAMNAADFIITSTYQEIAGTGEDIGQYESYMSFSLPDLYRVVRGIDVFDPKFNIVSPGADDRVYFPYTEE-ERRITGLHEEIEALLFGGHRD-DA  
350574485          FTADLIAMNTADFIITSTYQEIAGTDESLGQYESYMNFTMPGLYRVVAGVDVYDPKFNIVSPGADEEIYFPFTET-ERRLAHLHGEIEQLIFGEPVPGQS  
95929190           FTADLVSMNAADFIITSTYQEIAGTEESLGQYESYSSFTMPALYRVINGINIYDPKFNIVSPGADDRVYFPYYDE-ENRLTELHDELHELIYGDHME-GS  
298528445          FTADLIAMNTADFIITSTYQEIAGTEESVGQYETYNAFTMPDLYRVVSGIDVFDPKFNVVSPGADENVYFPYYEK-DRRLTELHDELSDYIYGPPGD-WA  
297602308          FTADMISMNTSDFIITSTYQEIAGSKEKPGQYEHHYAFTMPGLCRYATGINVFDPKFNIAAPGADQSIYFPFTQK-QKRLTDLHPQIDELLYSKDDTDEH  
115457664          FTADMISMNTSDFIITSTYQEIAGSKEKPGQYEHHYAFTMPGLCRYATGINVFDPKFNIAAPGADQSIYFPFTQK-QKRLTDLHPQIDELLYSKDDTDEH  
326504012          FTADMFAMNTTDFIITSTYQEIAGSKEKPGQYEHHYAFTMPGLCRFATGINVFDPKFNIAAPGADQSVYFPFTQK-QKRLTNLHPQIEELLYSKEDTDEH  
115450038          FTADMIAMNTSDFIIASTYQEIAGSKEKPGQYESHYAFTMPGLCRYATGINVFDPKFNIAAPGADQSVYFPFTQK-QKRLTDLHPQIEELLYSKEDNNEH  
326531526          FTADMIAMNTSDFIIASTYQEIAGSKDKPGQYESHYAFTMPGLCRYATGVNVFDPKFNIAAPGADQTVYFPFTQK-QARLTDLHPQIEELLYSKEDNDEH  
242063616          FTADMIAMNTSDFIIASTYQEIAGSKDKPGQYESHYAFTMPGLCRFATGINVFDPKFNIAAPGADQSVYFPFTLK-HKRLTDLHPQIEALVYGKEENDEH  
42568160           FTADLISMNSADFIIASTYQEIAGSKERAGQYESHMSFTVPGLYRVVSGINVFDPRFNIAAPGADDSIYFPFTAQ-DRRFTKFYTSIDELLYSQSENDEH  
297805240          FTADLISMNSADFIIASTYQEIAGSKERVGQYESHMSFTLPGLYRVVSGINVFDPRFNIAAPGADDTIYFPFTAQ-DRRFTKFYPSIEELLFSQNENDEH  
313770765          FMADIVAMNATDFIIASTYQEIAGSKDRTGQYESHAAFTLPGLCRVVSGVNVFDPKFNIAAPGADQSVYFPHTEK-QSRFTQFNPDIEELLYSKVVNDEH  
313770767          FMADTIAMNATDFIIASTYQEIAGSKDRPGQYESHASFTLPGLCRVVSGIDVFDPKFNIAAPGADQSVYFPYTEK-QSRFTKFHPAIEELLYSKVVNDEH  
255584097          FIADTISMNAADFIIASTYQEIAGSKERPGQYESHSAFTLPGLCRVVSGINVFDPKFNVAAPGADQSVYFPNTEK-QKRFSQFHSAIEELLYSKEENEEH  
225466221          FTADTISMNAADFIITSTYQEIAGSKDRPGQYESHTSFTLPGLCRVVSGINLFDPKFNIAAPGADQSVYFPYMER-HKRLTSFQPAIEELLYSKQDNNEH  
313770769          FTADMIAMNSADFIITSTYQEIAGSNVRPGQYESHTAFTMPGLCRVVSGINVFDPKFNIASPGADQSVYFPYTEK-QKRLTSFHPAIEELLYSNEDNHEH  
313770771          FTADMIAMNTADFIITSTYQEIAGSKNRPGQYESHVAFTMPGLCRVVSGINVFDPKFNIASPGADQTVYFPYTEK-QKRLTSFHPAIEELLYNNEDNNEH  
255570671          FTADMIAMNAADFIITSTYQEIAGSKDRPGQYESHKAFTMPGLCRVVSGVNVFDPKFNIAAPGADQSVYFPYTEK-RRRLTSFYPAIEELIYSKEGNDEH  
15219457           FTADLIAMNVTDFIITSTYQEIAGSKDRPGQYESHTAFTMPGLCRVVSGIDVFDPKFNIAAPGADQSVYFPYTEK-DKRFTKFHPSIQELLYNEKDNAEH  
297842089          FTGDLIAMNVTDFIITSTYQEIAGSKDRPGQYESHTAFTMPGLCRVVSGIDVFDPKFNIAAPGADQSVYFPYTEK-EKRFTKFHPSIQELLYNEKDNAEH  
115466896          FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHIAFTLPGLYRVVHGIDVFDPKFNIVSPGADMSVYFPYTEA-DKRLTAFHPEIEELLYSEVENDEH  
17980243           FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHIAFTLPGLYRVVHGIDVFDPKFNIVSPGADMSVYFPYTET-DKRLTAFHPEIEELIYSDVENSEH  
162460741          FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHIAFTLPGLYRVVHGIDVFDPKFNIVSPGADMSVYYPYTET-DKRLTAFHPEIEELIYSDVENSEH  
239984690          FTADLIAMNHTDFIITSTFQEIAGSKDSVGQYESHIAFTLPDLYRVVHGIDVFDPKFNIVSPGADMTVYFPYTET-DKRLTAFHSEIEELLYSDVENDEH  
162460681          FTTDLIAMNHADFIITSTFQEIAGNKDTVGQYESHMAFTMPGLYRVVHGIDVFDPKFNIVSPGADLSIYFPYTES-HKRLTSLHPEIEELLYSQTENTEH  
242035533          FTTDLIAMNHADFIITSTFQEIAGNKDTVGQYESHMAFTMPGLYRVVHGIDVFDPKFNIVSPGADLSIYFPYTES-HKRLTSLHPEIEELLYSQTENTEH  
62865493           FTTDLIAMNHADFIITSTFQEIAGNKDTVGQYESHMAFTMPGLYRVVHGIDVFDPKFNIVSPGADLSIYFPYTES-HKRLTSLHPEIEELLYSDVDNHEH  
17980241           FTTDLIAMNHADFIITSTFQEIAGNKDTVGQYESHMAFTMPGLYRVVHGIDVFDPKFNIVSPGADMSIYFPYSES-HKRLTSLHPEIEELLYSDVDNNEH  
115453437          FTTDLIAMNHADFIITSTFQEIAGNKDTVGQYESHMAFTMPGLYRVVHGIDVFDPKFNIVSPGADMSIYFPYSES-RKRLTSLHPEIEELLYSEVDNNEH  
115473359          FTADLIAMNHADFIITSTFQEIAGNKETVGQYESHMAFTMPGLYRVVHGIDVFDPKFNIVSPGADMSIYFPFTES-QKRLTSLHLEIEELLFSDVENTEH  
3980298            FTADLIAMNHADFIITSTFQEIAGKKDTVGQYESHMAFTMPGLYRVVHGIDVFDPKFNIVSPGADMSIYFPYTEQ-QKRLTSLHTEIEELLFSDVENAEH  
15242073           FTADIFAMNHTDFIITSTFQEIAGSKETVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMSIYFPYTEE-KRRLTKFHSEIEELLYSDVENKEH  
297812265          FTADIFAMNHTDFIITSTFQEIAGSKDTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMSIYFPYTEE-KRRLTKFHSEIEELLYSDVENEEH  
22331535           FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHRSFTLPGLYRVVHGIDVFDPKFNIVSPGADMSIYFAYTEE-KRRLTAFHLEIEELLYSDVENEEH  
297818772          FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMNIYFAYTEE-KRRLTAFHQEIEELLYSDVENEKH  
313770759          FTADLFAMNHTDFIITSTFQEIAGSKDTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADESIYFPYTDE-KRRLTSFHPEIDELLYSPVENEEH  
313770761          FTADLFAMNHTDFIITSTFQEIAGSKDTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADESIYFPYTEK-KLRLTSFHEEIEELLYSSVENDEH  






324984223          FTADLFAMNHTDFIITSTFQEIAGSKDTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMEIYFPYTEE-KRRLKHFHTEIEDLLYSKVENEEH  
258489633          FTADLFAMNHTDFIITSTFQEIAGSKDTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMEIYFPYTEE-KRRLKHFHTEIEDLLYSKVENEEH  
324984221          FTADLFAMNHTDFIITSTFQEIAGSKDTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMEIYFPYTEE-KRRLKHFHPEIEDLLYSKVENEEH  
324984229          FTADLFAMNHTDFIITSTFQEIAGSKDTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMEIYFPYTEE-KRRLKHFHPEIEDLLYSKVENEEH  
6683114            FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMSIYFPYTEE-KRRLKSFHPEIEELLYSDVENKEH  
4584690            FTADLFAMNHTDFIITSTFQEIAGSKDKVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADQTIYFPYTET-SRRLTSFYPEIEELLYSSVENEEH  
3915046            FTADLFAMNHTDFIITSTFQEIAGSKDKVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADQTIYFPYTET-SRRLTSFYPEIEELLYSSVENEEH  
3766299            FTADLFAMNHTDFIITSTFQEIAGSKDTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADQTIYFPYTET-SRRLTSFYPEIEELLYSTVENEEH  
3377764            FTADLFAMNHTDFIITSTFQEIAGSKDTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADQTIYFPYTET-SRRLTSFYPEIEKLLYSTGGNEEH  
225444613          FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHTGFTMPGLYRVVHGIDVFDPKFNIVSPGADMTIYFSYTEE-KMRLKALHPEIEELLFSPVENKEH  
3660531            FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHMAFTMPGLYRVVHGINVFDPKFNIVSPGADINLYFPYSES-EKRLTAFHPEIDELLYSDVENDDH  
31455440           FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHMAFTMPGLYRVVHGINVFDPKFNIVSPGADINLYFSYSET-EKRLTAFHPEIDELLYSDVENDEH  
304651488          FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHMAFTMPGLYRVVHGIDVFDPKFNIVSPGADVNLYFPYSEK-EKRLTTFHPEIEDLLFSDVENEEH  
28629438           FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHMAFTMPGLYRVVHGIDVFDPKFNIVSPGADVNLYFPYSEK-EKRLTTFHPEIEDLLFSDVENEEH  
115310618          FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHMAFTMPGLYRVVHGIDVFDPKFNIVSPGADTNLYFPHTEK-EKRLTSFHPEIEELLFSDVENEEH  
345286417          FTADLYAMNHTDFIITSTFQEIAGSKDTVGQYESHMAFTMPGLYRVVHGIDVFDPKFNIVSPGADMNLYFPYTEK-EKRLTALHPEIEELLYSNVENDEH  
38425095           FTADLIAMNHTDFIITSTFQEIAGNKDTVGQYESHMAFTLPGLYRVVHGIDVFDPKFNIVSPGADLSIYFNYTEE-KKRLTALHPEIEELLFSETQNEEH  
15235300           FTADLIAMNNADFIITSTYQEIAGTKNTVGQYESHGAFTLPGLYRVVHGIDVFDPKFNIVSPGADMTIYFPYSEE-TRRLTALHGSIEEMLYSPDQTDEH  
297814081          FTADLIAMNNADFIITSTYQEIAGTKNTVGQYESHGAFTLPGLYRVVHGIDVFDPKFNIVSPGVDMAIYFPFSEE-TKRLTALHSSIEEMLYSPEQTDEH  
6682841            FTADLIAMNNADFIITSTYQEIAGTKNTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMDIYFPYSEK-QKRLTALHGSIEQLLFDPEQNDEH  
255564236          FTADILAMNNADFIITSTYQEIAGSKNTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMSIYFPYSEK-QKRLTALHGSIEKMLYDPEQTDEW  
313770763          FTADVLAMNNADFIITSTYQEIAGTKTTVGQYESHTAFTLPGLYRVVHGINVFDTKFNIVSPGADMDIYFPYSDK-QKRLTTLHGSIEKMLYDSEQTDDW  
3915037            FTADLIAMNNADFIITSTYQEIAGTKNTIGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMTIYFPYSDK-EKRLTALHSSIEKLLYGTEQTDEY  
225437428          FTADLIAMNNADFIITSTYQEIAGSKNTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMCIYFPYSDV-EKRLTALHGSIEKLLYDPEQNEEH  
162458268          FTADIIAMNNADFIITSTYQEIAGSKNTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMSIYFPHTEK-AKRLTSLHGSIENLIYDPEQNDEH  
242035817          FTADIIAMNNADFIITSTYQEIAGSKNTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMSIYFPHTEK-AKRLTSLHGSIENLLYDPEQNDQH  
115452927          FTADIIAMNNADFIITSTYQEIAGSKNTVGQYESHTAFTLPGLYRIVHGIDVFDPKFNIVSPGADMSIYFPYTEK-AKRLTSLHGSLENLISDPEQNDEH  
241896730          FTADIIAMNNADFIITSTYQEIAGSKNTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMSIYFPFTEK-AKRLTALHGSIESLIYDPEQNDEH  
304651490          FTADLLSMNHSDFIITSTYQEIAGTKNTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMTIYFPYFDK-EKRLTSLHPSIEKLLFDPEQNEVH  
29289943           FTADLLSMNHSDFIITSTYQEIAGTKNTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMTIYFPYSDK-EKRLTSLHPSIEKLLFDPEQNEVH  
115310620          FTADLLAMNHSDFIITSTYQEIAGTNNTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMAIYFPYSDT-EKRLTSFHGSIENLLFDPEQNDEH  
4468153            FTADLLAMNNSDFIITSTYQEIAGTKNSVGQYESHAGFTLPGLYRVVHGIDVFDPKFNIVSPGADDGIYFSYSEK-ERRLTSYHDCLEKLLFDPQQTEEH  
345286419          FTADLLAMNHSDFIITSTYQEIAGTKSTVGQYESHASFTLPGLYRVVHGIDVFDPKFNIVSPGADECIYFPYSEK-DKRLTALHESLEKLIFDPQQTDEH  
4468151            FTADLLAMQHSDFIITSTYQEIAGTRNVVGQYESHVAFTMPGLYRVVHGIDVFDPKFNIVSPGADESIYFPYTDK-EKRLTNLQASIEKLLFDPEQNEEH  
151176306          FSADLMAMNHADFIITSTYQEIAGTKNTVGQYESHKAFTFPGLYRVVHGIDVFDPKFNIVSPGADMAIYFPFSEK-EHRLTSLHSFIEQLLFKPEQNEEH  
14530225           FSADLMAMNHADFIITSTYQEIAGTKNTVGQYESHKAFTFPGLYRVVHGIDVFDPKFNIVSPGADMAIYFPFSEKDVTCLTSLHRLIEQLLFKPEQNEEH  
15239816           FTADLIAMNNADFIITSTYQEIAGSKNNVGQYESHTAFTMPGLYRVVHGIDVFDPKFNIVSPGADMTIYFPYSDK-ERRLTALHESIEELLFSAEQNDEH  
297795665          FTADLIAMNNADFIITSTYQEIAGSKNNVGQYESHTAFTMPGLYRVVHGIDVFDPKFNIVSPGADMTIYFPYSDK-ERRLTALHESIEELLFSAEQNDEH  
225431790          FTADLIAMNNADFIITSTYQEIAGSKNHVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMSIYFSYSEK-ERRLTALHDSIESLLYDSEQNDDH  
255551835          FTADIIAMNNADFIITSTYQEIAGNKNNIGQYEGYTAFTLPGLYRVVHGINVFDPKFNIVSPGADSCIYFPYSDR-ERRLTALHGAIEELLYDPEQNEEH  
168009716          FTADLIAMNHADFIITSTYQEIAGSAKTVGQYESHQAFTMPGLYRVVNGVNVFDPKFNIVSPGADMDVYFPYTDK-ERRLTKLHPTIEDLLFGTEQSDEH  
168035060          FTADLIAMNHADFIITSTYQEIAGSAKTVGQYESHQAFTMPSLYRVVNGIDVFDPKFNIVSPGADMTVYYPFTDK-QHRLTKLHPAIEKLLFSSDQTDEH  
168058907          FTADLIAMNSADFIITSTYQEIAGSADTVGQYESHQAFTMPGLYRVVNGIDVFDPKFNIVSPGADMNIYYPFADK-ERRLTSLQESIEELLYSPEQTDEH  
168029793          FTADLIAMNQADFIITSTYQEIAGSEDTVGQYESHVAFSLPGLYRVVNGIDVFDPKFNIVSPGADTIVYFSFTEK-DRRLTDLHDKIEKLLYDPEQTAEH  
94266940           FMVDLIAMNQANFIVTSTAQEITGTENSIGQYESYQFFTMPGLLNITSGIDLFHPRFNVIPPGVNQEVYFPWNRK-RSRPTKLRRRVSELLFSGEDD-DC  
94264333           FMVDLIAMNQANFIVTSTAQEITGTENSIGQYESYQFFTMPGLLNITSGIDLFHPRFNVIPPGVNQEVYFPWNRK-RSRPTKLRRRVSELLFSGDDD-DC  






254416162          FTADLIAMNAANFIISSTYQEIVGKPDSVGQYESYQNFTMPDLYHVVNGIELFSPKFNVVPPGVNEQVYFPYTRS-EDRVPRDCERLEELLFTLDDPSQV  
332712456          FTADLIAMNAANFIISSTYQEIVGTADSVGQYESYQNFTMPDLYHVINGIELFSPKFNVVPPGVNETVFFPYTRT-QGRVASDIKRLDEFLFTLDDEAQV  
17232477           FTADLIAMNAANFVISSTYQEIVGTPDSIGQYESYKCFTMPELYHVVNGIELFSPKFNVVPPGVNENSYFPYTQT-QNRIESDRDRLEEMLFTLEDSSQI  
75908500           FTADLIAMNAANFVISSTYQEIVGTSDSVGQYESYKCFTMPELYHVVNGIELFSPKFNVVPPGVNENSYFPYTHT-QDRIESDRDRLEEMLFTLEDSSQI  
186682280          FTADLIAMNAANFVVSSTYQEIVGTPDSVGQYESYKCFTMPELYHVTNGIELFSPKFNVVPPGVNENNYFPYTRT-KDRVESDRQRLAETLFTLEDPTQI  
119512682          FTADLIAMNAANFVVSSTYQEIVGTPDSVGQYESYKCFTMPELYHVVNGIELFSPKFNVVPPGVNESYYFPYTRK-EDRVEADSDRLADILFTLEDPHQI  
334117431          FTADIIAMNAANCIVSSTYQEIVGQPDSVGQYESYHCFTMPDLYHVVNGIELFSPKFNVVPPGVNESVYFPYTRI-EDRVQGDRDRLNELLFTLEDPEQV  
218440696          FTADLIAMNAANCIISSTYQEIVGRTDSVGQYESYESFTMPNLYHVVNGIELFSPKFNVVPPGVNENVYFPYTRT-DERVPNKREHLEDLLFTLEDPSQV  
159031025          FTADLISMNAANFIISSTYQEIVGTSDSVGQYESYQCFTMPELYHVVSGIELFSPKFNVVPPGVNESYFFPYTNR-EERLLGEGERLEELLFTLEAPRRV  
220907171          FTADLIVMNAAHFIISSTYQEIVGTPDSVGQYESYSSFTMPELYHVISGIELFSPKFNLVPPGVNENYFFPYTKV-EERLVTERHRLEELLFTLDDPAQV  
22298591           FTADLIAMNAANFIISSTYQEIVGTPDSIGQYESYQSFTMPDLYHVVNGIELFSPKFNVVPPGVNEQVYFPYYHY-TERLEGDRQRLEELLFTLEDPQQI  
158339122          FTADLIAMNAANFIVTSTYQEIAGRPDTIGQYESYRSFTMPDLYHVVYGAELFSPKFNVVPPGVNESVYFPFTRH-QERTPGDIDRLEELLFTLEDPEHV  
284053161          FTADLIAMNAANFIISSTYQEIIGTTDSVGQYESYKSYTMPGLYHVVNGIELFSPKFNVVPPGVNETIFFPYTRT-EERISSDRQRLEELIFYLDDPNQV  
209523126          FTADLIAMNAANFIISSTYQEIIGTTDSVGQYESYKSYTMPGLYHVVNGIELFSPKFNVVPPGVNETIFFPYTRT-EERISSDRQRLENLIFHLDDPSQV  
17228554           FTADLITMNAADFIITSSYQEIFGTPESIGQYESYKFFTMPHLYHVVDGIDLFNPKFNMVPPGVNEQVFFPYSQT-ADRDPNVSKHVHDLLFHRQDS-QI  
75909957           FTADLITMNAADFIITSSYQEIFGTPESVGQYESYKFFTMPHLYHVVDGVDLFSPKFNMVPPGVNEQVFFPYSQT-ADRDPNLSQSVHDLLFHRQDS-QI  
186685043          FTADLISMNAADFIITSSYQEIVGTPDTIGQYESYKCFTMPQLYHVVDGIDLFSPKFNLVPPGVNESIFFPYSQK-ENRDSNLCTEIHNLLFSREDP-QI  
119510624          FTADLISMNAADFIITSSYQEIVGTPDTIGQYESYKCFTMPELYHVINGIDLFSPKFNMVPPGVSENIFFPFSQK-DRRNPKLTSQVHDLLFEREHP-QI  
298489784          FTADLISMNAADFIVASSYQEIVGTPDTMGQYESYKCFTMPQLYHVVDGIDLFNPKFNMIPPGVSETLFFPYSQT-EDRNPQESQKIKDLLFQQQDD-HI  
220909283          FTADLITMNAANFIITSSYQEIVGTPESVGQYESYKCFTMPQLYHVVNGIELCSPKFNRVPPGVNENIFFPYTHK-DSRDPCLCQRIHHLLFHHTDD-HI  
332708740          FTADLIAMNSADFILTSTYEELVGTPESVGYYESYKCFSMPELYHVVNGIELFSPKFNVVPPGVNENIFFPYTQT-SDRIAHDSERVKDLLLSKEDP-EI  
Clustal Consensus  :  *   *: :. :::*: :*: *     * ** :  : .* * .   * ::  .:**  .**..   ::                :   :           
 
                           610       620       630       640       650       660       670       680       690       700          
                   ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
114331077          RGILQDSDKPLIFTMARLDRIKNITGLVESYGASQRLRSLANLVIVGGKIDPQHSSDHEEQEQIHQMHHLMDEYKLDPQVRWLGMRLDKNLAGELYRYIA  
30249199           RGYLQDPDKPLIFTMARLDRIKNITGLVELYAASPRLRSLANLVIVGGKIDPQHSSDHEEQEQIHRMHQLMDEHELDQQVRWLGMRLDKNLAGELYRYIA  
82703384           RGYFADPAKPLIFTMARLDTVKNLTGLAAWFGQCEALSTAANLLVIGGHIDPAASCDGEERAEIEHMHALMNEYKLEGRMRWLGTRLEKNLAGELYRHVA  
198283392          RGVLKERDKPIIFSMARMDHIKNLSGLAEIFGASERLRKLANLVIIGGHVDLQNSQDEEEGAQIQRMHDIMDAHQLDGQMRWIGTLLEKNVAGELYRVIG  
344199811          RGVLKDRDKPIIFSMARMDHIKNLSGLAALFGASERLRTLANLVIIGGHVDPQDSQDEEERAQIHRMHGIMDAHQLDGQMRWIGTLLDKNVAGELYRVIG  
255021595          RGVLEDRQKPLLLSMARMDRIKNLSGLAELYGRSSRLRGLANLVIIGGHVDVGNSRDAEEREEIRRMHEIMDHYQLDGQLRWVGALLDKTVAGELYRVVA  
77166514           RGKLQDHTKPLLFTIARLDRIKNITGLVEWYGRCERLRKLANLVVVGGYIDKSQSADSEEQVQIARMHQLIEEYKLDSQVRWLGVMLQKNLAGELYRFIA  
300115586          RGKLQDRSKPLLFTIARLDRIKNITGLVEWYGRCERLRQLVNLVVVGGYIDKSQSADSEEQAQIARMHQLMEEYGLDGQVRWLGVMLQKNLAGELYRFIA  
292493898          RGRLQDKGKPLLFTMARLDRIKNITGLVEWYGRCERLRKQVNLVVVAGYVDEAQSADSEEQAQIARMHQLMEEYELDNQVRWLGTLLQKNLAGELYRFVA  
350552412          RGTLKHPERPLIFTMARLDRIKNIAGLVQWYAENEALREQANLLIVAGYTDAGKSADREEQEQIGYLHHLFTTHGLDEQVRWLGVRLDKVFAGELYRFIA  
220933364          RGVLAAPERPVIFTMARLDRIKNIAGLVSWYAQNAELRARANLVVVAGTVDPSRSDDQEEQAQIARMHQLFDAHDLNDCVRWLGVRLDKTLSGELYRCIA  
350574485          RGQLQDRDKPLLFSMARLDRIKNIGGLVDWYARAPELRNRVNLVVVAGHVDGNASGDDEEREQIDYIHYLMNTHGLDGQVRWLGVHLDKFLAGEFYRCIA  
95929190           RGLLDDKDKPLIFTMARLDKVKNITGLVECYAKSERLREQANLLVVAGSIHVDHSSDAEERYQIETMHRLFDEYQLDGQVRWLGKHLQKNKAGELYRYIA  
298528445          KGELQDRTKPILFTMARLDRIKNLTSLVRWYGENPELRQEANLVLVAGSLDVRDSQDEEEKACIQEMHRLFEEFDLHEQVRWLGTRLDKNMSGELYRFIA  
297602308          IGYLADRNKPIIFSMARLDKVKNITGLVEWYGQNKKLRDLVNLVVVAGLLDASQSKDREEIEEINKMHNLMDRYQLKGQIRWIKAQTDRVRNGELYRCIA  
115457664          IGYLADRNKPIIFSMARLDKVK-----------NKKLRDLVNLVVVAGLLDASQSKDREEIEEINKMHNLMDRYQLKGQIRWIKAQTDRVRNGELYRCIA  
326504012          IGYLADRSKPIIFSMARLDKVKNITGLVEWYGQNKKVRDLVNLVVVAGLLNAAQSKDREEIDEINKMHNLIDKYQLKGQIRWIKAQTDRVRNGELYRYIA  
115450038          IGHLADRSKPIIFSMARLDKIKNITGLVEWYGQNKRLRDLVNLVIVGGLLDPSQSKDREEIEEINKMHSLINKYQLVGQIRWIKGQTDRVRNGELYRCIA  
326531526          LGYLGDRSKPIIFSMARLDKVKNITGLVEWYGENKKLRDLVNLVIVGGLLEPSQSNDREEIEEINKMHSLMDKYQLKGQIRWIKAQTERVRNGELYRCIA  
242063616          IGYLENRRKPVIFSMARLDKVKNITGLVEWYGQDKRLRVLVNLVVVGGLLDPTQSKDREEIEEINKMHSLINKYQLKGQIRWIKAQTDRVRNGELYRCIA  
42568160           IGYLVDKKKPIIFSMARLDVVKNLTGLTEWYAKNKRLRDLVNLVIVGGFFDASKSKDREEISEIKKMHSLIEKYQLKGQFRWITAQTDRTRNGELYRSIA  






313770765          IGYLEDKKKPIIFSMARLDTVKNLTGLTEWYGKNKRLRGLVNLVIVGGFFDPNKSKDREEMAEIKKMHELIEKYQLKGQIRWIAAQTDRKRNGELYRCIA  
313770767          IGYLEDKKKPIIFSMARLDTVKNLTGLTEWYGKNKRLRGLVNLVIVGGFFDPNKSKDREEMAEITKMHGLIKKYRLNGQFRWIAAQTDRNRNGELYRCIA  
255584097          IGYLADKKKPIIFSMARFDTVKNLTGLTEWYGKNKRLRNLVNLVIVGAFFDPSKSKDREEMAEIKKMHALIDKYQLKGQIRWIAAQTDRQRNGELYRCIA  
225466221          IGFLADRKKPIIFSMARLDIVKNITGLTEWFGNNKRLRSLVNLVIVAGFFDPSKSKDREEMAEIKKMHTLIEKYQLKGQIRWIAAQNDRRRNGELYRCIA  
313770769          IGYLADRKKPIIFSMARLDTVKNITGLTEWFGKNTKLRNLVNLVVVAGFFDPSKSNDREEIAEIKKMHALIEKYQLKGQFRWIAAQTDRYRNGELYRCIA  
313770771          IGYLADKKKPIIFSMARLDTVKNITGLTEWYGKNAKLRNLVNLVVVAGFFDPSKSNDREEIAEIKKMHSLIEKYQLKGQFRWIAAQSDRYRNGELYRCIA  
255570671          IGYLADRKKPIIFSMARLDTVKNITGLTEWYGKNKRLRNLVNLVVVAGFFDPSKSKDREEIAEINKMHALIEKYQLKGQIRWIAAQTDRYRNGELYRCIA  
15219457           MGYLADREKPIIFSMARLDTVKNITGLVEWYGKDKRLREMANLVVVAGFFDMSKSNDREEKAEIKKMHDLIEKYKLKGKFRWIAAQTDRYRNSELYRCIA  
297842089          MGYLAEREKPIIFSMARLDTVKNITGLVEWYGKDKRLREMANLVVVAGFFDMSKSNDREEKAEIKKMHDLIEKYKLKGKFRWIAAQTDRYRNSELYRCIA  
115466896          KFVLKDKNKPIIFSMARLDRVKNMTGLVEMYGKNAHLRDLANLVIVCGDHG-NQSKDREEQAEFKKMYGLIDQYKLKGHIRWISAQMNRVRNGELYRYIC  
17980243           KFVLKDKNKPIIFSMARLDRVKNMTGLVEMYGKNAHLRDLANLVIVAGDHG-KESKDREEQAEFKRMYSLIDEYKLKGHIRWISAQMNRVRNGELYRYIC  
162460741          KFVLKDKKKPIIFSMARLDRVKNMTGLVEMYGKNARLRELANLVIVAGDHG-KESKDREEQAEFKKMYSLIDEYKLKGHIRWISAQMNRVRNGELYRYIC  
239984690          KFVLKDRNKPIIFSMARLDRVKNMTGLVEMYGKNAHLKDLANLVIVAGDHG-KESKDREEQAEFKRMYSLIEEYKLKGHIRWISAQMNRVRNGELYRYIC  
162460681          KFVLNDRNKPIIFSMARLDRVKNLTGLVELYGRNKRLQELVNLVVVCGDHG-NPSKDKEEQAEFKKMFDLIEQYNLNGHIRWISAQMNRVRNGELYRYIC  
242035533          KFVLNDRNKPIIFSMARLDRVKNLTGLVELYGRNKRLQELVNLVVVCGDHG-NPSKDKEEQAEFKKMFDLIEQYNLNGHIRWISAQMNRVRNGELYRYIC  
62865493           KFVLKDRNKPIIFSMARLDRVKNLTGLVELYGRNPRLQELVNLVVVCGDHG-NPSKDKEEQAEFQKMFDLIEQYNLNGHIRWISAQMNRVRNGELYRYIC  
17980241           KFVLKDRNKPIIFSMARLDRVKNLIGLVELYGRNPRLQELVNLVVVCGDHG-NPSKDKEEQAEFKKMFDHIEQYNLNGHIRWISAQMNRVRNGELYRYIC  
115453437          KFMLKDRNKPIIFSMARLDRVKNLTGLVELYGRNPRLQELVNLVVVCGDHG-NPSKDKEEQAEFKKMFDLIEQYNLNGHIRWISAQMNRVRNGELYRYIC  
115473359          KFVLKDKKKPIIFSMARLDHVKNLTGLVELYGRNPRLQELVNLVVVCGDHG-KESKDKEEQAEFKKMFNLIEQYNLNGHIRWISAQMNRVRNGELYRYIC  
3980298            KFVLKDKKKPIIFSMARLDRVKNMTGLVEMYGRNPRLQELVNLVVVCGDHG-KVSKDKEEQVEFKKMFDLIEKYNLSGHIRWISAQMNRVRNGELYRYIC  
15242073           LCVLKDKKKPILFTMARLDRVKNLSGLVEWYGKNTRLRELANLVVVGGDRR-KESKDNEEKAEMKKMYDLIEEYKLNGQFRWISSQMDRVRNGELYRYIC  
297812265          LCVLKDKKKPILFTMARLDRVKNLSGLVEWYGKNTRLRELANLVVVGGDRR-KESKDNEEKAEMKKMYDLIEEYKLNGQFRWISSQMNRVRNGELYRYIC  
22331535           LCVLKDKKKPIIFTMARLDRVKNLSGLVEWYGKNTRLRELVNLVVVGGDRR-KESQDNEEKAEMKKMYELIEEYKLNGQFRWISSQMNRVRNGELYRYIC  
297818772          LCVLKDKKKPILFTMARLDRVKNLSGLVEWYGKNTRLRELVNLVVVGGDRS-KESQDNEEKAEMKKMYDLIEEYKLNGQFRWISSQMNRVRNGELYRYIC  
313770759          LCVLKDRNKPILFTMARLDRVKNLSGLVEWYGKNTKLRELVNLVVVGGDRR-KESKDLEEQAEMKKMYSHIEKYNLNGQFRWISSQMNRVRNGELYRYIC  
313770761          LCVLKDRNKPILFTMARLDRVKNLTGLVEWYGKNTKLRELANLVVVGGDRR-KESKDIEEQAEMKKMYSHIEKYKLNGQFRWISSQMNRVRNGELYRYIC  
255550319          LCVLKDRSKPIIFTMARMDRVKNLTGLVEWYGKNAKLRELANLVVVGGDRR-KESKDLEEQAEMKKMHGLIEKYNLNGQFRWISSQMNRVRNGELYRCIC  
324984223          LCVLNDRNKPILFTMARLDRVKNLTGLVEWYGKNAKLRELANLVVVGGDRR-KESKDLEEKAEMKKMFELIEKYNLNGQFRWISSQMNRIRNGELYRYIC  
258489633          LCVLNDRNKPILFTMARLDRVKNLTGLVEWYGKNAKLRELANLVVVGGDRR-KESKDLEEKAEMKKMFELIEKYNLNGQFRWISSQMNRIRNGELYRYIC  
324984221          LCVLNDRNKPILFTMARLDRAKNLTGLVEWYGKNAKLRELANLVVVGGDRR-KESKDLEEKAEMKKMFELIDKYNLNGQFRWISSQMNRIRNGELYRYIC  
324984229          LCVLNDRNKPILFTMARLDRVKNLTGLVEWYGKNAKLRELANLVVVGGDRR-KESKDLEEKAEMKKMFELIDKYNLNGQFRWISSQMNRIRNGELYRYIC  
6683114            LCVLKDRNKPILFTMARLDRVKNLTGLVEWYGKNAKLRELVNLVVVGGDRR-KESKDLEEQAEMKKMYSLIDQYKLNGQFRWISSQMNRVRNGELYRYIC  
4584690            ICVLKDRNKPIIFTMARLDRVKNITGLVEWYGKNAKLRELVNLVVVAGDRR-KESKDLEEIAEMKKMYGLIETYKLNGQFRWISSQMNRVRNGELYRVIC  
3915046            ICVLKDRNKPIIFTMARLDRVKNITGLVEWYGKNAKLRELVNLVVVAGDRR-KESKDLEEIAEMKKMYGLIETYKLNGQFRWISSQMNRVRNGELYRVIC  
3766299            ICVLKDRSKPIIFTMARLDRVKNITGLVEWYGKNAKLRELVNLVVVAGDRR-KESKDLEEKAEMKKMYEHIETYKLNGQFRWISSQMNRVRNGELYRVIC  
3377764            ICVLKDRNKPIIFTMARLDRVKNITGLVEWYGKNAKLRELVNLVVVAGDRR-KESKDLEEKAEMKKMYEHIETYKLNGQFRWISSQMNRVRNGELYRVIC  
225444613          LCVLKDRNKPIIFSMARLDRVKNLTGLVEWYGKNTRLRELVNLVVVGGDRR-KESKDLEEQSEMKKMHELIETYKLNGQFRWISSQMDRVRNGELYRYIA  
3660531            LCVLKDRTKPILFTMARLDRVKNLTGLVEWYAKNPRLRGLVNLVVVGGDRR-KESKDLEEQAEMKKMYELIETHNLNGQFRWISSQMNRVRNGELYRYIA  
31455440           LCVLKDRTKPILFTMARLDRVKNLTGLVEWYAKNPRLRGLVNLVVVGGDRR-KESKDLEEQAEMKKMYELIETHNLNGQFRWISSQMNRVRNGELYRYIA  
304651488          LCVLKDRNKPIIFTMARLDRVKNLTGLVEWYAKNPRLRELVNLVVVGGDRR-KESKDLEEQAEMKKMYELIKTHNLNGQFRWISSQMNRVRNGELYRYIA  
28629438           LCVLKDRNKPIIFTMARLDRVKNLTGLVEWYAKNPRLRELVNLVVVGGDRR-KESKDLEEQAEMKKMYELIKTHNLNGQFRWISSQMNRVRNGELYRYIA  
115310618          LCVLKDKKKPILFTMARLDRVKNLTGLVELYAKNPKLRELVNLVVVGGDRR-KESKDLEEQAEMKKMYSLIETYNLNGQFRWISSQMNRVRNGELYRYIA  
345286417          LCVLKDKNKPIIFTMARLDRVKNPTGLVELYAKSPKLRQLVNLVIVGGDRR-KESKDLEEQAEMKKMYNLIETYKLNGQFRWISSQMNRVRNGELYRCIA  
38425095           ICVLKDRKKPIIFSMARLDRVKNMTGLVEWYGKNKKLRELVNLVVVAGDRR-KESKDTEEKEEMKKMYSLIEEYNLNGQFRWISAQMNRVRNGELYRYIA  
15235300           VGTLSDRSKPILFSMARLDKVKNISGLVEMYSKNTKLRELVNLVVIAGNIDVNKSKDREEIVEIEKMHNLMKNYKLDGQFRWITAQTNRARNGELYRYIA  
297814081          VGTLSDRSKPILFSMARLDKVKNISGLVEMYSKNTKLRELVNLVVISGNIDVNKSNDREEIAEIEKMDNLVKSYKLDGQFRWITAQTNRARNGELYRYIA  






255564236          IGTLKDKSKPLIFSMARLDRVKNITGLVEMYGKNAKLRELVNLVIVAGYIDVKKSKDREEIAEIEKMHDLMKKYNLEGQFRWITAQTNRARNGELYRYIA  
313770763          IGTLTDKSKPIIFSMARLDRVKNISGLVECYGKNARLRELVNLVVVAGYIDVKKSNDREEILEIEKMHELMKKYKLDGQFRWLTAQTNRARNGELYRYIA  
3915037            IGSLTDRSKPIIFSMARLDRVKNITGLVESYAKNSKLRELVNLVVVAGYIDVKKSSDREEIEEIEKMHDLMKQYNLNGEFRWITAQTNRARNGELYRYIA  
225437428          IGMLNDRSKPIIFSMARLDQVKNITGLVECYAKNAKLREMANLVVVAGYNDVKKSNDREEIVEIEKMHDLMKEYNLHGQFRWMSSQTNRARNGELYRYIA  
162458268          IGHLDDRSKPILFSMARLDRVKNITGLVEAFAKCAKLRELVNLVVVAGYNDVNKSKDREEIAEIEKMHELIKTHNLFGQFRWISAQTNRARNGELYRYIA  
242035817          IGHLDDRSKPILFSMARLDRVKNITGLVEAFAKCTKLRELVNLVVVAGYNDVKKSKDREEIAEIEKMHELIKTYNLFGQFRWISAQTNRARNGELYRYIA  
115452927          IGHLDDRSKPILFSMARLDRVKNITGLVEAYAKNARLRELVNLVVVAGYNDVKKSKDREEIAEIEKMHELIKTYNLFGQFRWISAQTNRARNGELYRYIA  
241896730          IGHLDDPSKPILFSMARLDRVKNMTGLVKAYSKNAKLRSLVNLVVVAGYNDVKKSKDREEIAEIEKMHELIKTYNLFGQFRWISAQTNRVRNGELYRYIA  
304651490          IGSLNDQSKPIIFSMARLDRVKNITGLVECYAKNATLRELANLVVVAGYNDVKKSNDREEIAEIEKMHALMKEHNLDGQFRWISAQMNRARNGELYRYIA  
29289943           IGNLNDQSKPIIFSMARLDRVKNITGLVECYAKNATLRELANLVVVAGYNDVKKSNDREEIAEIEKMHALMKEHNLDGQFRWISAQMNRARNGELYRYIA  
115310620          IGTLKDASKPIIFSMARLDRVKNITGLVECYAKNAELRELANLVVVAGYNDVKKSSDREEISEIEKMHMLMKEYNLDGEFRWIAAQTNRARNGELYRYIA  
4468153            IGVLNDQSKPIIFSMARLDKVKNITGLVEMYAKNAKLRELANLVVVAGYNDVKKSSDREEIAEIEKMHSLIKEYKLDGQLRWISSQTNRVRNGELYRYVA  
345286419          VGFLEDPSKPIIFSMARLDRVKNISGLVELYAKNARLRELANLVVVAGYIDVKKSSDREEISEIEKMHALIKQYDLDGQLRWISAQTNRARNGELYRYIA  
4468151            IGVLKDRSKPIIFSMARLDRVKNITGLVEMYAKNKKLRELTNLVVVAGYNDVKKSSDREEKDEIEKMHNLIDQYDLNGSLRWISAQSNKARNGELYRYIA  
151176306          IGVLDDTSKPIIFSMARLDRVKNITGLVECYGKNAKLRELANLVVVAGYNDVKKSNDREEIAEIEKMHRLIQEYNLRGQFRWIASQTNRVRNGELYRYIC  
14530225           IGVLDDTSKPIIFSMARLDRVKNITGLVECYGKNAKLRELANLVVVAGYNDVKKSNDREEIAEIEKMHRLIQEYNLRGQFRWIASQTNRVRNGELYRYIC  
15239816           VGLLSDQSKPIIFSMARLDRVKNLTGLVECYAKNSKLRELANLVIVGGYIDENQSRDREEMAEIQKMHSLIEQYDLHGEFRWIAAQMNRARNGELYRYIA  
297795665          VGLLSDQSKPIIFSMARLDRVKNLTGLVECYAKNSKLRELANLVIVGGYIDVNQSRDREEMAEIQKMHSLIEQYDLHGQFRWIAAQMNRARNGELYRYIA  
225431790          IGMLSDRSKPIIFSMARLDRVKNITGLVECFGKSSKLRELVNLVVVAGYIDVTKSRDREETKEIEKMHDLIKKYNLHGQFRWIPAQMNRARNGELYRYIA  
255551835          IGYLTDQSKPIIFSMSRLDRVKNLTGLVEWYGKSSKLRELVNLVVVGGSMDVNKSRDREEMAEIKKMHGLITEYNLAGQFRWVAAQMNRARNGELYRYIA  
168009716          IG-VIDKSKPILFTMARLDKVKNLTGLVELYGKNNKLKELTNLVIVGGEINPAKSKDREEVKEIAKMHDFIKEYNLHNSFRWIRSQTNRVQNGELYRYIA  
168035060          VG-IIDKDKPILFTMARLDRVKNLTGLVELYGKNEKLREMTNLVIVGGEIDPAKSKDREEVKEIEKMHSFIKQYNLHNHFRWIRSQTNRVQNGELYRYIA  
168058907          IG-LIDKEKPILFSMARLDRVKNLTGLVEMYGKNQKLKEFVHLVIVGGEINPSKSKDREEVREIEKMHNLIKRYKLENNFRWIRSQTNRIRNGELYRYIA  
168029793          IGSLKDRNKPILFSMARLDKVKNISGLVEMFAKNPRLRELVNLVVVAGNIQKEKSKDREEMAEIDKMHNLMKEYELDGDFRWLCAQTDRVLNGELYRYIA  
94266940           LGRLAEPDKPLLFTIARLDRIKNLTGLVEAYGRDSELRQRVNLVMVASVIDPQRSQDPEEAAEIRRMHEILEQYQLYGQVRWIGKFLGKVETGEAYRLVA  
94264333           LGRLAEPDKPLLFTIARLDRIKNLTGLVEAYGRDSELRQRVNLVMVASVIDPQRSQDPEEAAEIRRMHEILEQYQLYGQVRWIGKFLGKVETGEAYRLVA  
297569306          LGRLENLDLPPLFTIARLDRIKNLTGLVEAYGQDEELRRRVNLIMVASVTDPERSKDAEEAAEIRKMHGIIEQYGLRGQVRWVGKFLGKAETGEAYRIMA  
254416162          YGKLDDPTKRPLFSIARLDRIKNLTGLTECFGKSKALQEQCNLIFVAGKLRTEDSTDNEEKDEIVKLYRLIDEYNLHGKIRWLGVRLPKLDSGEIYRVIA  
332712456          FGKLDYPNKRPIFSMARLDRIKNLTGLAECFGKSRKLQERCNLILIAGNLRTEDSSDSEEKAEIIKLYQIIEEYNLYGKIRWLGVRLSKSDSGEVYRVIA  
17232477           FGKLDDPNKRPIFSMARLDRIKNLTGLAECFGQSQELQERCNLILVAGKLRIEESEDNEEKDEIVKLYRIIDEYNLHGKIRWLGVRLSKNDSGEIYRVIC  
75908500           FGKLDDPNKRPIFSMARLDRIKNLTGLAECFGKSKELQEHCNLILVAGKLRIEESEDNEERDEIVKLYRIIDEYNLHGKIRWLGVRLSKNDSGEIYRVIC  
186682280          FGKLDDPNKRPLFSMARLDHIKNLTGLAECYGQSKELQEHCNLILVAGKLRVEESGDNEERDEIIKLYNIIDEYNLHGKIRWLGVRLSKTDSGEIYRVIA  
119512682          FGKLDDPTKRPLFSVARLDRIKNLTGLAECYGKSPELQEHCNLILVAGKLRVEDSGDNEERDEIIKLYQIIEQYNLYGKIRWLGVRLTKSDSGEIYRVIA  
334117431          FGKLDDPHKRPLFSMARLDRIKNMTGLAELFGKSPELQEKCNLILVAGKLRVEETEDYEEAEEIKKLYAIIDQYNLHGKIRWLGVRLSKSLSGEIYRVIA  
218440696          FGKLDNPSKRPIFSMARLDRIKNLTGLAECFGRSPALQECCNLILVAGKLTVNESSDSEEREEIEKLYRIIDEHNLYGKIRWLGVRLPKADSGEIYRVIA  
159031025          FGHLDNPDKRPLFSLARLDRIKNLTGLAECFGKSEALQEQCNLILVAGKLRAEDSTDREEISEIQKLYHLIDQYNLEGKIRWLGIMLPKADAGEIYRIIA  
220907171          WGKLDHPDKRPLFSMARLDRIKNLTGLAEAFGQNPELQQHCNLILIAGKLRVEETIDHEEAMEIERLYEIIDRYQLTGKMRWLGVRLSKTDSGEVYRIIA  
22298591           YGYLEAPEKRPLFSMARLDRIKNLTGLAEAFGRSKALQERCNLILVAGKLRTADSSDREEIAEIEKLYQIIHQYNLHGKIRWLGIRLPKADSGEIYRIIA  
158339122          FGHLDNPGKPPLFSMARLDRIKNLTGLAECFGQHPQLQDHYNLILVAGKLRTSDSVDHEEINEIERLYRIIDQYNLHGKIRWLGVRFPKQDSGEIYRVVA  
284053161          FGKLADPTKPPLFSVARLDRIKNITGLVECYGQHPELQEKANLIFIAGKLRVEDSSDYEEAEEIKKMYHLIEHYNLYDKVRWLGVRLSKTDTGEMYRVIA  
209523126          FGKLADPTKPPLFSVARLDRIKNITGLVECYGQHPELQEKANLIFIAGKLRVEDSSDYEEAEEIQKMYHLIEHYNLYDKVRWLGVRLSKTDTGEMYRVIA  
17228554           FGYLDQPQKPPIFAVAPITSIKNLTGLAECFGRSQELQAHSNLILLTSKLNIDESTNPEEAREIEKLHNIINQYQLHGHIRWLGLRLPNQEVGEAYRLVA  
75909957           FGYLEQPQKPPIFAVAPITSIKNLTGLAECFGRSQELQAHSNLILLTSKLNIDETTNPEEAREIEKLHNIINQYQLQGHIRWLGLRLPNQEVGEAYRLVA  
186685043          LGHLDRPNKRPIFSVSSISSIKNLAGLAECFGQSQRLQEHCNLILLSSKLHPDEATNPEEAEEIQKLHNIIDRYHLHSKIRWLGMRIPSSSLGEAYRVVA  
119510624          IGKLDNPNKRPILTVAPITSVKNLTGLAECFAKNRGLQEHCNLIFITTKLYVNQATNPKEAEEIQRLHDIINQYELHGNIRCIGMRLPSPDLGEAYRVIA  
298489784          LGNIDDIHKRPIFAVAPVTSIKNLTGLVECFGKSQELQTRCNLILLTSNLSVNEATYPEEAGEIDKLHNLIKEHHLQGKIRWLGMRLPSQKIGEAYRIIA  






332708740          VGYLNSPNQRPILSIAPLTSIKNLSGLVECFASSKELQQKCNLILITSHVRVEDATDPEEKGEIEKLNQLIKQYNLHGKIRWIGLRLTTPDIGESYRVIA  
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114331077          DKRGIFVQPALFEAFGLTIIEAMASG--------LPTFATRYGGPLEIIQHNRSGFHIDPNQGTATADLIADFLEKSHEKPLEWERLSQGALARVASRYT  
30249199           DKRGIFVQPALFEAFGLTIIEAMASG--------LPTFATRYGGPLEIIQNNRSGFHIDPNQGAATADLIADFFEKNLENPQEWERISQGALDRVASRYT  
82703384           DRRGIFVQPARFEAFGLTIIEAMASG--------LPVFATCYGGPREIIQHGVSGYHFDPNDGLAGASAMADFFERVAADPGFWDRISQKALQRVEARYT  
198283392          DSRGCFVQPALFEAFGLTVIEAMSSG--------LPVFATRFGGPLEIIEDGISGFHIDPNNQQETAEKLADFLEAAAADIRVWETISDGALARVGAHYT  
344199811          DTHGCFVQPALFEAFGLTVIEAMSSG--------LPVFATRFGGPLEIIEDGVSGFHIDPNNQQETAEKLADFLAAAAADIRVWETISDGALARVSTHYT  
255021595          DGRGVFVQPALFEAFGLTVIEAMSSG--------LPVFATRFGGPLEIIEDGVSGFHIDPNDHEATAERLADFLEAARERPKYWLEISDAALARVAERYT  
77166514           DSRGAFVQPALFEAFGLTVIEAMSSG--------LPTFATCYGGPLEIIQEGVSGFHIDPNHGEKAADRIADFFEHCQTEAGYWDKFSQGALRRIKNHYT  
300115586          DSRGAFVQPALFEAFGLTVIEAMSSG--------LPTFATCYGGPLEIIQEGVSGFHIDPNHGEKVANRIADFFEHCQTEAGYWDRFSQGALHRIKNHYT  
292493898          DSRGAFVQPALFEAFGLTVIEAMSSG--------LPTFATCYGGPLEIIQDEISGFHINPNHGEEAAGSIADFFERCQVEPEYWENLSQGALRRIRRRYT  
350552412          DRRGVFVQPALFEAFGLTVIEAMVSG--------LPTFATHYGGPLEIIEHGQSGFHIDPMRGDQASAQLLAFLRECEQDPDYWVRISHGGMERVERHYT  
220933364          DRRGVFVQPALFEAFGLTVIEAMASG--------LPTFATRYGGPLEIIEDGVSGYHIDPNHGEQAARILMEFLERCASDPDHWQQISRSAIRRVEQRYT  
350574485          DHQGAFVQPALFEAFGLTVVEAMSCG--------LPTFATCYGGPSEIIEHGLSGFHIDPNHGDQAAALILEFFDACSQNPAHWQTFSTAAMARVQERYT  
95929190           DQKGVFVQPALFEAFGLTVIEAMATG--------LPIFATQYGGPLEIIVDGKSGFHIDPNDNEEMAEKICTFFERAANHPQYWKVISDACITRVEENYT  
298528445          DSRGAFVQPALFEAFGLTVVEAMNSG--------LPTFATIFGGPLEIIEDGKSGFHIDPTHGDEAAGLMANFFSRCRADASYWDTISNNSIKRVEEKYN  
297602308          DTKGAFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIIDGVSGFHVNPINGREAGIKIADFFQKCKEDPSYWNKVSTAGLQRIYEWQR  
115457664          DTKGAFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIIDGVSGFHVNPINDREAGIKIADFFQKCKEDPSYWNKVSTAGLQRICECYT  
326504012          DSKGAFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIVDGVSGFHINPMNGREAGTKIADFFQKCKEDPSYWNKMSTAGLQRIYECYT  
115450038          DTKGAFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIVDEVSGFHINPLNGKEASDKIADFFQKCKEDLIYWSKMSTAGLQRIYECYT  
326531526          DTRGAFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIVNEVSGFHINPLNGKESSDKIAAFFQKCKEDPTYWNKMSTAGLQRIYECYT  
242063616          DTRGAFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIVDEVSGFHINPLDGKEASNKIANFFQKCNEDPMYWNRMSTAGLQRIYECYT  
42568160           DTRGAFVQPAHYEAFGLTVIEAMSCG--------LVTFATNQGGPAEIIVDGVSGFHIDPSNGEESSDKIADFFEKSGMDPDYWNMFSNEGLQRINECYT  
297805240          DTRGAFVQPAHYEAFGLTVIEAMSCG--------LVTFATNQGGPAEIIVDGVSGFHIDPSNGEESSDKIADFFEKSGTDLDYWNMFSTEGLQRINECYT  
313770765          DTKGAFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPSEIIVDGISGFHIDPKNGDESSNIIADFFEKCKVDPGHWNKYSLEGLKRINECYT  
313770767          DTKGAFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIVDGISGFHIDPQNGDESSNIIADFFEKCKVDPGYWNKFAAEGLKRINECYT  
255584097          DTKGAFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIIDGVSGFLIDPNNGDESSNKIADFFEKCKIDAEYWNKFSEDGLKRINECYT  
225466221          DTKGAFVQPAIYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIVDGVSGFHIDPNIGDESSNKIADFFEKCRDDSDHWNKISKAGLQRINECYT  
313770769          DTKGAFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEILVDGISGFHIDPNNGDESSNKIADFFEKCKTDAEYWNKMSAAGLQRIYECYT  
313770771          DTKGAFIQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIVDGISGFHIDPNNGDESSNKIADFVEKCKTDAEYWNKMSATGLQRIYECYT  
255570671          DTKGAFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIVDGVSGFHIDPNNGNESSNKIADFFEKCKADPECWNKMSAAGLQRIHECYT  
15219457           DTKGVFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIVDGVSGFHIDPNNGDESVTKIGDFFSKCRSDGLYWDNISKGGLKRIYECYT  
297842089          DTKGVFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIVDGVSGFHIDPNNGDESVTKIGDFFSKCSSDGLYWDNISKAGLKRIYESYT  
115466896          DTKGVFVQPAFYEAFGLTVIEAMTCG--------LPTIATCHGGPAEIIVDGVSGLHIDPYHSDKAADILVNFFEKCKQDSTYWDNISQGGLQRIYEKYT  
17980243           DTKGVFVQPAFYEAFGLTVIESMTCG--------LPTIATCHGGPAEIIVDGVSGLHIDPYHSNKAADILVNFFEKCKEDPTYWDKISQGGLKRIYEKYT  
162460741          DTKGAFVQPAFYEAFGLTVIESMTCG--------LPTIATCHGGPAEIIVDGVSGLHIDPYHSDKAADILVNFFDKCKADPSYWDEISQGGLQRIYEKYT  
239984690          DTKGAFVQPAFYEAFGLTVIEAMTCG--------LPTIATCHGGPAEIIVDGVSGLHIDPYHSDKAADILVNFFEKSTADPSYWDKISQGGLKRIYEKYT  
162460681          DTKGAFVQPAFYEAFGLTVVEAMTCG--------LPTFATAYGGPAEIIVHGVSGYHIDPYQGDKASALLVDFFDKCQAEPSHWSKISQGGLQRIEEKYT  
242035533          DTKGAFVQPAFYEAFGLTVVEAMTCG--------LPTFATAYGGPAEIIVHGVSGFHIDPYQGDKASALLVDFFEKCQTDSSHWNKISQGGLQRIEEKYT  
62865493           DTKGAFVQPAFYEAFGLTVVESMTCG--------LPTFATAYGGPAEIIVHGVSGFHIDPYQGDKASALLVEFFEKCQQDHSHWTKISQGGLQRIEEKYT  
17980241           DTRGAFVQPAFYEAFGLTVVESMSCG--------LPTFATAYGGPAEIIVHGVSGFHIDPYQGDKASALLVEFFEKCQQDPAHWTKISQGGLQRIEEKYT  
115453437          DTKGAFVQPAFYEAFGLTVVESMTCG--------LPTFATAYGGPAEIIVNGVSGFHIDPYQGDKASALLVEFFEKCQEDPSHWTKISQGGLQRIEEKYT  
115473359          DMRGAFVQPALYEAFGLTVIEAMTCG--------LPTFATAYGGPAEIIVHGVSGYHIDPYQNDKASALLVEFFEKCQEDPNHWIKISQGGLQRIEEKYT  






15242073           DTKGAFVQPALYEAFGLTVVEAMTCG--------LPTFATCKGGPAEIIVHGKSGFHIDPYHGDQAADTLADFFTKCKEDPSHWDEISKGGLQRIEEKYT  
297812265          DTKGAFVQPALYEAFGLTVVEAMTCG--------LPTFATCKGGPAEIIVHGKSGFHIDPYHGDQAANTLADFFTKCKEDPSHWDEISKGGLQRIEEKYT  
22331535           DTKGAFVQPALYEAFGLTVVEAMTCG--------LPTFATCNGGPAEIIVHGKSGFHIDPYHGDKAAESLADFFTKCKHDPSHWDQISLGGLERIQEKYT  
297818772          DTKGAFVQPALYEAFGLTVVEAMTSG--------LPTFATCNGGPAEIIVHGKSGFHIDPYHGDQAAETLADFFTKCKHDPSHWDQISLGGLERIQEKYT  
313770759          DTKGAFVQPALYEAFGLTVVEAMTCG--------LPTFATCNGGPAEIIVNGKSGFHIDPYHGEKAAELLVDFFEKCKVDPAHWDKISHGGLQRIQEKYT  
313770761          DTKGAFVQPALYEAFGLTVVEAMTCG--------LPTFATCNGGPAEIIVHGKSGFHIDPYHGVQAAELLVDFFEKCKADPSYWDKISQGGLQRIQEKYT  
255550319          DTKGVFVQPALYEAFGLTVVESMSCG--------LPTFATCNGGPAEIIVHGKSGFNIDPYHGDQAAELLVEFFEKCKADPCVWDEISKGGLQRIQEKYT  
324984223          DTKGAFVQPALYEAFGLTVVEAMTCG--------LPTFATCNGGPAEIIVHGKSGFNIDPYHGDQAADILVDFFEKCKKDPSHWDKISQGGLKRIEEKYT  
258489633          DTKGAFVQPALYEAFGLTVVEAMTCG--------LPTFATCNGGPAEIIVHGKSGFNIDPYHGDQAADILVDFFEKCKKDPSHWDKISQGGLKRIEEKYT  
324984221          DTKGAFVQPALYEAFGLTVVEAMTCG--------LPTFATCNGGPAEIIVHGKSGFNIDPYHGDQAADILVDFFEKCKKDPSHWDKISQGGLKRIEEKYT  
324984229          DTKGAFVQPALYEAFGLTVVEAMTCG--------LPTFATCNGGPAEIIVHGKSGFNIDPYHGDQAADILVDFFEKCKKDPSHWDKISQGGLKRIEEKYT  
6683114            DTKGAFVQPALYEAFGLTVVEAMTCG--------LPTFATCKGGPAEIIVNGKSGYHIDPYHGEQAAEILVDFFEKCKADPSYWDKISLGGLKRIEEKYT  
4584690            DTKGAFVQPAVYEAFGLTVVEAMATG--------LPTFATLNGGPAEIIVHGKSGFHIDPYHGDRAADLLVEFFEKVKVDPSHWDKISQGGLQRIEEKYT  
3915046            DTKGAFVQPAVYEAFGLTVVEAMATG--------LPTFATLNGGPAEIIVHGKSGFHIDPYHGDRAADLLVEFFEKVKADPSHWDKISQGGLQRIEEKYT  
3766299            DTKGAFVQPAVYEAFGLTVVEAMATG--------LPTFATLNGGPAEIIVHGKSGFHIDPYHGDRAADLLVEFFEKVKTDPSHWDKISQGGLQRIEEKYT  
3377764            DTKGAFVQPAVYEAFGLTVVEAMATG--------LPTFATLNGGPAEIIVHGKSGFHIDPYHGDRAADLLVEFFEKVKTDPSHWDKISQGGLQRIEEKYT  
225444613          DTKGVFVQPAFYEAFGLTVVEAMTCG--------LPTFATCNGGPAEIIVHGKSGFHIDPYHGDKAAELLANFFEKCKADPTHWEKISKAGLKRIEEKYT  
3660531            DTKGAFVQPAFYEAFGLTVVEAMTCG--------LPTFATNHGGPAEIIVHGKSGFHIDPYHGEQAADLLADFFEKCKKEPSHWETISTGGLKRIQEKYT  
31455440           DTKGAFVQPAFYEAFGLTVVEAMTCG--------LPTFATNHGGPAEIIVHGKSGFHIDPYHGEQAADLLADFFEKCKKEPSHWETISTGGLKRIQEKYT  
304651488          DTRGAFVQPAFYEAFGLTVVEAMSCG--------LPTFATNQGGPAEIIVHGKSGFQIDPYHGEQAADLLAEFFEKCKVDPSHWEAISKGGLKRIQEKYT  
28629438           DTRGAFVQPAFYEAFGLTVVEAMSCG--------LPTFATNQGGPAEIIVHGKSGFQIDPYHGEQAADLLADFFEKCKVDPSHWEAISEGGLKRIQEKYT  
115310618          DTRGAFVQPAFYEAFGLTVVEAMTCG--------LPTFATNHGGPAEIIIHGKSGFHIDPYHGEQVSELLANFFERCKKEPSYWDTISAGGLKRIQEKYT  
345286417          DTKGAFVQPAFYEAFGLTVVEAMTRG--------LPTFATLHGGPAEIIVDGKSGFHIDPYNGEQVAETLVSFFEKCNKDPSHWEAISTGGLKRIQEKYT  
38425095           DTRGAFVQPAYYEAFGLTVVEAMTCG--------LPTFATCHGGPAEIIVHGKSGFHIDPYHGDKAADLLVDFFEKSTADPSYWENISKGGLQRIEEKYT  
15235300           DTRGAFAQPAFYEAFGLTVVEAMTCG--------LPTFATCHGGPAEIIEHGLSGFHIDPYHPEQAGNIMADFFERCKEDPNHWKKVSDAGLQRIYERYT  
297814081          DTRGAFAQSIRLLAMKTCILRGFWAYGSGSDDLRASDFRHLSGGPAEIIEHGLSGFHIDPYHPEQAGNIMADFFERGREDPNHWKKVSDAGLQRIYERYT  
6682841            DTKGAFVQPAFYEAFGLTVVEAMTCG--------LPTFATCHGGPAEIIEHGASGFHIDPYHPDQAAELMADFFGKCKENPSHWKKISDGGLKRIYERYT  
255564236          DTKGAFVQPAFYEAFGLTVVEAMTSG--------LPTFATCHGGPAEIIVDGVSGFHIDPYHPDQAAAIMADFFQQCKEDPSHWNKISDAGLQRIYERYT  
313770763          DTKGAFVQPAFYEAFGLTVVEAMTCG--------LPTFATCHGGPAEIIEHGVSGFHMDPYYPDQAAEFMADFFEKCKDDPSYWKKISDAGLQRIYERYT  
3915037            DTKGAFVQPAFYEAFGLTVVEAMTCG--------LPTFATNHGGPAEIIEHGVSGFHIDPYHPDQASELLVDFFQRCKEDPNHWNKVSDGGLQRIYERYT  
225437428          DTRGIFVQPAFYEAFGLTVVEAMTCG--------LPTFATCHGGPAEIIENGVSGFHIDPYHPDQVATTMVDFFEKCKEDSSHWNKISDAGLQRIYERYT  
162458268          DTHGAFVQPAFYEAFGLTVVEAMTCG--------LPTFATLHGGPAEIIEHGVSGFHIDPYHPEQAANLMADFFDRCKQDPDHWVNISGAGLQRIYEKYT  
242035817          DTHGAFVQPAFYEAFGLTVVEAMTCG--------LPTFATLHGGPAEIIEHGISGFHIDPYHPEQAANLMADFFERCKQDPNHWVKISEAGLKRIYEKYT  
115452927          DTHGAFVQPAFYEAFGLTVVEAMTCG--------LPTFATVHGGPAEIIEHGISGFHIDPYHPDQAANLIADFFEQCKQDPNHWVEVSNRGLQRIYEKYT  
241896730          DTHGAFVQPALYEAFGLTVVEAMTCG--------LPTFATLHGGPAEIIEHGISGFHIDPYHPDQAATLMADFFGQCKQDPNHWVKISDKGLQRIYEKYT  
304651490          DKRGIFVQPAYYEAFGLTVVEAMTCG--------LPTFATCHGGPMEIIQDGVSGYHIDPYHPNKAAELMVEFFQRCEQNPTHWENISASGLQRILDRYT  
29289943           DKRGIFVQPAFYEAFGLTVVEAMTCG--------LPTFATCHGGPMEIIQDGVSGYHIDPYHPNKAAELMVEFFQRCEQNPTHWENISASGLQRILDRYT  
115310620          DKRGIFVQPAFYEAFGLTVVEAMTCG--------LPTFATCHGGPKEIIEDGISGFHIDPYHPDKDSAAMVNFFQRCKEDPKYWEKISRGGLQRIYERYT  
4468153            DTRGIFVQPAFYEAFGLTVVEAMTCG--------LPTFATSHGGPMEIIEDRISGFHIDPYHPEKAADLMADFFGKCNEDPSYWVKISEAALRRIQERYT  
345286419          DKRGIFVQPAFYEAFGLTVVEAMTCG--------LPTFATCHGGPLEIIEDGISGFHIDPYHPDKSALLMADFFEKRNEDPSYWVKISEAALRRIQERYT  
4468151            DKRGIFVQPAFYEAFGLTVVEAMTCG--------LPAFATLHGGPHEIIEDGVSGFHIDPYHAEKAATRMADFFAKCDDDPSYWVKISEQALQRIRECYT  
151176306          DKGGIFAQPAFYEAFGLTVVEAMTCG--------LPTFATCHGGPAEIIEDGVSGFHIDPYHADQAAEKMTEFFVKCREDPNYWTKISAGGLLRIKERYT  
14530225           DKGGIFAQPAFYEAFGLTVVEAMTCG--------LPTFATCHGGPAEIIEDGVSGFHIDPYHADQAEK-MTEFFVKCREDPNYWTKISAGGLLRIKERYT  
15239816           DTKGVFVQPAFYEAFGLTVVESMTCA--------LPTFATCHGGPAEIIENGVSGFHIDPYHPDQVAATLVSFFETCNTNPNHWVKISEGGLKRIYERYT  
297795665          DTKGVFVQPAFYEAFGLTVVESMTCG--------LPTFATCHGGPAEIIENGVSGFHIDPYHPDQVAATLVSFFETCNTNPNHWVKISEGGLKRIYERYT  
225431790          DTKGAFVQPAFYEAFGLTVVEAMTCG--------LPTFATCHGGPAEIIEDGLSGFHIDPYHPDQVALRLADFFERCQKDPSYWDEISNGGLKRIYERYT  






168009716          EAGGVFVQPALYEGFGLTVVEAMTCG--------LPTFATLHGGPAEIIEHGISGFHIDPYHPDEVADELVTFFEKVKSDSSFWTKISEAALQRIYSSFT  
168035060          DAGGVFVQPALYEGFGLTVVEAMTCG--------LPTFATMHGGPAEIIVNGISGFHIDPYHPEGVAEVLVSFFEKVKTDPGVWTRISEAALQRIYSNFT  
168058907          DSQGAFVQPALYEGFGLTVVEAMTSG--------LPTFATSHGGPAEIIEHGISGYHIDPYYPDEAAEQIVAFFEKCKNEPGLWNKVSEAGLQRIYSSYT  
168029793          DSHGAFVQPALYEGFGLTVIEAMTCG--------LPTFATCHGGPKEIVVSDVSGFHIDPFHPESASKIIVDFFERCTKEKDYWTKLSDGGLERIRTKYT  
94266940           DRGGVFVQPALFEAFGLTILEAMHSG--------LPVFATQFGGPLEIIEHEHSGFLINPTDPQAMTARLNEFFAACQADPRHWQGFSQRGLERARSRFT  
94264333           DRGGVFVQPALFEAFGLTILEAMHSG--------LPVFATQFGGPLEIIEHEHSGFLINPTDPQAMTARLNEFFAACQADSRHWQGFSQRGLERARSRFT  
297569306          DRRGVFVQPALFEAFGLTILEAMHSG--------LPVFATQFGGPLEIIEHEKSGFLINPTDQPAMTARLREFFHHCEENPRYWQGFSQRALERARERFT  
254416162          DHRGIFVQPALFEAFGLTILEAMISG--------LPTFGTQFGGPLEIIQDKVNGFLINPTNLEETAQKILEFLSKCEQNPDYWLEISNRGMERVYSTYT  
332712456          DRHGIFVQPALFEAFGLTILESMISG--------LPTFGTQFGGPLEIIQDKVNGILINPTNQEEMAQKILDFVTKCEENPQYWEEISNQGIERVYSTYT  
17232477           DRQGIFVQPALFEAFGLTILESMISG--------LPTFATQFGGPLEIIQDKINGFYINPTHLEETATKILDFVTKCEQNPNYWNIISEKAIDRVYSTYT  
75908500           DRQGIFVQPALFEAFGLTILESMISG--------LPTFATQFGGPLEIIQDQINGFYINPTHLEETATKILDFVTKCEHNPNYWKIISEKAIDRVYSTYT  
186682280          DRQGIFVQPALFEAFGLTILESMVSG--------LPTFATQFGGPLEIIQDKVNGFLINPTNLDETATKIVDFITKCEQNPNYWNEISQRGIDRVYSTYT  
119512682          DRKGIFVQPALFEAFGLTILESMVSG--------IPTFATQFGGPLEIIQDKVNGFYINPTNLEETAEKILEFVTKCEQSSHYWDAVSEEAIKRVLTTYT  
334117431          DTQGIFVQPALFEAFGLTILEAMITG--------IPTFGTQFGGPLEIIQDGVNGFYINPTNHEDTAQKILDFLSKCEHNPNYWYEISTRGIDRVYSTYT  
218440696          DRRGVFVQPALFEAFGLTILEAMISG--------LPTFATQFGGPLEIIQDKVNGFYINPTNLEETADKILEFVTKCDHNPDHWIQLSNKAMERVYSTYT  
159031025          DRQGIFVQPALFEAFGLTVLEAMITG--------LPIFATEFGGPREIIQHGANGFLINPTHPEETATMILDFLAKCRQDPDYWREISEQAIQRVYSHYT  
220907171          DHQGIFVQPALFEAFGLTILEAMITG--------LPTFATQFGGPLEIIQEGVNGFLINPTQPEATAAKILQYVRQCEDNPQTWQSISERAIERVYSTYT  
22298591           DRQGIFVQPALFEAFGLTILEAMISG--------LPTFGTRFGGPLEIIQDGVNGFYINPTHLEEMAETIVRFLEACDRDPQEWQRISKAGIERVYSTYT  
158339122          DHKGIFVQPALFEAFGLTVLEAMISG--------LPTFATRFGGPLEIIRDGIDGFYINPTHNEEIATKLLEFAKECATNPDYWQQISEQAIERVYTTYT  
284053161          DHHGIFVQPALFEAFGLTILEAMISG--------LPTFATQFGGPLEIIKDKINGFYINPTNYDETAAKLDEFLVRCQYNIGFWNEISQRGMDRVYSSYT  
209523126          DHHGVFVQPALFEAFGLTILEAMISG--------LPTFATQFGGPLEIIKDKINGFYINPTNYDETAAKLDEFLLRCQYNIGFWNEISQRGMDRVYSSYT  
17228554           DYRGIYIHFARFEAFGRSILEAMISG--------LPTFATKFGGSLEIMEDQNNGFRINPTDLEGTAEKILAFFQECDTHPEHWQEVSQWMSQRIHQKYN  
75909957           DYRGIYLHFARFEAFGRSILEAMISG--------LPTFATKFGGSLEILEDQNNGFRINPTDLEGTAEKILAFFQECDTHPEHWQEVSQWMSQRIHQKYN  
186685043          DCQGISVHFARFESFGRSILEAMISG--------LPTFATQFGGSLEIIENQEEEFNVNPTDLVETAKKILDFFEKCNTHPEHWQEVSEWMSQRVHNRYN  
119510624          DAQGIYVHFARFESFGRSILEAMVSG--------LPTFVTKFGGAVEIIQDQEETFHINPTDFKATAHQILNFIDQCETQPERWTEVSQMMSQRVINKYN  
298489784          DYQGIYIHFALYEAFGRSILEAMISG--------LPTFATKFGGSSEILEDLQTGFHLNPTNLERTAKTILNFLDKCDANPEYWQETSQWMIQRIRHKYN  
220909283          DQRGFFVHFARFEAFGQTILEAMISG--------LPAFATQFGGCLEIIQDGENGFHINPTDPEGTVKKILAFIHACAADPTYWQGISERAIERVQQQYN  
332708740          DLGGFLVHPARFEAFGLTVLEAMISG--------LPTFATQFGGPSEIIQNGDNGFLINPTDLQDTAEKIQQFISKCEHTPDYWQKISQAGIKRVRDKYN  
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114331077          WKLYAERMMTLSRIYSFWKFVS-GLEREETDLYLNMFYHLQFRPLANRLAGDA-----------------------------------------------  
30249199           WKLYAERMMTLSRIYGFWKFVS-GLEREETDRYLNMFYHLQFRPLANRLAHEI-----------------------------------------------  
82703384           WRLYAERMMTLSRIYGFWKFVS-KLEHEETARYLNMFYHLQFRPMAQALPQ-------------------------------------------------  
198283392          WGNYAAQMMTLARIFGFWRFML-KADRHAARRYLQMFQHLQWRPLAHAVPLGES----------------------------------------------  
344199811          WGNYATQMMTLARIFGFWRFML-KTDHHAARRYLQMFQHLQWRPLAHAVPLGES----------------------------------------------  
255021595          WERYAERLMTIARIFGFWRFVL-DRESQVMERYLQMFRHLQWRPLAHAVPME------------------------------------------------  
77166514           WELYAERMMTLSRIYGFWKYVT-NLERAERRRYLEMFYNLQFRPLAQQIEH-------------------------------------------------  
300115586          WELYAERMMTLSRIYGFWKYVT-NLEREERRRYLEMFYNLQFRPLAQQMEH-------------------------------------------------  
292493898          WDLYAERMMTLSRIYGFWKYVT-NLEREESRRYLEMFYNLQFRPLAQQMEH-------------------------------------------------  
350552412          WSLYAQRMMTLSRIYGFWKYVT-NLERAEARRYLEMFYALQYRPLARSLTGE------------------------------------------------  
220933364          WKLYAERMMTLSRIYGFWKYVT-NLERAETRRYLEMFHALQYRPLALLK---------------------------------------------------  
350574485          WRRYAERMMTLSRVYGFWKYVT-DLERAETSRYLEMFYTLKLRPLAKAIQG-------------------------------------------------  
95929190           WSLYARRLLTLSRVYGFWKYVS-NLEREETRRYLEMFHGLMFRNLASETQ--------------------------------------------------  
298528445          WRLYAQRLLSFSRIYGFWKYVS-NLERDETRRYLDMFYSLKMRSLSH-----------------------------------------------------  






115457664          WKIYATRVLNMGSTYSFWKTLN-KEERQAKQRYLQIFYNVQYRNLAKAMARAGDQQARQTTTG---VAPSEIVVRPKERKPQTRMQRILTRLAGQKPPVS  
326504012          WKIYATKVLNMGSMYGFWRTLN-KEERVAKQRYMQMFYNLQYRNLVKTVPRVGEQPPRPAASTGAVAERNQIVARPRERKPQGRVQRMMTSLLGPKPPTY  
115450038          WQIYATKVLNMASIYGFWRTLD-KEERQAKQHYLHMFYNLQFRKLAKNVPTLGEQPAQ----PTESAEPNRIIPRPKERQVCPFLRNLLKKETGNN----  
326531526          WQIYATKVLNMGSMYGFWRTLN-KEERQAKQLYLQMFYNLLFRQLVKTVPKLGEQPAQ----PTTAP--ARIAPRPRERRPQTRIQRIATSLLGPVLPTS  
242063616          WQIYATKVLNMGSMYGFWRTLD-KEEKQAKQQYLQMFYNLHFRKLANAVPKVGEQPEQ----ATAVPLPDRSAPRPKERQVCPLLRNLLKIKWGSN----  
42568160           WKIYANKVINMGSTYSYWRHLN-KDQKLAKQRYIHSFYNLQYRNLVKTIPILSDIPEPPPLPPKPLVKPSASKGSKRTQPRLSFRLFGA-----------  
297805240          WKIYANKVINMGSTYSYWRYLN-KDQKLAKQRYIHSFYNLQYRNLVKNIQILSDIPQPPPPPPKPLVKPSASKGSRRTQSRLSFRLFGA-----------  
313770765          WKIYANKLLNMGNVYSFWRQLN-KEQKLAKQRYIQLFFNLKFRELVQSVPIPTEEAQTPASEPTARTQSSAR----------------------------  
313770767          WKIYAKKLLNMGNMYSFWRQLN-KEQKLAKQRYIQMLYNLQFRRLVVWSLSCNQEAWIRTAIILCHLTLLNMFIHNVFYLLLSEFNFSVYDH--------  
255584097          WKIYANKVLNMGCIYTYWRQMN-KEQKQAKRRYIQLFYNLQLRKLVKNVPIPTEEAQQQPAPKPVNKASSRQVP--------------------------  
225466221          WKIYANKVLNMGCVFSFWRQLN-TEHKQAKQKYIHMFYTLQFRNLVKNIPIPASEVQPPVSRAITKHHHQALTVSTGKVKPKSQLTDYPASAFSQVKNDL  
313770769          WKIYANKVLNMGSVYGFWRQTN-KEQKLAKQRYIEAFYNLQFNNLVGYCGQLVL----------------------------------------------  
313770771          WKIYANKVLNMGSVYGFWRQMN-KEQKLLKQRYIEAFYNLQFRNLVGYFRQLVT----------------------------------------------  
255570671          WKIYANKVLNMGSVYGFWRQLN-KEQKHAKQRYIETFYNLHFRNLVKNVPIASVGPQKQPSSSAGTSKTQEPSPPATTKSSQSQPTPKPKRKEESQKEKP  
15219457           WKIYAEKLLKMGSLYGFWRQVN-EDQKKAKKRYIEMLYNLQFKQLTKKVTIPEDKPLPLRLASLRNLLPKKTTNLGAGSKQKEVTETEKTKQKSKDGQEQ  
297842089          WKIYAEKLLKMGSIYGFWRQVN-EDQKKAKQRYIELLYNLQFKQLTKKVTIPEDKPLPLRLASLRNLLPKKTTPLGAGSKQKEVTEAEKTKQKSKDGQEQ  
115466896          WKLYSERLMTLTGVYGFWKYVS-NLERRETRRYIEMFYALKYRSLASAVPLAVDGESTSK----------------------------------------  
17980243           WKLYSERLMTLTGVYGFWKYVS-NLERRETRRYLEMFYALKYRSLASAVPLAVDGDSAAN----------------------------------------  
162460741          WKLYSERLMTLTGVYGFWKYVS-NLERRETRRYIEMFYALKYRSLASQVPLSFD----------------------------------------------  
239984690          WKLYSERLMTLTGVYGFWKYVS-NLERRETRRYLEMFYALKYRSLAAAVPLAVDGESSGN----------------------------------------  
162460681          WKLYSERLMTLTGVYGFWKYVS-NLERRETRRYLEMLYALKYRTMASTVPLAVEGEPSSK----------------------------------------  
242035533          WKLYSERLMTLTGVYGFWKYVS-NLERRETRRYLEMLYALKYRTMASTVPLAVEGEPSSK----------------------------------------  
62865493           WKLYSERLMTLTGVYGFWKYVS-NLERRETRRYLEMLYALKYRTMASTVPLAVDGEPSSK----------------------------------------  
17980241           WKLYSERLMTLTGVYGFWKYVS-NLERRETRRYLEMLYALKYRKMASTVPLAVEGEPSNK----------------------------------------  
115453437          WKLYSERLMTLTGVYGFWKYVS-NLERRETRRYLEMLYALKYRTMASTVPLAVEGEPSNK----------------------------------------  
115473359          WKLYSERLMTLSGVYGFWKYVT-NLDRRETRRYLEMLYALKYRKMATTVPLAIEGEASTK----------------------------------------  
3980298            WKLYSERLMTLSGVYGFWKYVS-NLDRRETRRTLKCSMPSSTAKWLQLSHWLLRARPRANDLSLPEK---------------------------------  
15242073           WQIYSQRLLTLTGVYGFWKHVS-NLDRLEARRYLEMFYALKYRPLAQAVPLAQDD---------------------------------------------  
297812265          WQIYSQRLLTLTGVYGFWKHVS-NLDHLEARRYLEMFYALKYRPLAQAVPLAQDD---------------------------------------------  
22331535           WQIYSQRLLTLTGVYGFWKHVS-NLDRLESRRYLEMFYALKYRPLAQAVPLAHEE---------------------------------------------  
297818772          WQIYSERLLTLTGVYGFWKHVS-NLDRLESRRYLEMFYALKYRPLAQAVPLAQEE---------------------------------------------  
313770759          WQIYSQRLLTLTGVYGFWKHVS-NLDRLESRRYMEMFYALKYRKLAESVPLTKE----------------------------------------------  
313770761          WKIYSQRLLTLTGVYGFWKHVS-NLDHRESRRYLEMFYALKYRKLADSVPLTIE----------------------------------------------  
255550319          WQIYSQRLLTLTGVYGFWKHVS-KLDRRESRRYLEMFYALKYKKLADSVPLTVE----------------------------------------------  
324984223          WKIYSERLLTLTGVYGFWKHVS-NLERRESRRYLEMFYALKYRKLAESVPLAEE----------------------------------------------  
258489633          WKIYSERLLTLTGVYGFWKHVS-NLERRESRRYLEMFYALKYRKLAESVPLAEE----------------------------------------------  
324984221          WKIYSERLLTLTGVYGFWKHVS-NLERRESRRYLEMFYALKYRKLAESVPLAEE----------------------------------------------  
324984229          WKIYSERLLTLTGVYGFWKHVS-NLERRESRRYLEMFYALKYRKLAESVPLAEE----------------------------------------------  
6683114            WKIYSQRLLTLTGVYGFWKHVS-NLDRLESRRYLEMFYALKYRKLAESVPLAVE----------------------------------------------  
4584690            WTIYSQRLLTLTGVYGFWKHVS-NLDRLESRRYLEMFYALKYRKLAESVPLAVE----------------------------------------------  
3915046            WTIYSQRLLTLTGVYGFWKHVS-NLDRLESRRYLEMFYALKYRKLAESVPLAVE----------------------------------------------  
3766299            WQIYSQRLLTLTGVYGFWKHVS-NLDRLESRRYLEMFYALKYRKLAESVPLAVEE---------------------------------------------  
3377764            WQIYSQRLLTLTGVYGFWKHVS-NLDRLESRRYLEMFYALKYRKLAESVPLAVEE---------------------------------------------  
225444613          WKIYSERLLTLAGVYGFWKYVS-NLDRRETRRYLEMFYALKYRKLAQSVPLAVEE---------------------------------------------  
3660531            WQIYSERLLTLAAVYGFWKHVS-KLDRLEIRRYLEMFYALKYRKMAEAVPLAAE----------------------------------------------  
31455440           WQIYSERLLTLAAVYGFWKHVS-KLDRLEIRRYLEMFYALKYRKMAEAVPLAAE----------------------------------------------  






28629438           WQIYSDRLLTLAAVYGFWKHVS-KLDRLEIRRYLEMFYALKFRKLAQLVPLAVE----------------------------------------------  
115310618          WQIYSDRLLTLAGVYGFWKCVS-KLDRQEIRRYLEMFYALKYRKLAEAVPLAVDQ---------------------------------------------  
345286417          WQIYSDRLLTLAGVYGFWKYVS-KLDRLEIRRYLEMFYALKYRKLAEAVPLAVE----------------------------------------------  
38425095           WKIYSDRLLTLAGVYGFWKYVS-NLDRREARRYLEMFYALKYKKLAESVPLAIEDAN-------------------------------------------  
15235300           WKIYSERLMTLAGVYGFWKYVS-KLERRETRRYLEMFYILKFRDLVKTVPSTADD---------------------------------------------  
297814081          WNIYSERLMTLAGVYGFWKYAS-KLERRETRRYLEMFYILKFRDLVKTVPLTADD---------------------------------------------  
6682841            WKIYSERLMTLAGVYGFWKYVS-KLERRETRRYLEMFYILKFRDLVKSVPLASENQH-------------------------------------------  
255564236          WKIYSERLLTLAGVYGFWKYVS-KLERRETRRYLEMFYILKFRDLVQTVPLAIDDQH-------------------------------------------  
313770763          WKIYSERLMTLAGVYGFWKYVS-KLERRETRRYLEMFYILKFRDLVKTVPLSIEDWH-------------------------------------------  
3915037            WKIYSERLMTLAGVYSFWKYVS-KLERRETRRYLEMFYILKFRDLANSVPIAKG----------------------------------------------  
225437428          WKIYSERLMTLAGVYGFWKYVS-KLSRRETRRYLEMFYTLKFRDLAKSVPLAIDDQH-------------------------------------------  
162458268          WKIYSERLMTLAGVYGFWKYVS-KLERLETRRYLEMFYILKFRELAKTVPLAIDQPQ-------------------------------------------  
242035817          WKIYSERLMTLAGVYGFWKYVS-KLERRETRRYLEMFYILKFRELAKTVPLAIDQPQ-------------------------------------------  
115452927          WKIYSERLMTLAGVYGFWKYVS-KLERRETRRYLEMFYILKFRELAKTVPLAVDEAH-------------------------------------------  
241896730          WKIYSERLMTLAGVYGFWKYVS-KLERRETRRYLEMFYILKLRELVKSVPLALDETH-------------------------------------------  
304651490          WKIYSERLMTLAGVYGFWKLVS-KLERRETRRYLEMFYILKFRELVKSVPLAVDEKQ-------------------------------------------  
29289943           WKIYSERLMTLAGVYGFWKLVS-KLERRETRRYLEMFYILKFRELVKSVPLAIDDKH-------------------------------------------  
115310620          WKIYSERLMTLAGVYGFWKYVS-KLERRETRRYLEMFYILKLRELVKSVPLAVDDQH-------------------------------------------  
4468153            WKKYSERLMTLAGVYGFWKHVS-KLERRETRRYLEMFYILKFRELVNSVPYAVDGSD-------------------------------------------  
345286419          WKIYSERLMTLAGVYGFWKYVS-KLERRETRRYLEMFYILKFRELVTSVPLAVDGSA-------------------------------------------  
4468151            WNIYSERLMTLAGVYSFWKYVS-KLERRETRRYLEMFYILKFRNLAKSVPYATE----------------------------------------------  
151176306          WQKYSERLMTLAGVYGFWKYVS-KLERRETRRYLEMFYILKFRDLANSVPLATDEEPSTTDAVATFRGP-------------------------------  
14530225           WQKYSERLMTLAGVYGFWKYVS-KLERRETRRYLEMFYILKFRDLANSVPLATDEEPSTTDAVATFRGP-------------------------------  
15239816           WKKYSERLLTLAGVYAFWKHVS-KLERRETRRYLEMFYSLKFRDLANSIPLATDEN--------------------------------------------  
297795665          WKKYSERLLTLAGVYAFWKHVS-KLERRETRRYLEMFYSLKFRDLANSIPLATDEN--------------------------------------------  
225431790          WKIYTERLLTLAGVYGFWKHVS-KLERRETRRYLEMFYILKLKDLATSIPLAVDEH--------------------------------------------  
255551835          WKIYSKRLLTLAGVYGFWKHVS-KLERREIRRYLEMFYILKFNNLVKSIPLAVDDQQ-------------------------------------------  
168009716          WKLYAERLMTLTRVYGFWKYVS-NLHRREARRYLEMFYTLKFRELVRSLTLPHPILHLHLQLHNRQLLYSICIVNSTFQLSTICGNLCDQVKTVPLSKDD  
168035060          WKLYAERLMTLTHVYGFWKYVS-NLQRRESKRYLEMFYTLKYRELVRKSPCPTYSFFIVSNFLMKNLMASYKFQ--------------------------  
168058907          WKIYAERLMTLSAVYGFWKYVS-KLHRQEARRYLEMFYILKFRELARTVPLSKDDEDVLEKVEKKAQLGPGVGAIVGEAATAVEARKAVTGHT-------  
168029793          WEIYAERLLTLSRVYGFWKFVS-KLGRRETRRYLEMFYILKFRELVKTVPVASDDKSYLKEQEKKV----------------------------------  
94266940           WQLHCRSLTRLTKVYGFWRYSISQQAKTRLNQYSEVLYHLYFKEQAANLL--------------------------------------------------  
94264333           WQLHCRSLTRLTKVYGFWRYSISQQAKTRLNQYSEVLYHLYFKERAANLL--------------------------------------------------  
297569306          WQRHCRELTRLTKVYGFWRYSTSQQAKMRLNQYSEVLYHLFYKARAEQIR--------------------------------------------------  
254416162          WKIHTSRLLSLARIYGFWNYTS-KEKREDLLRYIESLFYLIYKPRAQQLLEEHLKR--------------------------------------------  
332712456          WKIHTTRLLSLARIYGFWNYTS-KANQEDMLRYLEALFHLIYKPRAKKLLEEHLTLPARA----------------------------------------  
17232477           WKIHTTKLLTLARIYGFWNFTS-KEKREDLLRYLESLFYLIYKPRAQQLLEQHKYR--------------------------------------------  
75908500           WKIHTTKLLTLARIYGFWNFAS-KEKREDLLRYLESLFYLIYKPRAQQLLEQHKYR--------------------------------------------  
186682280          WKIHTSKLLSLARIYGFWNFTS-KENREDLLRYLEALFYLIYKPRAQQLLEQHKYR--------------------------------------------  
119512682          WKIHTTKLLSLARIYGFWNFTS-KENREDLLRYLEALFYLIYKPKAQELLEQHQHR--------------------------------------------  
334117431          WKIHTTKLLTLARTYGFWNYSS-KENREDMLRYIESLFYLIYKPKAKALLAEHANR--------------------------------------------  
218440696          WKIHTSKLLSLSRIYGFWNFIS-KENREDILRYVESLFYLLFKPRAKELLEQHMHR--------------------------------------------  
159031025          WKIHTTRLLSLARIYGFWNHTS-QENREELLRYIETLFYLLFKPRAQHLLEIHGQR--------------------------------------------  
220907171          WKIHTTRLLSLARTYGFWNYSL-QENREDLLRYIESLFYLLFKPRAQQLLAEHLQR--------------------------------------------  
22298591           WKIHCTRLLSLAKIYGFWNFSS-QENREDMMRYMEALFHLLYKPRAQALLAEHLQR--------------------------------------------  
158339122          WKIHTSRLLSLAKIYGFWNYTS-REKREDMLRYIETIFYLLYKPMAKKLLAKHMDS--------------------------------------------  






209523126          WKIHTSRLLTLTRVYGFWKYIS-KEKRADMMRYLEALFYLIYKPRSQELLQQHLQR--------------------------------------------  
17228554           WQLHTSQLLALTKIYSFWNFIR-PESSEARVRYMESLFHLIYKPRAEQILAKHMSCH-------------------------------------------  
75909957           WQLHTSQLLALTKIYSFWNFIR-PESSEARVRYMESLFHLIYKPRAEQILAKHMSCH-------------------------------------------  
186685043          WHLYSNQLLLLAKMFTFWNFVA-PENNEARDRYMETLFHLIYKPRAEKILEKHMGANS------------------------------------------  
119510624          WHLHTSQILLLAKIFSFWNFAL-PENNAAKHRYLETLFYLIFKPRAEKILEKHQQYSVIMNH--------------------------------------  
298489784          WESYTEQLLLIAKIFSFWNFIV-PEANDARDRYMEILFHLIYKPRAEQIIGQHQQRYAHIYK--------------------------------------  
220909283          WPSHIRQLLLLTKIYGFWNCMA-QQQREALLNYMDALYHLIYKPRAAEILAQHLYR--------------------------------------------  
332708740          WQLHTKQLLSLAKIYGFWSETS-KESREALLRYLEALFYLIYKPRATNLLAKHRSR--------------------------------------------  
Clustal Consensus                  :                                                                                     
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114331077          ------------------------------------------------------------------------------------  
30249199           ------------------------------------------------------------------------------------  
82703384           ------------------------------------------------------------------------------------  
198283392          ------------------------------------------------------------------------------------  
344199811          ------------------------------------------------------------------------------------  
255021595          ------------------------------------------------------------------------------------  
77166514           ------------------------------------------------------------------------------------  
300115586          ------------------------------------------------------------------------------------  
292493898          ------------------------------------------------------------------------------------  
350552412          ------------------------------------------------------------------------------------  
220933364          ------------------------------------------------------------------------------------  
350574485          ------------------------------------------------------------------------------------  
95929190           ------------------------------------------------------------------------------------  
298528445          ------------------------------------------------------------------------------------  
297602308          ------------------------------------------------------------------------------------  
115457664          E-----------------------------------------------------------------------------------  
326504012          EQNGYR------------------------------------------------------------------------------  
115450038          ------------------------------------------------------------------------------------  
326531526          NFSQDAA-----------------------------------------------------------------------------  
242063616          ------------------------------------------------------------------------------------  
42568160           ------------------------------------------------------------------------------------  
297805240          ------------------------------------------------------------------------------------  
313770765          ------------------------------------------------------------------------------------  
313770767          ------------------------------------------------------------------------------------  
255584097          ------------------------------------------------------------------------------------  
225466221          ------------------------------------------------------------------------------------  
313770769          ------------------------------------------------------------------------------------  
313770771          ------------------------------------------------------------------------------------  
255570671          KPETITTRHVI-------------------------------------------------------------------------  
15219457           HDVKVGEREVREGLLAADASERVKKVLESSEEKQKLEKMKIAYGQQHSQGASPVRNLFWSVVVCLYICYILKQRFFGANSAQEY  
297842089          NDGKVGERDVSETFLAAEASERTKKVLETSEEKQKLEKMKIAYGQQQNQGASPVRNLFWSVVVCLYICYILKQRFFGANSAQEY  
115466896          ------------------------------------------------------------------------------------  
17980243           ------------------------------------------------------------------------------------  
162460741          ------------------------------------------------------------------------------------  






162460681          ------------------------------------------------------------------------------------  
242035533          ------------------------------------------------------------------------------------  
62865493           ------------------------------------------------------------------------------------  
17980241           ------------------------------------------------------------------------------------  
115453437          ------------------------------------------------------------------------------------  
115473359          ------------------------------------------------------------------------------------  
3980298            ------------------------------------------------------------------------------------  
15242073           ------------------------------------------------------------------------------------  
297812265          ------------------------------------------------------------------------------------  
22331535           ------------------------------------------------------------------------------------  
297818772          ------------------------------------------------------------------------------------  
313770759          ------------------------------------------------------------------------------------  
313770761          ------------------------------------------------------------------------------------  
255550319          ------------------------------------------------------------------------------------  
324984223          ------------------------------------------------------------------------------------  
258489633          ------------------------------------------------------------------------------------  
324984221          ------------------------------------------------------------------------------------  
324984229          ------------------------------------------------------------------------------------  
6683114            ------------------------------------------------------------------------------------  
4584690            ------------------------------------------------------------------------------------  
3915046            ------------------------------------------------------------------------------------  
3766299            ------------------------------------------------------------------------------------  
3377764            ------------------------------------------------------------------------------------  
225444613          ------------------------------------------------------------------------------------  
3660531            ------------------------------------------------------------------------------------  
31455440           ------------------------------------------------------------------------------------  
304651488          ------------------------------------------------------------------------------------  
28629438           ------------------------------------------------------------------------------------  
115310618          ------------------------------------------------------------------------------------  
345286417          ------------------------------------------------------------------------------------  
38425095           ------------------------------------------------------------------------------------  
15235300           ------------------------------------------------------------------------------------  
297814081          ------------------------------------------------------------------------------------  
6682841            ------------------------------------------------------------------------------------  
255564236          ------------------------------------------------------------------------------------  
313770763          ------------------------------------------------------------------------------------  
3915037            ------------------------------------------------------------------------------------  
225437428          ------------------------------------------------------------------------------------  
162458268          ------------------------------------------------------------------------------------  
242035817          ------------------------------------------------------------------------------------  
115452927          ------------------------------------------------------------------------------------  
241896730          ------------------------------------------------------------------------------------  
304651490          ------------------------------------------------------------------------------------  
29289943           ------------------------------------------------------------------------------------  
115310620          ------------------------------------------------------------------------------------  
4468153            ------------------------------------------------------------------------------------  






4468151            ------------------------------------------------------------------------------------  
151176306          ------------------------------------------------------------------------------------  
14530225           ------------------------------------------------------------------------------------  
15239816           ------------------------------------------------------------------------------------  
297795665          ------------------------------------------------------------------------------------  
225431790          ------------------------------------------------------------------------------------  
255551835          ------------------------------------------------------------------------------------  
168009716          EGPEEKTETKARLGPGQAAIVGTPASA---------------------------------------------------------  
168035060          ------------------------------------------------------------------------------------  
168058907          ------------------------------------------------------------------------------------  
168029793          ------------------------------------------------------------------------------------  
94266940           ------------------------------------------------------------------------------------  
94264333           ------------------------------------------------------------------------------------  
297569306          ------------------------------------------------------------------------------------  
254416162          ------------------------------------------------------------------------------------  
332712456          ------------------------------------------------------------------------------------  
17232477           ------------------------------------------------------------------------------------  
75908500           ------------------------------------------------------------------------------------  
186682280          ------------------------------------------------------------------------------------  
119512682          ------------------------------------------------------------------------------------  
334117431          ------------------------------------------------------------------------------------  
218440696          ------------------------------------------------------------------------------------  
159031025          ------------------------------------------------------------------------------------  
220907171          ------------------------------------------------------------------------------------  
22298591           ------------------------------------------------------------------------------------  
158339122          ------------------------------------------------------------------------------------  
284053161          ------------------------------------------------------------------------------------  
209523126          ------------------------------------------------------------------------------------  
17228554           ------------------------------------------------------------------------------------  
75909957           ------------------------------------------------------------------------------------  
186685043          ------------------------------------------------------------------------------------  
119510624          ------------------------------------------------------------------------------------  
298489784          ------------------------------------------------------------------------------------  
220909283          ------------------------------------------------------------------------------------  
332708740          ------------------------------------------------------------------------------------  




SucSase sequences from P. patens subsp. patens (group IV) are clearly separated from 
those of vascular plants (Figure 35). Interestingly, groups V and VII are further divided in 
two major branches, containing the sequences from dicots (green) and monocots (blue), 
respectively. This separation is less clear in group VI (Figure 35). SucSase from N. 
europaea is in a small branch with other β-proteobacteria in group III (proteobacteria). 
Clearly, NeuSucSase is well separated from plant and cyanobacterial enzymes, though 
they share a significant similarity among all of them. For instance the identity between 
NeuSucSase and AthSucSase is 52.2% and between NeuSucSase and SucSase from T. 
elongatus is 48.5%. 
Protein Expression and Characterization 
The gene of the putative SucSase in N. europaea (NCBI Protein ID NP_841269) 
codes for 794 amino acids. To shed light on Suc metabolism of group III (Figure 35), we 
amplified this sequence and expressed the recombinant protein in E. coli cells. The 
enzyme was purified to homogeneity by HisTrap column and gel filtration 
chromatography as mentioned in “Materials and Methods”. The recombinant protein 
migrated in SDS-PAGE as a single band of ~95 kDa (data not shown), which is in good 
agreement with the predicted molecular mass of 93 kDa (including the His-tag provided 
by the pET28c vector). NeuSucSase eluted from the Superdex 200 (size exclusion) 
column as a protein of ~360 kDa (data not shown), suggesting a tetrameric quaternary 







Substrate Specificity of NeuSucSase 
SucSases from plants have shown a certain degree of promiscuity to transfer 
glucoses from ADP-Glc and UDP-Glc, though UDP-Glc is generally preferred. We tested 
the substrate specificity of SucSase from N. europaea in the Suc synthesis direction 
(Table 4), and observed that ADP-Glc is a more efficient substrate than UDP-Glc. The 
main difference is not given by Vmax, but by a higher apparent affinity towards ADP-Glc. 
The S0.5 for ADP-Glc is 0.044 mM in presence of optimal concentrations of Fru (20 mM); 
whereas the S0.5 for UDP-Glc is 0.98 mM in presence of optimal concentrations of Fru 
(500 mM). On the other hand, the apparent affinity for Fru is higher in presence of ADP-
Glc rather than UDP-Glc. The S0.5 for Fru at saturated concentrations of ADP-Glc is 5.6 
mM whereas the S0.5 for Fru in presence of UDP-Glc is significantly higher. Because of 
the high concentrations of Fru needed to reach saturation, it is not possible to measure the 
S0.5 for Fru with high precision; but it is at least ~20-fold higher (120 mM). The catalytic 
efficiencies calculated for ADP-Glc and Fru(ADP-Glc) were 17- and 37-fold higher than 
those obtained for UDP-Glc and Fru(UDP-Glc), respectively (Table 4). These results indicate 
that NeuSucSase prefers ADP-Glc over UDP-Glc as substrate. Similar conclusions were 
obtained for the enzyme from the cyanobacterium T. elongatus, which showed a 26-fold 












Table 4. Kinetic parameters for substrates of NeuSucSase in the direction of sucrose 
synthesis. Assays were performed using the conditions described in the “Materials and 
Methods” section. Analogous values to catalytic efficiency (Vmax/S0.5) were calculated 









 (mM-1 s-1) 
UDP-Glc 0.89 ± 0.05 4.3 ± 0.1 1.1 7.5 
ADP-Glc 0.044 ± 0.006 3.7 ± 0.1 1.3 130.3 
Fru(UDP-Glc) 120 ± 10 2.8 ± 0.2 1.3 0.036 
Fru(ADP-Glc) 5.6 ± 0.4 4.8 ± 0.2 1.6 1.33 
 
X-ray Diffraction, Data Processing, Model Building, and Refinement 
The best data set collected at synchrotron beamline was processed to 3.05 Å and 
indexed as space group P65. It was integrated and scaled producing good statistics (Table 
5). After the molecular replacement search, four copies of the starting model described in 
“Materials and Methods” were found in one asymmetric unit. Iterative cycles of model 
building and refinement were conducted yielding a well-defined structure for 
NeuSucSase with Rwork and Rfree values of 17.37 % and 21.75 %, respectively (Table 5). 
The truncated GT-B(D) domain was built according to the electron density map. The 
final structural model contains all the residues except the first three at the N-terminus and 





Figure 37. The crystal structure of NeuSucSase. A. Tetrameric structure of NeuSucSase. 
B. Monomeric structure and its four different domains: SSN-1, SSN-2, GT-B(A), and 
GT-B(D). 
 
Structural Analysis of NeuSucSase 
Overall structure. Although the resolution of the data set was 3.05 Å, the backbone of the 
protein and some of the key residues side chains were well defined by the electron 
density (Figure 38 and Figure 39). This allowed us to conduct detailed structural analysis 
on SucSase’s conformational changes involving backbone movement, which are relevant 
to the catalytic cycle. The crystal structure of NeuSucSase displayed a similar fold to the 
previously reported structural model of AthSucSase (PDB ID 3S29) 84. NeuSucSase is a 
tetramer composed of four identical subunits (Figure 36A), where each monomer 
contains four domains (Figure 36B). The first domain designated as “Sucrose Synthase 
N-terminal-1” (SSN-1) domain included residues 1-119 (Figure 36B, red) and contained 
five α-helixes and four β-strands. The second domain, which included residues 159-264, 





helixes. The third is the GT-B(D) domain (Figure 36B, cyan), which included residues 
514-742 with eight α-helixes and three β-strands. This domain functions in the GT-B 
family as the sugar donor (D) in catalysis 84, 86, 91. The fourth domain is the GT-B(A) 
domain (Figure 36B, blue), which consists of residues from three separate regions: 120-
158, 265-513, and 743-794. These separate regions are encompassed by the SSN-1, SSN-
2 and GT-B(D) domains in the center of the monomer. The GT-B(A) domain included 
nine α-helixes and eight β-strands and functions in the GT-B family as the sugar acceptor 
(A) in catalysis 84, 86, 91. Both the GT-B(D) and GT-B(A) domains directly facilitate the 
glycosyltransferase reaction 84.  
 
Figure 38. The NeuSucSase monomer structure is shown in backbone trace. The electron 
density (2Fo-Fc map at 1 sigma) is shown as mashes. The green portion of the electron 
density covers the GT-B (D) domain in the “open” position, while the cyan portion of the 






Figure 39. The “hinge”. The picture displays the hydrogen bond between W73 and G514. 
The electron density (2Fo-Fc map) is shown as blue mesh at 1.5 sigma level. 
 
The obtained NeuSucSase structure with no substrates bound has a clearly 
different overall conformation when compared to AthSucSase with UDP and Fru 84. This 
implies that substrate binding induces significant conformational changes (Figure 40). 
After superimposition of only the GT-B(A) domains of AthSucSase and NeuSucSase 
(using the least squares function in COOT), the SSN-1, SSN-2, and GT-B(A) domains 
from both structures overlapped well while the GT-B(D) domains were in a different 
relative position. The angle between the GT-B(A) and GT-B(D) domains in NeuSucSase 
was about 23.5 degrees wider than in the AthSucSase structure. Based on such 
comparison, we suggest that the NeuSucSase structure in this work was in an “open” 





structural determinants (hinges and latches) related to the movements of the sugar (GT-
B(A)) and nucleotide (GT-B(D)) binding domains. 
Sugar-binding GT-B(A) domain. Analysis of a difference distant matrix map of 
the Fru-binding GT-B(A) domain as described in “Materials and Methods” (Figure 41) 
highlights three main regions that move closer upon sugar binding. These are 325-375 to 
280-290 (~5 Å), 425-435 to 280-290 (~4 Å), and 425-435 to 325-375 (~3 Å) (Figure 41). 
Other pair of regions that move towards each other are 280-290 to 490-505 (~3 Å) and 
280-290 to 450-460 (~2 Å) (Figure 41). From this analysis, the area 280-290 is the most 
involved in an induced fit interaction with Fru. Further inspection of these areas reveals 
that Fru induces local conformational changes via superimposition of the GT-B(A) 
domains of the AthSucSase (closed) and the NeuSucSase (open) (Figure 42). These 
include the side chain of K431 and the backbone of residues 288-290. The re-shaping of 
the Fru binding site facilitates the closing via a set of inter-domain hydrogen bonds 
(Figure 42 in green). These local conformational changes along with the presence of Fru 





propose that Fru binding contributes to the induced fit closing of the structure. 
 
Figure 40. Comparison of the open and closed monomeric forms. The open form 
structure is represented by the NeuSucSase structure reported in this paper; the closed 
form is represented by the AthSucSase structure (PDB ID 3S29). The SNN-1, SNN-2 and 
GT-B(A) domains are shown in blue for the open form structure and in cyan for the 
closed form structure. The GT-B(D) domain is shown in magenta for the open form and 
in green for the closed form. The “hinge-latch” features of the domain movement are 








Figure 41. Difference distance matrix map of the GT-B(A) domain. Distances were 
calculated between all pair of Cα carbon of the open structure (NeuSucSase). A second 
pairwise distance matrix was calculated for the close structure (homology model of 
NeuSucSase using AthSucSase as template as described in “Materials and Methods”). 
Afterwards, these two matrices were subtracted, and the Δdistance was color coded. The 
negative and zero values are represented in white.  Red colors (higher Δdistance values) 
are pairs of Cα carbon that are getting closer upon closing of the enzyme. Only residues 






Figure 42. Overlap comparison of the fructose binding sites of the open (NeuSucSase) 
and closed (AthSucSase, PDB ID 3S29) structures. The carbon atoms in the closed form 
structure are in pale yellow. The carbon atoms in the open form structure are in cyan 
(GT-B(A) domain) and pink (GT-B(D) domain). Conserved residues between two 
structures are labeled with respective residue numbers; the residue numbers of the open 
form structure (NeuSucSase) are in parenthesis. The hydrogen bonds in the GT-B(D) 
domain are shown in black. The hydrogen bonds in between GT-B(A) and GT-B(D) 
domains and the ones in GT-B(A) domains are shown in green. 
 
 Nucleotide-binding GT-B(D) domain. The GT-B(D) domain binds to sugar 
nucleotide (synthesis direction) or nucleotide (cleavage direction) substrates. When 
overlapping GT-B(D) domains from both AthSucSase and NeuSucSase, residues 
interacting with the phosphate and ribose moieties of the nucleotides are not only 
conserved, but also at the same positions (Figure 43). On the other hand, two residues 
interacting with the nucleotide base are not conserved. Residues Q648 and N654 from 





creates a more spacious binding site in NeuSucSase, which may accommodate bulkier 
adenosine nucleotide substrates. Similar sequence differences were observed in the 
SucSase from T. elongatus 77. Based on sequence analysis and homology modeling it was 
suggested that these two residues could be responsible for the preference towards 
ADP/ADP-Glc over other nucleotides such as UDP/UDP-Glc in the cyanobacterial 
enzyme. It is important to notice that the side chains in R636 and A642 in NeuSucSase 
are not conserved in the E. coli Glycogen synthase, which is another glycosyltransferase 
that binds ADP-Glc 92. E. coli Glycogen synthase has a different motif in that position 
with a Tyr and Ser instead of Arg and Ala 86, 92, 93, implying a different structural 
arrangement for accommodating ADP-Glc. Overall, the nucleotide binding to the GT-
B(D) domain does not seem to trigger significant local conformational changes (Figure 
43). The direct interactions with the nucleotide do not make major contributions to the 






Figure 43. Overlap comparison of the nucleotide binding sites of the open (NeuSucSase) 
and closed (AthSucSase, PDB ID 3S29) structures. The carbon atoms in the closed form 
structure are in pale yellow. The carbon atoms in the open form structure are in cyan 
(GT-B(A) domain) and pink (GT-B(D) domain). Conserved residues between two 
structures are labeled with respective residue numbers; the residue numbers of the open 
form structure (NeuSucSase) are in parenthesis. The asterisks indicate the non-conserved 
binding residues with the closed form residues labeled in front of the ones in the open 
form structure.  
 
 Hinge Analysis. We scanned the structures of the acceptor and donor domains for 
hinges and subtle conformational changes that could be functionally important in 
catalysis. We used the in-house program hingescan described in “Materials and 
Methods”. Using several window sizes we detected several local conformational changes 





~515 and ~744 (Figure 45). These two elements actually form a single “hinge” that 
comprises a hydrogen bond between two conserved residues (G514 and W743) in a 
flexible area (Figure 40, Figure 39, and Figure 44). These two residues remain at the 
same position in both the open and the closed conformations of the enzyme. For smaller 
windows, we found other significant local secondary structure rearrangements (Figure 44,  
Figure 46, and Figure 45). Upon closing, two α-helices in the GT-B(D) domain are 
extended, and a β-strand replaces a previously coiled stretch. The outcome is a more 
ordered peripheric structure of the GT-B(D) domain. We propose that this secondary 
structure rearrangement, despite the local entropy decrease, would release extra energy to 
close the conformation facilitating the binding of substrates.  
 Latches. A feature that contributes to the stabilization of the closed form is a 
“latch”, E609, which comprises the highly conserved E609 residue located at the 
periphery of the GT-B(D) domain (Figure 37). Going from an open to a closed 
conformation, this glutamate residue moves ~11 Å towards the GT-B(A) domain and 
ends up hydrogen-bonded to two tyrosine residues (Y432 and Y446) stabilizing the 






Figure 44. Hinge analysis of NeuSucSase . Comparison between the open form and the 
modeled closed form of the enzyme was performed with the program hingescan as 
described in Materials and Methods. In the top panel, a color coded hinge score (0 to 
4.5 .) is plot for different window sizes at each residue. Three points are highlighted, A 
(control) and two hinge regions that are near in space (B and C). In all four panels (A, B, 
C, and B+C), maroon structures belong to the closed form, and yellow ones to 
the open form. Panel A shows optimal rigid body superposition of regions 307-357 of the 





The left, center and right overlaps are optimal rigid body superposition of the Cα of 
residues 489-539, 514-539, and 489-514, respectively. The center and right overlaps were 
performed to highlight the differences on the other half of the region. Spheres represent 
center residue 514.Panel C displays regions 718-768 of both the close and open form. 
The left, center and right overlaps are optimal rigid body superposition of the Cα of 
residues 718-768, 718-743, and 743-768, respectively. The center and right overlaps were 
performed to highlight the differences on the other half of the region. Spheres represent 
center residue 743. Panel B+C shows both regions (489-539 and 718-768), in 





Figure 45. Hinge analysis by comparison of the open v. closed conformations. The blue 
and red show the “hinge score” using 51 and 9 windows, respectively. The magmata dots 
(also point with black arrows) shows the two distinct hinges: G514 and W743. The 








Figure 46. Secondary structure rearrangement during conformational changes between 
open and closed structures of bacterial SucSases. A. Open conformation of the 
NeuSucSase structure. B. Closed conformation of the AthSucSase structure (PDB ID 
3S29). The GT-B(D) domain and a long bending helix is show in orange. The SNN-1, 
SNN-2, and GT-B(A) domains are in grey. The side chains of the residues in the “latch” 
and the “hinge” are shown as green sticks. The secondary structural rearrangement is 
shown in magenta. T 
Figure 47. The open “latch”. E609, Y446 and Y432 are shown in sticks. The electron 
density (2Fo-Fc map) is shown as blue mesh at 1.0 sigma level around there key residues. 
Local secondary structure fetures are shown in cartoon style. 
 
 
rearrangements in the vicinity of this latch, which could facilitate the interaction between 









the latch described, there is a hydrophobic patch that contributes to seal the closing 
(Figure 48). Two hydrophobic residues (M635, L637) in the GT-B(D) domain get in 
contact with a hydrophobic cluster (V281, L282 and L284) in the GT-B(A) domain, upon 
closing. The side chain of N280 also provides a methylene to build a non-polar pocket 
that latches on to M635 and L637 (Figure 48). On the other hand, the amide polar group 





Figure 48. Hydrophobic residues contribute to the latch action. Panel A depicts the open 
(NeuSucSase crystal structure) and B a homology model of a closed structure, which was 
built as described in the “Materials and Methods” section. Upon closing, the hydrophobic 
residues: M635, L637 in the GT-B (D) domain and N280, V281, L282 and L284 in GT-
B(A) domain generate a hydrophobic environment that stabilize the close action.  
 
 The closed structure seems to induce stronger interactions with the nucleotide and 
vice versa. In NeuSucSase, the conserved E671 is in the same position as E369 in the E. 
coli trehalose-6-phosphate synthase (OtsA) 92, 94. In OtsA, as well as in the close 
conformation of AthSucSase (E683), the carboxylate of this side  chain forms two  
hydrogen bonds with the hydroxyl groups of the ribose of the nucleotide. In these 












T668 in NeuSucSase, Y533, Y658, L679 and T680 in AthSucSase), which makes the 
hydrogen bonds stronger in the non-polar environment. In the open form of the 
NeuSucSase structure, V291 (V306 in AthSucSase) moves away from the side chain of 
the glutamate residue (Figure 49). This implies that the closing recruits a non-polar side 
chain to completely surround the carboxylate. Consequently, nucleotide binding 
stabilizes he carboxylate charge and facilitates the interaction with V291 upon closing.   
Interestingly, in another glycosyltransferase such as bacterial glycogen synthase, E671 
has been replaced by a Tyr, and V291 was replaced by Asp, thus, switching their roles 92. 
Therefore, this ligand-dependent interaction may be a common feature in this family of 
enzymes. 
Site Directed Mutagenesis of Critical Residues  
Previously, important residues for catalysis were identified in other retaining GT-
B glycosyltransferases. A triad of critical residues has been found in the active site of 
maltodextrin phosphorylase 95, 96 and glycogen synthase from E. coli 97. Based on X-ray 
structures, these residues were also predicted to be important for catalysis in OtsA 94 and 
AthSucSase 84. The homologue residues in NeuSucSase are R567, K572, and E663 
(Figure 50). When any of those residues were replaced by alanine the activity in the 
direction of Suc synthesis severely decreased, either in presence of ADP-Glc or UDP-Glc 
(Table 6). The most active of all these mutants was E663A in presence of ADP-Glc, but it 
was still 200-fold less active than the wild type. These results indicate that this triad is 





other retaining glycosyltransferases with a GT-B fold share the same reaction mechanism  
(Figure 50). 
 
Figure 49. Conserved hydrophobic residues are involved in substrate binding in both 
open conformation of NeuSucSase (A and B), and closed conformation of AthSucSase 
(PDB ID: 3S29) (C and D). In the open conformation, V291, E691 two conserved 
hydrophobic residues are shown in sticks in figure A, and V291, Y520, Y646, L667, 
T668 (rotate 90 degree from A) are shown in sticks in figure B. In the closed 
conformation, V 306 and E 683 are conserved hydrophobic residues in figure C, and 
V306, Y533, Y658, L679 and T680 (rotate 90 degree from C) are shown in sticks in 






Figure 50. Three highly conserved catalytic residues in different members of the retaining 
GT-B glycosyltransferase family. The structures analysed in this figure are maltodextrin 
phosphorylase (PDB ID 1E4O), trehalose-6-phosphate synthase (PDB ID 1GZ5), and 
glycogen synthase (PDB ID 2ZQS) from E. coli, AthSucSase (PDB ID 3S29), and 



















Table 5. Data collection and refinement statistics for NeuSucSase 
Data Processing  
Space group P65 
Cell dimensions  
a; b; c (Å) 236.90; 236.90; 231.44 
α; β; γ (°) 90.00; 90.00; 120.00 
Resolution (Å) 3.05 
Mosaicity (°) 0.47 
aRmerge 0.169 (0.963) 
I/sigma 9.6 (2.1) 
Completeness 97.9 (98.6) 
Multiplicity 6.3 (6.3) 
Refinement  
Resolution (Å) 3.05 
No. reflections 794715 
No. unique reflections 126170 
bRwork/cRfree 17.37/21.75 
dRMSD Bond length (Å) 0.009 
RMSD Bond angle (°) 1.439 
 
The values for the highest resolution bin are in parentheses.  
aLinear Rmerge = Σ|Iobs-Iavg|/ ΣIavg 
bR = Σ|Fobs-Fcalc|/ ΣFobs.  
cFive percent of the reflection data were selected at random as a test set and only these 
data were used to calculate Rfree. 





Table 6. Activity of wild type and mutants of NeuSucSase. Assays were performed using 





WT R567A K572A E663A 
UDP-Glc 4.3 ± 0.1 < 0.0017 < 0.0019 < 0.01 
ADP-Glc 3.7 ± 0.1 < 0.0014 < 0.0016 0.020 ± 0.02 
 
Materials and Methods 
Materials: Chemicals and coupled enzymes used for activity assays were from 
Sigma-Aldrich (St. Louis, MO). Escherichia coli BL21 (DE3) cells were purchased from 
New England BioLabs (Ipswich, MA). Bacterial growth media and antibiotics were from 
Fisher Scientific (Pittsburgh, PA) and Sigma-Aldrich. Crystallization screen solutions 
and other supplies were purchased from Hampton Research (Aliso Viejo, CA) and 
Emerald Bio (Bedford, MA). All the other chemicals were of the highest quality 
available. 
Cloning: The sequence coding for NeuSucSase was amplified by PCR using 
genomic DNA from N. europaea ATCC 19718 as template, the specific oligonucleotides 
CATATGACCACGATTGACACACTCGCCACCTGTACCC (forward, NdeI site 
underlined) and GTCGACTCATATCTCATGGGCCAGCCTGTTTGCCAGCGGCC 
(reverse, SalI site underlined) as primers, and Phusion HF DNA polymerase (Thermo 
Fisher Scientific, Rockford, IL) following the manufacturer’s instructions. The program 
used included an initial denaturation of 30 s at 98 °C; 30 cycles of 98 °C for 5 s, 50 °C 
for 20 s, and 72 °C for 2 min; and a final extension of 72 °C for 5 min. The PCR product 





the StrataClone Blunt PCR cloning kit (Agilent Technologies, Santa Clara, CA). 
Sequence identity was checked by automated DNA sequencing at CRC (Comprehensive 
Cancer Center at University of Chicago, IL). Afterwards, the sequence was subcloned 
into the pET28c vector (Merck KGaA, Darmstadt, Germany) between NdeI and SalI sites 
to obtain pNESS1, which is the plasmid that encodes the recombinant NeuSucSase with 
an N-terminal His6-tag. 
Site-directed mutagenesis: Site-directed mutagenesis was performed by PCR 
overlap extension as previously described using Phusion DNA polymerase 98, 99. Plasmid 
encoding the NeuSucSase (pNESS1) was used as a template for mutagenesis.  
To introduce mutations in the sequence coding for NeuSucSase we used the following 
primers: TTTACCATGGCGgcgCTGGATCGGATC (forward) and 
GATCCGATCCAGcgcCGCCATGGTAAA (reverse) for mutant R567A; 
CTGGATCGGATCgcgAACATTACCGGC (forward) and 
GCCGGTAATGTTcgcGATCCGATCCAG (reverse) for mutant K572A; and 
CCAGCCCTGTTCgcgGCATTCGGCCTG (forward) and 
CAGGCCGAATGCcgcGAACAGGGCTGG (reverse) for mutant E663A. PCR 
conditions were the same as those described above. Flanking primers for the PCR overlap 
extension were the same used for cloning (described above). All mutations were 
confirmed by DNA sequencing. 
Protein expression and purification: Transformed E. coli BL21 (DE3) cells with 
pNESS1 were grown in 4 x 1 L of LB supplemented with 100 µg/ml carbenicillin. This 





~0.6. Protein expression was induced by the addition of 0.5 mM isopropyl-β-D-1-
thiogalactopyranoside. Cells were incubated at 25 °C and harvested after 16 h by 
centrifuging at 5000 x g and 4 °C for 15 min. The cell paste was resuspended in Buffer C 
[20 mM Tris-HCl pH 8.0, 200 mM NaCl, 5% (v/v) glycerol, 10 mM imidazole] and 
disrupted by sonication. The resulting suspension was centrifuged twice at 30000 x g and 
4 °C for 15 min and the soluble fraction (crude extract) was loaded onto a 5 ml HisTrap 
column (GE Life Sciences, Piscataway, NJ) containing Ni2+ and previously equilibrated 
with Buffer C. Elusion of the retained proteins was achieved with a linear imidazole 
gradient (20 column volumes, 10-300 mM). Fractions containing SucSase activity were 
pooled, concentrated to 2 ml, and loaded onto a 16/60 Superdex 200 column (GE Life 
Sciences) previously equilibrated with 50 mM HEPES-NaOH pH 8.0 and 300 mM NaCl. 
Fractions containing enzyme activity were pooled, concentrated, supplemented with 5% 
(v/v) glycerol, and stored at -80 °C until use. Under these conditions the enzyme 
remained stable and fully active for at least 3 months. 
Protein assay and detection: Protein concentration was determined by measuring 
the protein absorbance at 280 nm using a NanoDrop 1000 (Thermo Fisher Scientific) and 
an extinction coefficient of 1.153 ml mg-1 cm-1, determined from the amino acid sequence 
using the ProtParam server (http://web.expasy.org/protparam/). Denaturing protein 
electrophoresis was performed as described by Laemmli 100. 
Enzyme assays: Activity assays were performed as previously described 77, with 
minor modifications. In the direction of Suc synthesis, the reaction medium contained 50 





phosphoenolpyruvate, 0.3 mM NADH, 1 U pyruvate kinase, 1 U lactate dehydrogenase, 
0.2 mg ml-1 BSA, and enzyme in an appropriate dilution in a final volume of 50 µl. 
Alternatively, activity was measured with 1 mM ADP-Glc and 20 mM Fru. NADH 
oxidation was followed by measuring the absorbance at 340 nm in a Multiskan Ascent 
microplate reader (Thermo Fisher Scientific) at 37 °C. One unit of enzyme activity (U) is 
defined as the amount of protein necessary to produce 1 µmol of product in 1 min under 
the specified conditions. 
Kinetic characterization: Data of initial velocity (v) versus substrate 
concentration (S) were plotted and fitted to a modified Hill equation: v = Vmax SnH / (S0.5nH 
+ SnH), where S0.5 is the concentration of substrate necessary to obtain 50% of the 
maximal velocity (Vmax) and nH is the Hill coefficient. Fitting was performed by a non-
linear least-squares algorithm provided by the software Origin 7.0 (OriginLab 
Corporation). Kinetic parameters were obtained using the averages of two independent 
datasets that were reproducible within errors of ± 10%. 
Phylogenetic analysis: We searched for protein sequences using the term “sucrose 
synthase” and the RefSeq filter in the National Center for Biotechnology Information 
(NCBI) database. Sequences were analyzed with the program BioEdit 7.0.5.3 101, 
manually curated, and aligned using the ClustalW server 
(http://www.genome.jp/tools/clustalw/). Tree reconstruction was performed using the 
Neighbor-Joining algorithm with a bootstrap of 1000 in the program SeaView 4.4.0 102. 






Crystallization and data collection: After the initial crystallization screen and 
optimization, the recombinant protein was crystallized via the hanging drop method. The 
hanging drops were prepared with 1 µl of 15 mg ml-1 NeuSucSase protein solution and 1 
µl of the reservoir solution, containing 5% Tacsimate pH 5.0, 5% (w/v) PEG 3350, and 
0.1 M sodium citrate pH 5.6. The hanging drops were kept at 20 °C for crystallization. 
Crystals appeared in 3 days and were allowed to continue growing at 20 °C for 4 more 
days until they reached their maximum sizes. Crystals with good morphology and large 
sizes were transferred to a cryo-condition, which contained 25% glycerol in addition to 
the components of the reservoir solution, before being frozen in liquid nitrogen.  
X-ray diffraction data sets were collected at the SBC19-ID beamline at the Advanced 
Photon Source (Argonne National Laboratory, Chicago, IL). The wavelength used in the 
monochromatic data collection was 1.008 Å. All the collected data sets were indexed and 
integrated using iMosflm and scaled with Scala in the CCP4 program suite (Collaborative 
Computational Project Number 4) 103. The resolution cut-off was decided by applying all 
following criteria on the highest resolution bin: i) I/Sigma > 2, ii) completeness > 90%, 
and iii) Rmerge < 1.0. 
Phasing, model building, and refinement: Molecular replacement was carried out 
using the program Phaser 61 from the CCP4 program suite. The starting search model in 
molecular replacement was modified from the known A. thaliana SucSase structural 
model (PDB ID: 3S29) 84. We truncated the GT-B(D) domain (cyan domain in Figure 
36B) and used the rest of the molecule as the search model for molecular replacement in 





GT-B(D) domain was built according to the electron density maps. Rigid body 
refinement and restrained refinement were conducted in refmac5 104. In order to remove 
model bias and achieve the best refinement results possible, simulated annealing 
refinement and ordered solvent identification were conducted using PHENIX.refine 44. 
Final model and the structure factor have been deposited in the RCSB Protein Data Bank 
with the accession code 4RBN. 
Homology modeling: A model of the monomeric closed form of NeuSucSase 
(residues 16 to 788) was constructed with the program Modeller 9.11 
(http://salilab.org/modeller/) 105. As template we used the atomic coordinates of the A. 
thaliana sucrose synthase (3S27) with the ligands UDP and fructose 84. Before the 
modeling process, sequence alignment was performed manually to match functionally 
conserved residues and secondary structures. An identity of 52.2% ensured a high 
confidence alignment since we only had to introduce four one-residue indels. The 
accuracy of the models was assessed with the Verify3D Structure Evaluation Server 
(http://nihserver.mbi.ucla.edu/Verify_3D/) 106. 
Difference distance matrix map: We used and ad hoc program written in C 
applying previously developed concepts to detect domain motion and identify regions 
that move closer upon conformational changes 107.  Distances were calculated between all 
pair of Cα of one reference structure (open), and a second pairwise distance matrix was 
calculated for the target (closed) structure. Afterwards, the target matrix was subtracted 






Hinge analysis: In order to detect possible local conformations or hinges, we 
performed an analysis with the ad hoc program “hingescan” 
(https://github.com/ballicoragroup/hingescan).  We compared the open crystal structure 
of NeuSucSase with a NeuSucSase homology model based on the template provided by 
the close structure of the AthSucSase. To detect if there is a significant local 
conformational change around a given residue (“hinge”), we extracted the coordinates of 
a given number (n) of Cα before the putative hinge and the same given number (n) of 
residues after (window size = 2n+1). This was done for both the open and closed forms 
and obtained two fragments to compare. After optimal rigid body superposition of only 
these two set of coordinates, an average distance was calculated (RMSD). This RMSD 
calculated in these conditions was called the “hinge score”. When this score is at a peak, 
the “flanking” n number of Cα at both sides display a maximum change between the two 
structures. For that reason, a hinge is detected. The bigger the window, the bigger the 
domain movement is detected surrounding the hinge. To identify hinges that link small 







We analyzed the sequences of SucSases from divergent organisms, including 
proteobacteria, cyanobacteria, and plants. The obtained phylogenetic tree shows that 
sequences from proteobacteria (including the one from N. europaea) are clearly separated 
from those present in cyanobacteria and plants. To the best of our knowledge, SucSases 
from proteobacteria have never been characterized. In this work, we expressed, purified 
the recombinant NeuSucSase, and solved its crystal structure. In addition, our analysis 
provided evidence for a proposed “open” conformation for SucSases. Based on the 
comparison with a previously published “closed” AthSucSase structure 84, a “hinge-latch” 
combination was identified as critical features responsible for the open-close enzyme 
actions.  
We also mutated three highly conserved amino acids proposed to be critical for 
catalysis. These mutations severely reduced the activity of NeuSucSase; therefore, we 
conclude that the triad composed of residues R567, K572, and E663 (numbers according 
to NeuSucSase) plays a key role for catalysis not only in SucSases, but probably also in 
all the retaining GT-B glycosyltransferases 84, 94-97. 
With both structural and kinetic results we propose that NeuSucSase has a 





similar to the one observed for T. elongatus SucSase 77. It was proposed that the 
difference in specificity towards the nucleotide substrate in the cyanobacterial enzyme 
could be due to changes in two specific residues, R647 and S653 (Q648 and N654 in 
AthSucSase). Interestingly, we found that NeuSucSase presents similar evolutionary 
variances to those observed in T. elongatus SucSase: R636 (R647) and A642 (S653). 
Residues Q648 and N654 from AthSucSase are strictly conserved in plants and the moss 
P. patens, whereas they are more variable in cyanobacteria and proteobacteria. Based on 
this finding and taking into account kinetic and structural data obtained for SucSases 
from T. elongatus 77, AthSucSase 84 and NeuSucSase (this work), we hypothesize that 
these residues may contribute to determining the specificity towards the nucleotide 
substrate. 
The evolutionary origin of enzymes from Suc metabolism in proteobacteria has 
been previously discussed 65, 66, 69. The evolution of SucSases in cyanobacteria, 
proteobacteria, and plants is not yet fully understood, but most likely it involved 
horizontal gene transfers. On one hand, NeuSucSase is closer to plant enzymes in the 
phylogenetic tree (Figure 35), but on the other hand, the specificity for nucleotides is 
similar to several cyanobacterial enzymes examined 69, 77. It is possible that NeuSucSase 
evolved from a protein already present in the common ancestor of proteobacteria and 
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